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Background: The loss of balance between components of body composition is significantly 
linked to a wide range of adverse clinical outcomes. Whilst the sharp rise in the rate of 
adiposity-based chronic diseases has caused substantial health concerns across the globe, 
sarcopenia has emerged as an important risk factor for increased morbidity and mortality 
among the aging population. Therefore, assessment of body composition phenotypes using 
the conceptual model of metabolic capacity and metabolic load enables an insightful 
evaluation of metabolic homeostasis association with health outcomes. Nevertheless, the 
evidence on such associations in the adult population is still lacking.  
Objectives: To examine the relationship of anthropometric measures with total and 
segmental adiposity and muscularity; to investigate variations of blood pressure across body 
composition phenotypes; to explore the interaction effect of fatness and leanness on lung 
function, and to evaluate bidirectional association of lung function and blood pressure. 
Study design and subjects: This project was a cross-sectional study of fifty healthy adults 
(22 men, 28 women) aged 19-65 years old. Anthropometric, body composition (Tanita MC-
980 and InBody 720 segmental multifrequency bioelectric impedance analysers, and the 
BODPOD air displacement plethysmography system), blood pressure (OMRON M7 
automated oscillometric monitor), grip strength (Takei 5001 analogue dynamometer) and 
spirometric (COSMED Quark PFT) measurements were carried out in Nutrition Physiology 
Laboratory at London Metropolitan University from 2016 to 2018. 
Statistical analysis: Moderation analyses of the associations between body composition, 
blood pressure and lung function were conducted by the PROCESS modelling tool for SPSS 
Results: None of the anthropometric measures were exclusively related to muscle mass.  
Neck circumference (NC) and upper arm circumference (AC) were the strongest and a body 
shape index (ABSI) was the only negative predictor of total and segmental muscularity in 
the entire population. Also, waist to height ratio (WHtR), waist circumference (WC), waist 
to hip ratio (WHR) and body mass index (BMI) were all strong correlates of total, truncal, 
visceral and upper arm fatness. None of the anthropometric measurements showed moderate 
or strong correlations with lower limb fatness. Fat mass (FM) to fat-free mass (FFM) ratio 
was only significantly associated with diastolic pressure (DBP) (ꞵ=17.6, p<0.001) whereas 
truncal FM (TFM) to appendicular skeletal muscle mass (ASM) ratio was associated 
significantly with systolic pressure (SBP) (ꞵ=15.94, p<0.01), DBP (ꞵ=27.47, p<0.001) and 
pulse pressure (ꞵ=-11.38, p<0.01). Stature-normalised truncal and appendicular adiposity 
(TFMI, AFMI) impaired lung function (FEV1, FVC and FEF25-75%) respectively at high 
levels of truncal and appendicular muscularity (TSMI, ASMI). The negative impact of 
whole-body (high FM/FFM) and segmental (high TFM/ASM) metabolic overload on 
expiratory flow rate (FEV1) was respectively conditioned on low DBP and high SBP (ꞵ=-
.104, p<0.01, ꞵ=-.163; p<0.001). Negative effect of increased FM/FFM and TFM/ASM on 
FEV1 and FVC was also operable at high levels of grip strength. There was a bidirectional 
association between lung function and systemic blood pressure. SBP and DBP were 
independently and negatively associated with FEV1 (ꞵ=-.011 and -.019; p<0.001) and FVC 
(ꞵ=-.011 and -.022; p<0.001). FEV1 and FVC demonstrated inverse associations with SBP 
(standardised ꞵ=-.38 and -.30; p<0.001) and DBP (standardised ꞵ=-.35 and -.40; p<0.001). 
Notably, the effect of FEV1 and FVC on SBP was operated at higher levels of visceral 
adiposity whilst their influence on DBP was conditioned on higher levels of FFMI. 
Conclusion: Whole-body and segmental metabolic homeostasis, pulmonary function and 
systemic blood pressure are complexly cross-linked. Therefore, phenotyping the individuals 
with or at risk of respiratory diseases and/or cardiometabolic disorders by their total and 
regional body composition, spirometric, and haemodynamic characteristics may result in 
more accurate risk stratification, personalised care and effective management strategies, 
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Cardiovascular and respiratory diseases are leading causes of death and disability 
around the world. Annually, 3 million people die from chronic obstructive 
pulmonary disease. More than 25% of the world’s population has high blood 
pressure while more than 300 million people suffer from asthma. Also, hypertension 
is the main modifiable risk factor for heart disease and stroke. Thus, hypertension 
and lung disease are substantial public health issues. Contemporaneously, the 
epidemic of obesity and the growing prevalence of sarcopenia have raised serious 
health concerns across the globe. Deviations from normal body composition and 
metabolic balance have been recognised as the important contributors to the 
development and/or worsening of cardiopulmonary disease; however, the 
mechanisms linking these entities are poorly understood and the complex cross-talk 
between body composition, respiratory capacity, and vascular function in health and 
disease warrants extensive research. The present research aims to probe these links 
using a phenotypic approach to provide an informative baseline for future 
exploration of the interactions among metabolic homeostasis and cardiorespiratory 

















Over a period of 50 years, the rapid pace of modernisation coupled with the 
advances in healthcare and standards of living have improved longevity and the 
quality of life across the globe. These advantages have been achieved at the cost of 
widespread lifestyle diseases. Such a broad range of chronic conditions may be 
caused or intensified by the potentiating interactions of excessively stored fat 
(obesity), as well as progressively diminished muscle mass and strength 
(sarcopenia), collectively termed “sarcobesity” (Parr, Coffey and Hawley, 2013). 
 
1.1 Globesity  
Obesity and being overweight, usually classified by a set of anthropometric 
measures, is now considered by many professional bodies as a chronic relapsing 
progressive disease arising from the pathologic alterations in the quantity, 
distribution and function of adipose tissue in genetically predisposed and/or 
environmentally influenced individuals, that can have a damaging impact on 
multiple organ systems, leading to a wide range of potentially debilitating 
complications  (Jensen et al., 2014; Frühbeck et al., 2019). As demonstrated in the 
Diabetes Prevention Programme and Outcomes Study (DPPOS) and Look AHEAD 
(Action for Health in Diabetes) Trial, the long-term change in the body mass index 
(BMI) of the control groups with or at risk of type II diabetes who had elevated BMI 
levels at baseline was not significant. Besides, a large proportion of the weight lost 
in short-term in the lifestyle intervention groups was regained after a few years 
(Venditti et al., 2008; Look AHEAD Research Group, 2013). 
The rate of obesity has been rising sharply over the past few decades, making it one 
of the most important global public health issues of the new century. Since 1975, the 
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number of men and women with obesity has respectively increased by three and two 
folds.  According to the latest World Health Organisation (WHO) report on obesity 
and overweight, approximately 40% of the world’s adult population had excessive 
body mass in 2016, with obesity affecting more than 650 million adults over 18 
years of age. The United Kingdom, with an obesity rate of 27%, ranks sixth in the 
world and is the second European country with the highest prevalence of obesity 
(OECD, 2017). In England alone, more than 60% and 50% of adult men and women 
have excess weight, respectively. The situation is similar in Scotland and Wales 
where more than one quarter of adults are obese (Conolly et al., 2017). It is 
estimated that by 2025, 1 in 5 adults around the world will have obesity. A third of 
men and women living in the UK would probably be affected by this chronic 
condition if the present trend continues (Di Cesare et al., 2016). Knowing this 
progressive ascent, it seems impossible to attain the targets set by the UN to stop 
global rise in obesity by 2025 ( World Health Organisation, 2015). 
Excessive adiposity exerts unfavourable effects on health, quality of life, and life 
expectancy of individuals. The most widely known co-morbidities of increased fat 
accumulation may fall into the following 10 domains: insulin resistance (IR) and 
type 2 diabetes (T2DM), cardiovascular disease (CVD), airway and pulmonary 
disease, gastrointestinal and liver disease, functional limitations, cancer, renal 
disease, musculoskeletal disorders, mental health status and body image. Among 
these, CVD and malignancies are the major contributors to the obesity-related 
mortality (Abdelaal, le Roux and Docherty, 2017). There is, however, a curvilinear 
relationship between commonly applied measures of obesity (body weight or body 
mass index) and a large proportion of adiposity-related pathologic states. 
Prospective Studies Collaboration report on the large-scale analyses of long-term 
follow-up data from almost 900,000 people demonstrated that, above the range of 
22·5–25 kg/m² and adjusting for smoking, overall mortality as well as cause-specific 
mortality were significantly associated with overweight and obese categories of 
body mass index (BMI). For each 5-unit increase in BMI, all-cause mortality rose by 
approximately 30% while mortality from diabetic, renal, vascular, respiratory, and 
neoplastic causes increased by 120%, 60%, 40%, 20%, and 10%, respectively. 
Below this range, there was a strongly negative association between BMI and deaths 
from those causes except for ischaemic heart disease (MacMahon et al., 2009). 
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Globesity would have inevitable impacts on the health and economy of the world. 
Given the above-mentioned trends, the projected health burden of the obesity 
epidemic in the UK and the USA by 2030 would add, on average, an excess of 7.2 
million cases of diabetes, 6.5 million of coronary heart disease (CHD) and 
cerebrovascular accident (CVA), and more than 0.5 million cases of cancer, in 
addition to an average loss of 40 million quality-adjusted life-years (QALYs) in both 
countries combined. The healthcare expenditure attributable to adiposity-related 
conditions are projected to approach £2 billion excess annual spending in the UK by 
2030 (Wang et al., 2011). 
From a clinical perspective, the term obesity is being replaced by the 
pathophysiologically more relevant, diagnostically useful and non-stigmatic term, 
adiposity-based chronic disease (ABCD) which conceptualises obesity as a chronic 
disease. This implies the longstanding disequilibrium between adaptive and 
maladaptive complex biological responses that underlie insidiously progressive 
derangements in the quantity, distribution, and functional status of body fat mass. 
Moreover, it avoids the ambiguities and inadequacies of a body mass index-centric 
definition of obesity and the stigma attached to it in the public domain (Mechanick, 
Hurley and Garvey, 2017). 
Incorporating these three major features of adiposity into a complication-centric 
model creates a scientifically robust link between biological drivers of adiposopathy, 
their physical and non-physical contextual modifiers, and the adverse sequela of 
excess adiposity (Mechanick, 2016). 
This new comprehensive approach promotes the application of anthropometric as 
well as more advanced body composition technologies (e.g. bioelectrical impedance 
analysis, air displacement plethysmography, hydrodensitometry, or dual-energy X-
ray absorptiometry scan) in the evaluation of obesity (Garvey et al., 2016). 
 
1.2 Sarcopenia  
Parallel to the rapid upsurge in the global rate of obesity and its complications, age-
related decline in the quantity and quality of skeletal muscle, underpinned by the 
improved life expectancy and increased sedentariness, has emerged as a challenging 
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health concern which threatens the future of the ageing population all over the 
world. Given the ascending trend in the median age of the world’s population, it is 
estimated that the number of elderly people would be tripled by 2050 (WHO, 
2015b). As reflected in the Foresight report, the proportion of UK adults aged 60 and 
above will be growing steadily until 2040, amounting 22 million people (Foresight, 
2016). In total, adults older than 40 may experience an average muscle mass loss of 
40% and 1 to 3% annual decline in functionality over the course of their lives 
(Doherty, 2003; Toran et al., 2012). The age-related progressive decline in skeletal 
muscle mass and strength, widely known as sarcopenia, is defined by the European 
Working Group on Sarcopenia in Older People (EWGSOP) as low muscle mass, 
low muscle strength and/or low physical performance based on sex-specific cut-off 
points (Cruz-Jentoft et al., 2014). According to consensual definitions, worldwide 
prevalence of sarcopenia is about 10% in healthy men and women 60 years old and 
above (Shafiee et al., 2017). In 2010, over 50 million people were estimated to be 
sarcopenic. This figure is projected to increase more than fourfold by 2050 (Cruz-
Jentoft et al., 2014). A secondary analysis of the Hertfordshire Sarcopenia Study 
(HSS) shows that 5 to 8% of free-living older adults in the UK are affected by 
sarcopenia (Patel et al., 2013). 
Sarcopenia imposes considerable burden on the health and well-being of the elderly. 
Primary(age-related) and secondary (activity, disease or nutrition-related) 
sarcopenia, especially combined with frailty and/or cachexia have deleterious 
impacts on morbidity, mortality, length of admission, quality of life, mobility, and 
physical performance of the individuals. Overall, sarcopenic individuals have 3 to 4 
times higher adjusted risk of functional limitation, mortality, falls and fractures. 
Likewise, the length of hospital-stay and the incidence of hospitalization are 
increased 1.5fold in sarcopenic men and women (Beaudart et al., 2017). 
 
1.3 Sarcobesity 
Deleterious effects of obesity and sarcopenia can compounded into a distinct 
phenotype called sarcopenic obesity (SO).Depending on the definition criteria, the 
age and gender adjusted prevalence of SO varies between 4 to 12% (Baumgartner, 
2000; Zoico et al., 2004). Reduced skeletal muscle mass and dysfunctional striated 
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muscle fibres coupled with the abnormalities in the number, size, distribution, and 
function of adipocytes can synergistically deteriorate physical functioning, 
cardiometabolic risk profile, and all-cause mortality of those with SO compared to 
individuals who are either obese or sarcopenic (Shao et al., 2017). In the British 
Regional Heart Study, SO men older than 60 years (classified using waist 
circumference (WC) and midarm muscle circumference (MAMC) cut-offs), had 
significantly higher excess risk of all-cause mortality as compared to those with 
obesity, sarcopenia, and optimal WC and MAMC distribution, even after adjustment 
for lifestyle variables and established cardiovascular risk factors. Nevertheless, the 
risk of CHD or CVD was not elevated in this group (Davison et al., 2002). 
As a risk factor for hypertension, coexistence of low muscle mass and central 
adiposity seem to outpower sarcopenia or obesity alone. An analysis of Korea 
National Health and Nutrition Examination Survey (KNHANES) found that Korean 
adults with SO, defined by WC and the appendicular skeletal muscle mass (ASM) to 
body weight (ASM/Wt) ratio, had 6 times higher risk of essential hypertension than 
those without sarcopenia and obesity. Further, the chance of becoming hypertensive 
was 2 and 3 times higher in the sarcopenic obese phenotype compared with obese 
and sarcopenic phenotypes, respectively (Park et al., 2013). 
Sarcopenia is also a prevalent finding in patients with chronic obstructive pulmonary 
disease (COPD) with detrimental impact on their lung function, exercise 
performance, and cardiometabolic risk profiles. However, concomitant central 
obesity appears to counteract the negative effects of skeletal muscle loss and 
dysfunction on physical functioning and exercise capacity in the SO phenotype of 
COPD (Van De Bool et al., 2015). 
Given the critical role of deviations from normal body composition in the 
development, continuation, and deterioration of abnormal health conditions and 
morbid entities, it seems prudent to examine the main and interactive effects of fat 
mass (FM) and fat-free mass (FFM) on a wide array of health outcomes in the form 
of discrete body composition phenotypes and subclassifications. If applicable, these 
phenotypes should be defined according to age, sex, and ethnicity-specific cut-points 
as well.  
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In view of the recent shifts towards the integrated use of objective measures of 
adiposity and skeletal muscle dysfunction in the evaluation of lifestyle-related 
adverse end-points, many studies have used a phenotypic approach to investigate the 
influence of body composition status on musculoskeletal health, cardiometabolic 
health, aging, and survival rate in different subpopulations. (Waters et al., 2010; 
Dufour et al., 2012; Chung et al., 2013; Rossi et al., 2016).  Nonetheless, these 
studies have been mainly conducted on geriatric groups and only few of them have 
addressed confounder-adjusted interaction of total and regional fat and lean mass on 
the baseline parameters of pulmonary and vascular function (Van Pelt et al., 2002; 
Olsen et al., 2005; Beckett et al., 2010; Scott et al., 2012; Park et al., 2013, 2014). 
Also, there are scarce data on the compartmental contribution of body composition 
to the variations in health outcomes among otherwise healthy active young adults, 
especially in conjunction with their physical functioning. In addition, the influence 
of general, visceral, and appendicular body composition ratios over 

















To address the preceding gaps in the literature, the present research utilises body 
composition phenotyping of otherwise healthy adults in the context of a metabolic 
load – metabolic capacity model to elucidate the following topics: 
• Differential utility of anthropometric measurements as the indicators of total 
and segmental body composition. 
• Variations in measures of vascular function across body composition 
phenotypes  
• The combined influence of total and regional fat and muscle mass on 
pulmonary function 
• The role of systemic blood pressure and muscle strength in the association 
between metabolic homeostasis and respiratory physiology 
• Metabolic homeostasis as a link between systemic blood pressure and lung 
function 
 
Research hypotheses  
1. Certain anthropometric measures can specifically correspond to total, truncal 
and appendicular adiposity or muscularity 
2. Systemic blood pressure and arterial stiffness can be influenced by total and 
regional proportions of adipose and skeletal muscle tissues  
3. Disparity between metabolic load and metabolic capacity may alter dynamic 
lung function 
4. The effect of whole-body and segmental metabolic balance on respiratory 
capacity is modified haemodynamically   
5. Respiratory and vascular systems are physiologically linked via shared 






In the following chapter, an in-depth review of the extant literature on the 
implications of alterations in the quantity, distribution, and function of adipose 
tissue and skeletal muscle in health and disease is provided with an emphasis on the 
cardiovascular and respiratory systems. There, both observational and interventional 
studies are critically appraised in the matter of connections between obesity, 
sarcopenia, dynapenia, cardiorespiratory fitness and cardiometabolic health. Then, in 
chapter 3, there is a methodology of this cross-sectional research which utilises air 
displacement plethysmography (ADP), bioelectrical impedance analysis (BIA), 
anthropometry, dynamometry, spirometry, and sphygmomanometry to examine the 
abovementioned relations in a sample of active free-living adults. Thereafter, the 
results of descriptive and inferential analyses of the collected data are presented and 
critically discussed in chapters 4 to 7 to shed light on the application of total and 
segmental body composition phenotypes to the changes in pulmonary outcomes with 
an emphasis on the metabolic load- metabolic capacity model. Further, the 
modifying effects of blood pressure and muscle strength on the association of 
whole-body and segmental metabolic imbalance with respiratory capacity are 
probed. Finally, mutual relationships between systemic blood pressure and lung 
function are explored and the moderating role of adiposity and leanness are 
evaluated in chapters 8 and 9. It is not a purpose of this research to provide a 
detailed description of body composition models or the technical properties of 
measurement techniques applied to them. In the same way, fundamentals of 
respiration, spirometry, and the regulation of blood pressure are not thoroughly 
discussed. It is also worth mentioning that, from a body compositional perspective, 
this study mainly concerns fat mass and skeletal muscle mass. Therefore, the 
exploration of reciprocal changes in lung function and blood pressure in relation to 
the estimated hydration, protein, and mineral states are not the objectives of the 
current study. Moreover, the influence of fat mass and fat-free mass on the outcomes 
other than those pertinent to cardiovascular and pulmonary systems is beyond the 
scope of this research. This study does not intend to assess dietary intake and 
physical activity as the covariates of blood pressure and pulmonary function; thus, it 
does not include nutritional and activity data. Since this research does not employ 
dual-energy X-ray absorptiometry (DXA) scan or CT/MRI, direct measurements of 
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2.1. Body composition in health and disease 
Body composition is an essential determinant of human health and a dynamic 
indicator of the nutritional status. Hence, the analysis of body composition plays a 
crucial role in the assessment of physiological as well as pathological states in both 
individuals and populations (Barr et al., 2004; Kyle et al., 2004a). The study of the 
components of body mass has been steadily gaining popularity in clinical practice, 
mostly due to the ongoing epidemic of obesity, increasing rate of lifestyle diseases, 
growing issue of age-related chronic conditions, and the emerging phenomenon of 
sarcopenic obesity which are directly or indirectly linked to over- and/or 
undernutrition. In a broader sense, malnutrition, as consensually endorsed by the 
European Society for Clinical Nutrition and Metabolism (ESPEN), and the 
American Society for Enteral and Parenteral Nutrition (ASPEN), is defined as a 
subacute or chronic inflammatory state of disordered nutrition in which the 
imbalance of energy, protein, and other nutrients adversely affects body 
composition, function, and clinical outcome (Jensen et al., 2010). Thus, the 
assessment of body size, composition, and function in high-risk groups or 
malnourished people provides very useful information about the constituents of total 
body mass, broadly dichotomised as FM and FFM. Clinically, the assessment of 
nutritional status, fluid balance, bone mineral density, leanness, muscularity 
adiposity and energy requirement can be a cost-effective practically useful method 
for the nutritional and functional evaluation, identification and management of 
oedema, osteopenia, sarcopenia and/or obesity, outcome prediction and tailoring of 
medical treatment (Thibault and Pichard, 2012) in patients with a number of 
conditions, including frailty, pulmonary, cardiovascular, neoplastic, 
musculoskeletal, gastrointestinal, renal, and neurological diseases (Kyle and 
Pichard, 2000; Barbosa-Silva et al., 2003; Kyle, Genton and Pichard, 2005; Prado et 
al., 2008, 2011; Clark and Manini, 2010; Walter-Kroker et al., 2011).  
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Such data can be applied in primary, secondary, and tertiary levels of care to predict 
health risks and gauge supportive measures and interventions accordingly (Soeters et 
al., 2008, 2017). In light of recently decrypted molecular cross-talks between 
adipose tissue, skeletal muscle, bone and a plethora of biological abnormalities, the 
position of body composition measurement is strengthening in the diagnostic, 
therapeutic, and preventive strategies targeting a host of morbid conditions (Garvey, 
2013; Mechanick et al., 2013). This would entail more efficient decision-making 
about patients with a variety of comorbidities and at-risk populations as well as 
more satisfactory outcomes, and lower medico-economic costs (Guest et al., 2011; 
Cefalu et al., 2015). In this context, the feasibility and validity of total and 
segmental body composition analyses have been shown in large-scale population 
studies, including the UK Biobank imaging study, EU Childhood Obesity Program, 
German National Cohort, Korean Longitudinal Study of Healthy Aging and the 
National Health and Nutrition Examination Survey (GNC, 2014; Kim et al., 2014; 
Luque et al., 2014; Sudlow et al., 2015; West et al., 2016). 
 
2.1.1. Overview of the models and methods of assessment 
Since direct analysis of body compartments is only possible post-mortem, indirect 
techniques are employed to examine lean and fat tissues in vivo. There are many 
techniques available with varying degrees of accuracy, reliability, complexity, and 
feasibility, ranging from simple anthropometric measurements to sophisticated 
predictive methods. Because these techniques provide estimates of different aspects 
of body composition, all of them are subject to random and systematic errors and 
there is no single optimal method applicable to all conditions. Thus, a combination 
of methods are often jointly used to achieve greater accuracy(Wells and Fewtrell, 
2006). 
So far, several compartmental models have been suggested for the analysis of body 
composition. In the traditional two-compartment model(Welham and Behnke, 
1942), the body is assumed to be made up of two chemically distinct compartments: 
fat mass (FM) and fat-free mass (FFM), possessing a constant density (0.9007 g/cm3 
and 1.100 g/cm3, respectively) at 36°C. Due to the extremely difficult direct 
measurement of fat mass, FM is indirectly determined by subtracting total FFM 
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from body weight (Brožek et al., 1963). This model is based on the measurement of 
total body density (Db) by hydrodensitometry or total body water (TBW) via 
isotopic dilution. Because this 2-component model was originally derived from the 
chemical analysis of cadavers, it did not separate out the nonessential extractible 
triglycerides stored in adipose tissue from the essential lipids (cholesterol, lecithin, 
and phospholipids) found in non-adipose structures (cell membrane, bone marrow, 
neural structures, and between myofibers) (Behnke, 1942). Ignoring the later portion 
that comprises 2.5% of the body mass in the conventional hydrodensitometry gives 
rise to the underestimation of FM. To distinguish the storage fat (adipose tissue) 
from the structural and functional fat, the terms lean body mass (LBM) or the 
triglyceride free mass (TGFM) have been proposed as conceptually more relevant 
alternatives to FFM (Withers, Laforgia and Heymsfield, 1999), although it is almost 
impossible to measure the essential lipids in living subjects (Mazzoccoli, 2016). 
Another limitation of this model is the inaccurate assumption of FFM constancy 
(0.723L/kg)(Pace and Rathbun, 1945). Unlike FM which has a relatively constant 
density, FFM density varies considerably with age, gender, race, hydration and 
nutritional status, and certain medical conditions(Withers et al., 1998). To overcome 
these limitations, a three-compartment model was developed by Siri (Siri, 1961). 
This model subdivides FFM into TBW and fat-free dry mass (FFDM) that is 
composed of protein (and glycogen), osseous minerals (mainly calcium 
hydroxyapatite) and non-osseous minerals. It extends the previous model by 
combining underwater weighing (UWW) and deuterium dilution to measure body 
density and TBW. In this manner, the three-compartment model outperforms the 
basic one as it controls for the interindividual variability in the hydration fraction of 
FFM. However it assumes a constant ratio of mineral to protein (0.354) (Brozek and 
Henschel, 1961; Snyder, 1974). 
Despite the theoretical influence of cumulative measurement errors arising from a 
larger number of body composition assessment techniques, this error (0.7% body fat 
percentage(%BF)) would not offset the excess accuracy gained by the three-
compartment model, as it is much less than the propagated error pertinent to the 
classic two-compartment model (3.8%BF). Despite this improvement, it still fails to 
provide an accurate estimation of FM in those with protein depletion or low bone 
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mineral density (BMD) whose solid mass, and subsequently fat mass, would be 
incorrectly estimated(Withers, Laforgia and Heymsfield, 1999). 
By contrast, a four-compartment model which includes DXA, obtains a direct 
measurement of bone mineral content (BMC) analogous to bone ash (Wahner et al., 
1985). This model is (at the molecular level) composed of FM, TBW, mineral, and 
residual (protein, non-bone minerals, glycogen, and the essential fat), thereby 
improving the accuracy of body composition analysis as it makes allowances for 
variations in bone mineral mass in addition to that of TBW and avoids the 
assumption of constant mineral to protein ratio. But the assumptions of protein, total 
mineral, and bone to non-bone mineral ratio constancy remain (Fuller et al., 1992; 
Ellis, 2000). Nevertheless, the propagated error for the four-compartment model is 
equal to that of three-compartment model (0.7 %BF). Therefore, both models 
determine FM and FFM with acceptable precision and reliability(Withers, Laforgia 
and Heymsfield, 1999). A multicompartment 5-level model developed by Wang et 
al., has generated a comprehensive framework which enables researchers to conduct 
body composition analysis in an organised and integrated fashion. This model 
clusters the compositional components of human body at five levels, namely atomic 
(body elements), molecular (BMC, fat, protein, and TBW), cellular (bone cell mass, 
extracellular water, extracellular solids, and fat), functional (skeletal muscle, adipose 
tissue, blood, bone, and others), and whole-body (FM, FFM) levels (Wang, Pierson 
Jr and Heymsfield, 1992). Hence, multicompartment profiling of body composition 
has enough accuracy to be considered the in vivo equivalent of carcass analysis and 
to act as the criterion method for the validation of other more frequently employed 
techniques(Wang et al., 1993, 1998). 
Notwithstanding the accuracy gained by the addition of compartments, 
impracticality (safety, complexity, availability, and expensiveness) of some methods 
used in multicompartment models e.g., neutron activation analysis or whole-body 
counting) together with the propagated error of measurement attributable to the 
increased number of body composition assessment techniques limit their appeal. 
Furthermore, the comparison of three- and four-compartment models to 
multicomponent models in healthy adults have displayed a standard error of 
estimates <1% BF, implying that the incorporation of more components in the 
models of body composition measurement may not be so helpful in the clinical 
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setting (Wang et al., 1998; Duren et al., 2008; Kuriyan et al., 2014). In the absence 
of a standardised method which can accurately merge all important components of 
body composition, nutritional assessment and risk estimation of various health 
related conditions would still be subject to uncertainty, inconsistency, non-
expansiveness, as well as non-optimal specificity, predictive value, and clinical 
utility. 
 
2.1.2. Bioelectric Impedance Analysis 
Bioelectric impedance analysis (BIA) is the most frequently applied tool in body 
composition studies because it is a vastly available, non-invasive, convenient, quick, 
easy-to-handle, portable, and relatively inexpensive method.  
In the contemporary BIA methods, the human body is thought to be formed of FM 
and FFM. FFM is usually considered to be composed of bone minerals and body cell 
mass (BCM) encompassing TBW and protein (including skeletal muscle mass 
(SMM))(Kyle et al., 2004). 
BIA measures body resistance (R) and reactance (Xc) against the flow of a low 
intensity alternating current. While R arises from extra-and intracellular fluids, Xc is 
caused by the capacitance of cell membranes. In fact, BIA determines body volume 
by means of resistance measurement. Based on the two-compartment model, FM is 
the non-conductive component of the human body whereas FFM is the conductor of 
electric current (73% of which is assumed to be TBW in euvolemic states). Thus, 
conductivity of the electrical current in biological systems is dependent on the 
electrolyte rich TBW as the compartment with the lowest resistance. Hence, 
components with higher fluid content (skeletal muscle) permit easier passage of the 
current. The impedance (Z), defined as the frequency-dependent opposition of a 
conductor (the body) to the flow of an alternating current (AC) circuit, is then 
calculated from the R and Xc.  
Under basic assumptions of uniformity of surface area and homogeneity of 
composition, body volume (mainly TBW) can be proportional to body resistivity (ρ) 
and the conductive length (L) and inversely related to resistance(R): V= ρ L2/R. This 
empirical relationship can be expressed as the impedance index (height2/R), 
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substituting the conductive length (from wrist to ankle) by the more practically 
measurable height (Ht) (Rush et al., 2013; Mialich, Sicchieri and Junior, 2014). 
However, the human body is neither a uniform cylinder nor an electrically isotropic 
conductor. Therefore, TBW (0.73* FFM) viewed as the conductive body volume, 
can be estimated in specific groups of subjects by using regression equations 
(validated against the reference methods) that include the impedance index (Ht2/R). 
Then, FFM and FM can be predicted. The precision of this technique is inferior to 
that the criterion multicompartment methods. 
Since 1987, a multitude of BIA equations for TBW, extracellular water (ECW), 
intracellular water (ICW), BCM, FFM, and FM have been published for various 
which also include age, anthropometric measurements, and constants of resistivity to 
improve prediction accuracy (Davies et al., 1988; Deurenberg et al., 1990; 
Houtkooper et al., 1992). Nonetheless, standard error of the estimate (SEE) for these 
equations vary widely (0.7 to 12.3 kg, with the errors <3kg and 2.3 kg considered 
very good in men and women, respectively) (Houtkooper et al., 1992). 
BIA estimation of body composition suffers from several limitations. Because the 
experimental regression models relate to a certain reference population, validity of 
the estimations from these equations depends on a close match between the subject 
and the corresponding reference population, therefore, the BIA estimates for FM and 
FFM components are not generalisable. As mentioned before, the relation between 
body composition and impedance index is heavily modified by age, sex, ethnicity, 
anthropometric measurements, hydration, and health status (Houtkooper et al., 1996; 
Ellis et al., 1999; Mialich, Sicchieri and Junior, 2014). Age related dissociation 
between FM and FFM is a well-known phenomenon caused by gradual fat 
deposition (particularly visceral fat) and continuous muscle, body water, and bone 
loss. However, in advanced age, total fat mass tends to diminish due to the depletion 
of subcutaneous fat depots (Buffa et al., 2011). Ethnicity is another source of bias in 
the impedance-based prediction equations for body composition. The SEE of TBW 
estimation by total and segmental BIA across ethnic groups varies with their 
corresponding body water distribution (ECW/TBW) and body build indices (arm 
span and leg length). Of note, total body impedance index has a higher correlation 
with TBW compared with segmental impedance indices (Deurenberg, Deurenberg-
Yap and Schouten, 2002). There is an established sexual dimorphism in body 
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composition from childhood to late adulthood in a manner that females tend to have 
higher relative FM and lower relative FFM due to physiological and evolutionary 
reasons (Kirchengast, 2010). In addition, the accuracy of some reference methods 
used to develop many of these equations is questionable. For instance, densitometric 
methods make the incorrect assumption of FFM constancy. There have been 
inconsistencies in software versions used in the validation process too (Hofsteenge, 
Chinapaw and Weijs, 2015). 
Bioimpedance measurement of body composition is conducted by two methods: 
whole-body BIA and segmental BIA. Whole-body bioimpedance analysers apply 
different arrangements of electrodes (hand to foot, hand to hand, and foot to foot) 
and various ranges of frequencies (single or multiple). Likewise, segmental BIA that 
views the body as five electroconductive cylinders (upper limbs, lower limbs, and 
trunk) uses different types of protocols for the attachment of voltage and current 
(unilateral dual current and quad voltage, bilateral dual current and quad voltage, 
and bilateral quad current and quad voltage) and two categories of frequency (single 
vs multiple). For a detailed review, please refer to De Lorenzo and Andreoli (De 
Lorenzo and Andreoli, 2003). 
Owing to uneven cross-sectional area of the body, total body impedance is 
predominantly determined by the resistance of extremities (with smallest cross-
sectional area). Consequently, whole-body BIA fails to adequately capture the 
changes in truncal FFM (skeletal muscle mass or BCM).  For the same reason, it is 
not so sensitive to the intraabdominal fluid changes (Deurenberg, Deurenberg-Yap 
and Schouten, 2002). On the contrary, segmental-BIA (SEG-BIA) measures the 
phase angle (reactance/resistance ratio) of the trunk and extremities separately. This 
compensates for the lack of agreement between the resistance of trunk and the limbs 
in the whole-body bioimpedance measurements. Hence, SEG-BIA can be utilised as 
a reliable tool in the assessment of individuals with altered hydration status 
(Mialich, Sicchieri and Junior, 2014). Given the inverse association between the 
phase angle of the trunk and total body fat, segmental BIA performs significantly 




In comparison to DXA, however, SEG-BIA underestimates %BF in normal-weight 
and overestimates it in overweight/obese adults. SEG-BIA is superior to total body 
BIA in estimating whole body skeletal muscle volume (SMV) when cross-validated 
against MRI(Baumgartner, Chumlea and Roche, 1989). SEG-BIA can also predict 
FFM more accurately than whole-body BIA over a range of body shapes and 
muscularity states using ADP as the reference method(Kimberly J Shafer et al., 
2009). 
There are also several nutritional, biologic, and technical factors that affect 
estimations by BIA, including previous exercise, dietary intake, posture, 
temperature, skin condition, geometrical properties and the arrangement of 
electrodes as well as measurement errors caused by motion, mispositioning, 
connector length and fabrication errors. There is considerable variability in the 
measurement of body composition between BIA devices too (a range of 1 to 8% has 
been reported for the coefficients of variation and SEE of BIA estimated TBW and 
FFM values, depending on the frequency, device, operator, and reference 
group)(Ishiguro et al., 2005; Tanaka et al., 2007). Thus, standardised protocols and 
regular calibration of the analysers and their components (signal generator, scale, 
sensors, and electrical interference) should be followed when undertaking BIA 
measurements (Kyle et al., 2004). 
In contrast, MF-BIA that uses a range of low and high (generally <20KHz and 
>50KHz) frequencies makes more accurate prediction of ECW than SF-BIA.(Patel 
et al., 1996; Rikkert et al., 1997; Simpson et al., 2001). But it is not a sensitive 
indicator of transcellular fluid shifts in geriatric patients. In cross validation trials, 
SEEs of 5 to 8% have been reported for the estimation of TBW and ECW in healthy 
as well as overweight/obese adults (Bedogni et al., 2002; Sartorio et al., 2005). In a 
similar way, when validated against DXA, SEG MF-BIA underestimates %BF in the 
individuals at low levels of BMI (-1.56%) and overestimates it in those with high 
BMI (3.40%) (Kimberly J. Shafer et al., 2009). It also fails to detect training-
induced changes in FM and %BF (Sillanpää, Häkkinen and Häkkinen, 2013). 
Indirect measurement of truncal resistance by distally placed limb electrodes is 
another impediment to the accurate estimation of truncal body composition because 
of the unequal distribution of current in adjacent segments with dissimilar cross-
section areas (Cornish et al., 1999). This is contrary to direct and indirect resistance 
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measurements of the limbs which demonstrate high degrees of association by site 
and limb (Organ et al., 1994). In addition, trunk resistivity is affected by altered 
hydration and fat distribution in the individuals with high levels of BMI. The 
reported estimation errors of %BF in obese people assessed by segmental MF-BIA 
are partly due to these factors (Medici et al., 2005).  
Despite these limitations, direct segmental multi-frequency bioelectrical impedance 
analysis (DSM-BIA) using the In-Body (720) body composition analyser which 
directly measures the impedance of trunk, arms, and legs at six different frequencies 
(1 kHz, 5 kHz, 50 kHz, 250 kHz, 500 kHz, 1000 kHz) has shown excellent 
agreement to DXA in the quantification of total FFM, FM and %BF (ICC ≥0.88) as 
well as segmental lean mass in the limbs (ICC ≥0.83) and good agreement in the 
measurement of truncal lean mass (ICC > 0.70) in middle-aged men and women 
from the Leiden Longevity Study. However, the limit of agreement for FM and 
%BF was wider than that of FFM. In this study, the overestimation of FM and 
underestimation of FFM was proportional to the rise in BMI (Ling et al., 2011). 
Comparably, %BF and FFM estimated by DSM-BIA using TANITA MC780 
displayed considerable correlation (r=0.85 and 0.98, respectively) and agreement 
(ICC =0.84 and 0.95, respectively) with measurements taken by DXA. in healthy 
young adults. However, visceral fat rating (VFR) was only a weak correlate of 
central fat percentage measured by DXA (Verney et al., 2015). This index of 
visceral adiposity is highly dependent on the obesity status, underestimating visceral 
fat in those with BMI≤35 kg/m² and overestimating it at higher levels of BMI 
(Berker et al., 2010). Therefore, DSM-BIA is an accurate method for the assessment 
of FFM, FM and %BF but not visceral fat in otherwise healthy adults, mainly with a 
normal range BMI. 
In practice, BIA has many important diagnostic and monitoring applications because 
it allows the observation of fluctuations in body composition and detection of 
deviations of FM, FFM, and body fluids from the normal range. Furthermore, 
measurement of phase angle enables the healthcare professionals to accurately 
assess nutritional and clinical states of the individuals with a wide array of 
conditions. The most frequently BIA-examined bodily systems include pulmonary, 
cardiovascular, circulatory, musculoskeletal, gastrointestinal, renal, and neural 
systems (Bracco et al., 1998; Cox-Reijven, Van Kreel and Soeters, 2003; Zlochiver 
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et al., 2007; Moreno, Djeddi and Jaffrin, 2008; Hoyle, Chua and Soiza, 2010; 
Cumming et al., 2014). BIA has also been shown to be practically advantageous for 
the phenotypic classification of patients with COPD. Using the information from 
BIA, these patients can be divided into normal, overweight/obese but malnourished, 
cachectic, oedematous, and anorectic groups (Walter-Kroker et al., 2011).  
Taken together, modern BIA techniques can be regarded as reliable and accurate 
tools for the estimation of body composition in a wide variety of conditions. 
However, further research is required to specify the indications and cut-offs in 
different populations. 
 
2.1.3. Air Displacement Plethysmography 
Air displacement plethysmography (ADP) is a method for the assessment of human 
body composition that relies upon the calculation of body density to estimate body 
fat and fat-free mass. This system has been introduced as an alternative to the gold-
standard hydrodensitometry (underwater weighing) because of the impracticality of 
the underwater weighing (UWW) in certain (elderly, children, severely obese, 
disabled) populations. 
BODPOD is a commercially available whole-body air-displacement plethysmograph 
that determines body composition by calculating whole-body density(densitometry) 
under the same principles applied to the UWW. The only exception is that it 
measures the displacement of the air volume in the testing chamber instead of water 
volume to calculate body density (Db). The BODPOD is a two-chamber unit where 
the subject is seated motionless inside the front chamber while breathing normally. 
The unit is equipped with an electronically controlled diaphragm between the front 
and reference chambers that produces sinusoidal volume and pressure changes in 
both chambers. The computer attached to the unit then uses the body volume and 
body mass (measured by an accurate scale connected to the system) to calculate 
subject’s Db, and subsequently, to estimate %BF, FM and FFM (Dempster and 
Aitkens, 1995). 
Technically, this device determines the body volume based upon the 
pressure(P)/volume (V) relationship under adiabatic (labile temperature) condition. 
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This relationship is explained by the Poisson's Law as P1/P2 = (V2/V1)
γ  where γ is 
the ratio of the specific heat of the gas at constant pressure to that at constant volume 
(1.4 for air), V1 and P1 are the volume and pressure prior to subject entry into the 
test chamber and V2 and P2 are the volume and pressure while the subject is in the 
test chamber(Sly, Lanteri and Bates, 1990). 
When utilising ADP, the effect of isothermal-like air close to body surface (air 
trapped within the fabric of clothing and the hair on the head and body) and 
isothermal air emanating from the lungs should be taken into consideration. This is 
because the isothermal gas is 40% more compressible than an equivalent volume of 
adiabatic air enclosed in the plethysmograph, resulting in a lower pressure output for 
a given body volume (Dempster and Aitkens, 1995). The interference of isothermal 
air with adiabatic air results in the overestimation of the air volume inside the 
BODPOD, and the underestimation of body volume. If uncorrected, this 
underestimation of actual body volume causes overprediction of Db and 
consequently underestimation of %BF (Fields, Hunter and Goran, 2000). To account 
for the effect of the isothermal air, thoracic gas volume (VTG) is measured directly 
according to the following formula:  VTG = functional residual capacity + (0.5 × tidal 
volume) (Dempster and Aitkens, 1995). Because performing the breathing 
manoeuvre to measure intrathoracic gas volume is cumbersome for some groups of 
population, VTG is sometimes estimated using validated prediction equations to 
predict FRC (Crapo et al., 1982). Also, the surface area artefact (SAA) is 
automatically computed by the BODPOD’s software as SAA(L) = k (L/cm2) x BSA 
(cm2), where k is an empirically derived constant of 1. BSA is the body surface area 
calculated from body weight and height according to DuBois formula. (Du Bois, 
1989). VTG-corrected Db is then used to estimate %BF (Siri, 1993). Although the 
estimation error is negligible, it may become an issue in very thin or extremely large 
individuals whose body size influences the magnitude of error (Fields, Higgins and 
Radley, 2005). Nevertheless, the BODPOD can accommodate subjects weighing 23 
to 190 kg (Petroni et al., 2003; Ginde et al., 2005). 
Environmental factors such as increased body temperature, body moisture, body 
hair, and clothing may increase the quantity of isothermal-like air surrounding the 
skin. Moisture retention may also be erroneously regarded as weight gain.  In 
addition, the evaporation of water may change the correction constant γ (Higgins et 
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al., 2001). These sources of error may confound the estimation of %BF by up to 2% 
(scalp and facial hair may result in 2 and 1% underestimation of %BF while clothing 
can lead to 2-5% error in the estimation %BF)(Higgins et al., 2001; Hull and Fields, 
2005). 
The validity of this instrument has been tested against the reference methods of body 
composition assessment in different clinical conditions and several groups of 
individuals. In an adjusted regression analysis of two birth cohort studies at 18 and 
30 years, BODPOD-estimated FM and FFM were found to be the oppositely 
directed significant of the absolute FEV1 and FVC in Brazilian adults. These 
changes in FEV1 and FVC were larger than those estimated by DXA-measured FM 
and FFM in both follow-up groups (De Oliveira et al., 2016). In patients with 
moderate-to-severe COPD, ADP-determined FFM has been shown to be clinically 
useful in detecting lean mass depletion (Flakoll et al., 2004).  
Across levels of BMI, the BODPOD has been shown to overestimate %BF by 
approximately 6.8% in the underweight group compared to DXA. In the normal-
weight group, the BODPOD tends to overestimate %BF by approximately  2% 
whereas in the overweight/obese group it underestimates %BF by 3% (Lowry and 
Tomiyama, 2015). In contrast, no significant between-method difference in Db 
measurements (0.001 to 0.002g/cm3) and no %BF estimation bias has been found for 
ADP and UWW. %BF estimates from UWW and ADP were also strongly correlated 
(r=0.94, SEE= 3.58%) in overweight and obese adults (Ginde et al., 2005). In a 
study of middle-aged healthy white men, Sardinha et al. showed that the precision of 
Db measurement by ADP on repeated trials was comparable to that of UWW (trial-
to-trial variation ≈ 0.0020 kg/L). In contrast, the researchers observed that ADP 
underestimated %BF compared to DXA (2.6 ± 2.7%). In addition, adjusted multiple 
regression models that used ADP estimates of %BF, FM, and FFM had greater 
predictive ability (highest r2 and lowest SEE) against the corresponding DXA 
measured parameters as compared to other models of body composition assessment 
(Sardinha et al., 1998). Concurrent validity of the BODPOD and DXA in 
determining %BF has also been supported in white college-aged women (24.3 ± 
1.1% versus 23.8±0.8%) (Maddalozzo, Cardinal and Snow, 2002).Validity and 
reliability of the BODPOD in determining %BF has also been confirmed against 
UWW in a heterogenous sample of adults from different age, ethnic and fatness 
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groups (test-retest coefficient of variation=1.7±1.1% and mean difference= -0.3± 
0.2%)(McCrory et al., 1995). However, BODPOD overestimated %BF by 1.9% and 
1.6% compared with UWW and DXA in a sample of young black men (Wagner, 
Heyward and Gibson, 2000). Moreover, ADP and DXA may not be used 
interchangeably for the assessment of FFM in the community dwelling older adults, 
as their limits of agreement exceed the maximum allowed difference between 
methods (95% LOA -11.0 to 2.4 kg in males and -4.8 to 2.2 kg in females) (Bertoli 
et al., 2008). Nonetheless, a study of free-living elderly men and women reported no 
significant difference between Db measurements by ADP versus UWW (Yee et al., 
2001). 
These discrepant findings may be due to dissimilarities in measurement protocols 
(separated measurements of lung volume and body volume, predicted versus 
measured calculation of lung volume), test equipment, software version, test 
conditions (clothing, moisture, metabolic rate), VTG prediction, estimation 
inaccuracies inherent in the models, gender, body size, and  food or drink 
ingestion(Fields and Goran, 2000; Wells et al., 2003).  
Compared to other techniques, ADP is less time-consuming, easier to operate, and 
more convenient, making it a favourable tool applicable to a broad range of 
population. Furthermore, it is more feasible for obese individuals whose large body 
size limits the use of other instruments (scanning area in DXA, seat size in 
hydrostatic weighing, weight-recording potential of the footplate in BIA). 
 
2.2. Spirometry  
Spirometry is a valuable physiologic test for the assessment of respiratory health in 
public health and clinical settings. It’s been globally employed by researchers and 
healthcare professionals for epidemiological, diagnostic and monitoring purposes. 
Basically, spirometry measures the flow and volume of air (litre) exhaled during the 
forced expiratory manoeuvre as a function of time (seconds). These measurements 
are graphically displayed as volume-time and flow-volume curves in the spirogram. 
Due to laminar characteristics of the expiratory flow inside the airways, flow rate is 
determined by the Hagen–Poiseuille equation: Q = πr4∆P /8ηl, where P is the 
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pressure drop in the air moving along the continuum of a tube of certain length (l), 
radius(r), and viscosity (η) (Sutera and Skalak, 1993). 
The most widely used parameters of the spirometric test include the forced vital 
capacity (FVC), forced expiratory volume in one second (FEV1), the ratio of forced 
expiratory volume in 1 second to forced vital capacity (FEV1/FVC%), and the mean 
forced expiratory flow between 25% and 75% of FVC (FEF25–75%). FVC is the 
maximum volume of air delivered during a forceful and complete expiratory effort 
(lasting 6 seconds) following a maximal inspiration. FEV1 is the maximal volume of 
air exhaled in the first second of a forced expiration starting from full inspiration. 
Both spirometric indices are expressed in litres at BTPS (body temperature, 
pressure, saturated with water vapour) condition. In healthy individuals, FEV1 
comprises about 70-80% of FVC (FEV1/FVC%). FEF25–75% also known as the 
maximum mid-expiratory flow is derived from the blow with the greatest sum of 
FVC and FEV1 (Levy et al., 2009). 
Spirometers are usually divided in two categories: volume sensing devices and flow-
sensing spirometers. Volume displacement spirometers calculate the airflow by 
directly measuring the volume of the expired air based on the movements of a bell 
(water seal), piston (dry rolling seal) or bellows in response to breathing excursions. 
The wet (water-seal) spirometer consists of a counterweighted rigid cylinder (bell) 
inverted into a water tank. Water creates an airtight seal between the two containers. 
Vertical displacement of the cylinder through the respiratory cycle is conveyed to 
the recording device. Because of the inertia of the moving parts, wet spirometer 
suffers from a lag time which means the initial portion of the expired breath would 
fill the dead volume of the cylinder and would not be measured. Therefore, the 
accuracy of this instrument is lost at higher respiratory flow rates, particularly 
during FVC manoeuvre, making it clinically less useful. A dry (rolling-seal) 
spirometer is practically more convenient and consists of a piston moving 
horizontally in a larger cylinder. A U-shaped rolling diaphragm between the two 
parts provides the seal and minimizes the friction. The volume is recorded by a 
sensor that detects horizontal displacement of the piston. In the bellow-type 
spirometer, the volume changes of the exhaled air are transferred to a recording 
scriber via expansion of the wedge-shaped bellows. As this instrument produces a 
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volume-time curve, it can measure forced expiratory volume and flow rates in a 
single vital capacity breath(Mandal, 2006). 
These traditional types of spirometers, however, have been largely supplanted by 
flow-sensing spirometers because of their smaller size, easier operability, 
maintenance, and cleaning and even their compatibility with disposable sensors. 
These modern devices calculate the exhaled volume from the flow rate information 
recorded by various flow transducers, i.e., turbines(respirometer), pressure-
differential sensors(pneumotachometer), heated-wire sensors(anemometer), and 
ultrasonic sensors(Gibbons, 2004). 
Pneumotachographs measure rapidly changing flow rates of the inspiratory and 
expiratory air based on the variable pressure changes across a resistive element 
(Hagen–Poiseuille relationship) that are sensed by a differential manometer. Tubular 
configuration of this flow meter maintains the laminarity of the air stream while the 
heating system prevents condensation and ensures constancy of the gas temperature. 
These arrangements make pneumotachographs sensitive and accurate pieces of 
equipment. 
Anemometer measures flow rate of the expired air from the temperature drop in an 
electronically heated (platinum) wire induced by the cooling effect of the flowing 
air. Changes in the exhaled gas temperature, humidity, and composition are 
compensated by appropriate corrections. This instrument is sensitive and 
accurate(Mandal, 2006). 
Respirometers are the most commonly used spirometer in the clinical setting. 
Present-time turbine spirometers are equipped with deflector endplates which spiral 
the airflow that travels through the body of the turbine, rotating a vertically placed 
vane. Vane rotations are counted by the optical sensors and are used to measure the 
volume of the flowing gas. Flow rate is then derived from the recorded volumes 
over time. Although the sensors are relatively insensitive to the variations in gas 
composition, water vapour and altitude (Pedersen et al., 1994),  the accuracy of the 
turbine flowmeter may be affected by friction, inertia, vane area, and the efficiency 
of deflectors at the extremes of flow rate spectrum. Wide intervals of agreement in 
peak expiratory flow (PEF) and FEV1 measurements have been reported between 
turbine and pneumotachograph spirometers. Under-reading occurs at low tidal 
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volume whereas over-reading happens at high tidal volume or high peak flow (Jones 
and Mullee, 1995). These factors should be corrected by the software supplied with 
the respirometer.  In a multi-centre comparative study of the office and standard 
spirometers of various types, all spirometers were shown to be comparably precise 
in measuring FEV1 (upper limits of precision fixed at 200ml); however, proportional 
bias was reported for small turbine flowmeters at lower and higher values of FEV1. 
In addition, small spirometers had poor FVC repeatability (>200ml) and broad levels 
of agreement with standard spirometers for FEV1 (>350ml) and FVC (>500ml) 
(Liistro et al., 2006). 
Spirometric parameters are usually recorded during forced expiratory manoeuvres. 
The manoeuvre consists of three phases: 1) maximal inspiration; 2) forceful 
exhalation; and 3) continued complete exhalation to the end of test (EOT) when the 
subject cannot carry on with the forced expiration any further or the volume–time 
reaches a plateau(volume changes <0.025 L) that lasts ≥ 1s after an expiratory effort 
of ≥3s (in children) or 6s (in adults). Although, prolonged exhalation (>6s) is 
commonly observed in older people or those with airway obstruction. This sequence 
of events is also graphically captured in the flow-volume curve as a steep rise in the 
expiratory flow followed by a gradual decline until the EOT. It is worth noting that 
the test should be terminated at the first indication of discomfort, dizziness, or 
imminent syncope (Bellamy and Booker, 2005). As maximal expiratory volume and 
flow values are highly effort dependent, standard procedures should be carefully 
observed to minimise the variability in measurements (please refer to chapter 3 for a 
detailed description of the FVC protocols, pre-test instructions, and prompts given 
by the operator during the test).  
Although the FVC manoeuvre can be performed in the sitting or standing position, 
the former may lead to lower vital capacity in middle-aged and centrally obese 
individuals. Nevertheless, for safety reasons, an upright sitting position is preferred 
in the elderly. Tendency to lean head and trunk forward towards the end of forced 
expiration should be discouraged as it may lead to tracheal compression and the 
accumulation of saliva in the mouthpiece (Quajer et al., 1993). 
An adequate spirometry requires three acceptable FVC manoeuvres out of maximum 
8 attempts (to reduce breath-to-breath variations and to prevent fatigue ) meeting the 
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following criteria: absence of artefacts (coughing in the first second of expiratory 
effort, Valsalva manoeuvre, early termination, partial expiration before connecting 
the mouthpiece, submaximal attempt, mouthpiece obstruction by tongue, teeth or 
lips, leak, extra breath), good start (automatically back-extrapolated volume, <5% 
FVC or 0.150 L ), no hesitation at full inspiration (<2s), satisfactory exhalation (≥6 s 
for subjects>10 years, ≥3s for children <10 years) or a plateau in the volume–time 
curve). Repeatability of these acceptable attempts should also be ascertained (no 
greater than 0.150 L difference between the two largest values of FVC as well as 
FEV1) (Quajer et al., 1993). Figure 2.1 summarises the stepwise application of the 
criteria. 
 
Figure 2.1 Flow chart outlining how acceptability and repeatability criteria are to be 
applied. FVC: forced vital capacity; FEV1: forced expiratory volume in one second (Miller 
et al., 2005, p 326) 
 
Perform FVC manoeuvre 
Met manoeuvre acceptability? 
Three acceptable manoeuvre? 
Met between manoeuvre repeatability criteria? 
Determine largest FVC and FEV1 
Select the manoeuvre with the largest sum of FVC and FEV1 






Biological variability is another source of error in the spirometric measurements. 
Factors such as sex, age, ethnicity, posture, physique, diurnal variation, exposure to 
airway irritating substances (tobacco, inhalants, allergens, pollutants, drugs), and 
respiratory pattern may influence the accuracy and precision of lung function tests 
(Miller, Hankinson, et al., 2005). 
The accuracy of a spirometry system is also considerably affected by the internal 
characteristics of the equipment and the environmental conditions. This requires 
regular quality-control and calibration checks to ensure the volume accuracy (±3.5% 
using a 3-L calibrated syringe discharged daily), absence of leaks (<30 ml volume 
loss upon application of constant pressure 3.0 cmH2O for 1 minute), linearity (tested 
weekly with a 3-L syringe by delivering relatively constant flows at low, mid, and 
high- flow ranges, with an accuracy requirement of ±3.5% at each range), and time-
scale accuracy (±2% assessed quarterly with a stopwatch). In addition, the 
differences between the ambient temperature and pressure (ATP) and the BTPS 
(condition in the lungs) should be accounted for by the appropriate BTPS correction 
factors when recording expiratory volume and flow measurements (Quajer et al., 
1993; Miller, Hankinson, et al., 2005). Table 2.1 shows a summary of the American 
Thoracic Society and the European Respiratory Society ATS/ERS task force 













Table 2.1 Recommendations specified for forced expiratory manoeuvres (Miller et al., 









Resistance  Test signal 
FVC  
 
0.5–8 L, ±3% of 
reading or ±0.050 L, 
whichever is greater 






FEV1 0.5–8 L, ±3% of 
reading or ±0.050 L, 
whichever is greater 




PEF Accuracy: ±10% of 
reading or ±0.30 L.s-
1, whichever is 
greater; repeatability: 
±5% of reading or 
±0.15 L.s-1, 
whichever is greater 
0–14  Mean resistance at 
200, 400, 
600 L.min-1 (3.3, 
6.7, 10 L.s-1) 







7L ±5% of reading or 
±0.20 L.s-1, 
whichever is greater 




BTPS: body temperature and ambient pressure saturated with water vapour; FVC: forced vital 
capacity; ATS: American Thoracic Society; FEV1: forced expiratory volume in one second; PEF: 
peak expiratory flow; FEF25-75%: mean forced expiratory flow between 25% and 75% of FVC 
 
There are also certain conditions where performing FVC manoeuvre may be 
absolutely or relatively contraindicated (Levy et al., 2009). Please refer to Chapter 3 
for a detailed description of these conditions. 
Based on the spirometric curves, three distinct patterns are recognisable: normal, 
obstructive and restrictive. The FEV1/FVC ratio and a subsequent FVC are used to 
distinguish between the abnormal spirometric patterns. While a reduced value 
represents an obstructive ventilatory pattern, a normal/increased ratio is indicative of 
a restrictive pattern. It is not uncommon though to observe a mixed pattern of 
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ventilatory abnormality(Pauwels et al., 2001). An extensive review of the diagnostic 
guidelines (Pellegrino et al., 2005) is beyond the scope of this research. 
Until recently, percent predicted values were widely employed to define the low 
values of spirometric indices. These values were derived from the reference linear 
regression equations including sex, age, height and ethnicity. For adults older than 
18 years, cut-offs of 0.7 (FEV1/FVC) and 80% predicted (FVC) were recommended 
by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) as the 
diagnostic thresholds for obstructive lung defects (Fabbri and Hurd, 2003). It should 
be remembered, however, that the assumptions of linearity and homoscedasticity are 
not met in these prediction equations in different combinations of age and height, 
particularly for FEV1 values, leading to systematic underestimation of the predicted 
values and large variability in the reported reference values. As the predicted 
residuals are disproportional to the predicted values, considering a fixed percent 
predicted value as the lower limit of normal (e.g., 80% implying 20% deviation from 
the predicted normal value) would result in the misinterpretation of the spirometry 
data (Stanojevic et al., 2008; Miller et al., 2011). These non-linear relationships can 
be captured by adding splines that correct for the age-specific predicted values 
(Rigby and Stasinopoulos, 2005; Pistelli et al., 2007). Moreover, adopting a fixed 
FEV1/FVC cut-off (0.7) for diagnosing airway obstruction does not account for the 
age and height-related declines in FEV1/FVC ratio (including the healthy lifelong 
non-smokers), leading to over-diagnosis in the elderly and under-diagnosis in young 
subjects (Quanjer et al., 2011). 
The ATS and ERS have instead supported the recommendations of Global Lung 
Function Initiative (GLI-2012) to define lower limit of normal (LLN) by Z-scores. 
LLN represents the 5th percentile (1.64SD below the mean) of spirometry data 
obtained from the reference healthy non-smoking population (for the ATS criteria, it 
is derived from the Third National Health and Nutrition Examination Survey 
(NHANES III)). GLI-2012 reference equations adjust for the age, height, gender and 
ethnicity-dependent coefficients of variation in the predicted spirometric indices and 
smooth out the non-linear regression curve by including a spline. Further, using Z-
scores standardises the residuals of these predicted indices, making the LLN-based 
interpretation of PFT results independent of the abovementioned covariates (Quanjer 
et al., 2012). Importantly, lung function, respiratory performance and pulmonary 
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health are anatomically, physiologically and metabolically linked to the body 
composition. Alterations in the quantity, distribution, and functional attributes of the 
lean and fat mass exert significant direct and indirect influences over lung function.  
The purpose of the next sections is to review the existing evidence on the effects of 




2.3. Body Composition and Lung 
2.3.1. Adiposity and lung physiology 
Adipose tissue influences several aspects of lung physiology including lung volume, 
respiratory mechanics, airway function, ventilation and gas exchange. Truncal fat 
accumulation mechanically distorts the balance of inward and outward elastic forces 
effected by the lung and the chest wall, leading to diminished functional residual 
capacity (FRC), i.e., the volume of air remaining in the lungs after a normal tidal 
expiration (Pelosi et al., 1998). FRC decreases exponentially with BMI, tapering off 
to the residual volume (RV), the volume of air left in the lungs after a maximal 
expiration, at the extremes of BMI (Jones and Nzekwu, 2006). In contrast, the effect 
of fat mass on the RV is negligible, especially in men (Watson, 2004) whereas total 
lung capacity (TLC) is modestly affected by the changes in BMI and fat 
distribution(Collins et al., 1995). Although the space-occupying effect of 
intrathoracic fat may reduce TLC (Watson et al., 2010), the impeded descent of the 
diaphragm is thought to be the primary mechanism underlying the TLC-lowering 
effect of central adiposity (Salome, King and Berend, 2010). Since the RV and TLC 
are not markedly affected by excessive adiposity, FRC reduction in overweight or 
obese individuals is mainly due to the marked reduction in the expiratory reserve 
volume (ERV), i.e., the additional volume of air that can be exhaled forcefully after 
a normal tidal expiration (Jones and Nzekwu, 2006). 
Anatomical location of fat depots also plays a modifying role in the associations 
between fatness and lung volume. As opposed to the lower body fat which has not 
been shown to be an important contributor to the altered lung volume in the 
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individuals with higher BMI, upper body fat exhibits inverse relationships with FRC 
and ERV in adults of both genders (Canoy et al., 2004; Chen et al., 2007). MRI-
quantified visceral and anterior subcutaneous (rib cage and abdominal) fat have been 
found to be significant correlates of lower end-expiratory lung volumes (EELV) in 
overfat adults  as compared to those with normal fatness (Babb et al., 2008). Thus, 
the association of BMI with the components of lung volume is mediated by the 
cumulative effect of thoracic and abdominal fat. These fat depots make comparable 
contributions to reduced TLC, FRC, and ERV in adults (Sutherland et al., 2008). 
The absolute static lung compliance, defined as the volume changes in lungs per unit 
changes in transpulmonary pressure (the slope of pressure-volume curve), also 
appears to decline exponentially with the incremental changes in BMI (Pelosi et al., 
1998). This could be due to the reduced lung volumes, deposition of subcutaneous 
fat on the plural surfaces and chest wall with subsequent overloading of the 
respiratory muscles, increased pulmonary blood volume and congestion of 
bronchoalveolar vessels followed by the narrowing of the small airways, and the 
increased alveolar surface tension caused by FRC reductions (Rubinstein et al., 
1990). Nevertheless, mixed results have been reported on the impact of obesity on 
chest wall compliance. While several studies have not found significant differences 
between obese and non-obese individuals in various postures and levels of 
consciousness (Sharp et al., 1964; Hedenstierna and Santesson, 1976; Suratt et al., 
1984), chest wall and lung compliance were found to be lower in sedated 
postoperative morbidly obese patients as compared to normal weight subjects 
(Pelosi et al., 1996).  
Lower EELV (in the presence of an unchanged RV) and reduced lung compliance of 
individuals with excessive adiposity lead to tidal airway closure and expiratory 
airflow limitation (EFL), particularly in the supine position. These, in turn, increase 
the risk of air-trapping in lung bases, peripheral airway injury (obstruction), 
maldistributed ventilation, and impaired gas exchange (Milic-Emili, Torchio and 
D’Angelo, 2007).  
Other than lung compliance, airway resistance is also affected by the excessive 
adiposity. Notably, male individuals with high BMI have more resistant airways 
than those with normal BMI. This relationship can be partly explained by low lung 
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volume, reduced FRC, narrower and remodelled airways, and intrathoracic lipid 
deposition (Inselman, Wapnir and Spencer, 1987; Salome, King and Berend, 2010). 
By reducing FRC, truncal adiposity removes the mechanical restraints against the 
hypercontractility of airway smooth muscles. Furthermore, breathing at lower tidal 
volumes impairs the bronchodilating effect of normal tidal strain on these smooth 
muscles, accentuating airway hyperresponsiveness in individuals with obesity 
(Shore and Fredberg, 2005).  
In addition to lower airways, the upper respiratory tract is also influenced by the 
abnormally accumulated fat around the pharynx (reflected in the increased neck 
circumference) and torso. Deposition of adipose tissue in these areas reduces the 
calibre of the upper airways. This mechanical load together with and lower lung 
volumes predispose the individuals with obesity to pharyngeal collapsibility, upper 
airways narrowing and sleep apnoea (Schwartz et al., 2008). Moreover, release of 
pro-inflammatory cytokines from the abnormally expanded (visceral) adipose tissue 
blunts the central and peripheral compensatory neuromuscular responses to the 
altered structure and function of upper airways (Schwartz et al., 2009) 
In the upright position, , the optimal ventilation occurs at the lower dependent lobes 
of normal-weight individuals whereas the gradient of ventilation can be reversed in 
the individuals with excessive adiposity due to the occlusion of small airways, 
leaving the lower zones of the respiratory system under-ventilated in this group of 
people (Demedts, 1980). Concurrently, the pulmonary blood supply is 
predominantly distributed to the lower lobes, creating regional ventilation-perfusion 
(V/Q) mismatch in the misconfigured lungs of the obese individuals with low ERVs, 
particularly in the sitting and lateral decubitus positions (Holley et al., 1967). V/Q 
mismatch then gives rise to the widening of the alveolar-arterial oxygen (A-aO2) 
gradient (>15 mmHg) and, in the morbidly obese subjects, hypoxemia 
(PaO2<80mmHg) (Hakala et al., 1995; Pelosi et al., 1998) that may improve after 
bariatric surgery (Thomas et al., 1989). In fact, measures of central adiposity, i.e., 
waist to hip ratio (WHR) and WC have been found to be significant predictors of the 
A-aO2 gradient and PaO2 before and after weight loss, with larger effects in men and 
in the supine position (Vaughan, Cork and Hollander, 1981; Zavorsky et al., 2007).  
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Maintenance of a proper match between perfusion and ventilation, and 
consequently, unabated pulmonary gas exchange in individuals with overfatness 
during exercise is the result of the overactivity of respiratory musculature (Babb, 
Buskirk and Hodgson, 1989; Chlif et al., 2007). Higher resistive and elastic works 
of breathing secondary to the volume reducing, thoracic stiffening, and possibly 
airway remodelling effects of truncal adiposity (Salome et al., 2008), generate a 
rapid shallow respiratory pattern both at rest (BMI≥35 kg/m2) and on exertion 
(BMI≥30 kg/m2) (Sampson and Grassino, 1983). The increased frequency of 
breathing in obese people is an adaptive response against the elastic overloading of 
the chest wall to ameliorate the activity-related respiratory discomfort (Ofir et al., 
2007). 
Both anthropometric and body compositional measures of adiposity have been 
consistently shown to be negatively related to FVC and FEV1 in adults. In a cross-
sectional analysis of the British Regional Heart Study, adiposity measures (WHR, 
WC, FM, and %BF) were inversely related to height-standardised and BMI-adjusted 
FVC and FEV1 but not FEV1/FVC in men aged 40–59 years (Wannamethee, Shaper 
and Whincup, 2005). The BMI-independent inverse relationship between WC and 
spirometric parameters was also corroborated by the Humboldt Study that reported 
13ml and 11ml decrease in FEV1 and FVC per 1cm increase in WC (Chen et al., 
2007).  
In addition to the cross-sectional negative impact of adiposity on pulmonary 
function, respiratory capacity tends to deteriorate with progressively accumulating 
total and truncal fat. Sutherland et al. demonstrated that BIA-estimated %BF and 
trunk fat mass (TFM) were inversely associated with spirometric and 
plethysmographic parameters in non-smoking non-asthmatic young adults (with 
stronger effect in men) from Dunedin Multidisciplinary Health and Development 
birth cohort at 32 years (FEV1, FVC, TLC, FRC and RV) and between 32 to 38 
years (FEV1 and FVC, FEV1/FVC (women), TLC, FRC and RV(men)), indicating 
the longitudinal effect of total and central adiposity on static and dynamic measures 
of lung function (Sutherland et al., 2016). Similarly, in a large prospective study of 
adults aged 18-72 years, the longitudinal changes in weight, BMI, WC, and %BF 
over five years were inversely associated with height-adjusted changes in FVC and 
FEV1. These associations were also dependent on gender and pre-existing adiposity. 
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In men, 1 standard deviation (SD) increase in BMI, WC, and %BF was respectively 
associated with 114, 91, and 54 ml decrease in FVC as well as 78, 66, and 52 ml 
decrease in FEV1. These changes were two to three times higher than those recorded 
in women. In addition, 5-year adiposity change had a significantly larger impact on 
FVC and FEV1 in those with a BMI≥25kg/m
2 at baseline as compared to 
participants who were normal-weight at baseline, particularly among men. 
FEV1/FVC ratio remained unchanged despite alterations in the adiposity status of 
the participants (Fenger et al., 2014). Sex-specific changes in the spirometric indices 
of the overfat individuals can be due to the differential distribution and function of 
the adipose tissue, anatomical and physiological dissimilarities of the pulmonary 
structures, and varied risk profile of men and women (Chen et al., 2012; 
Karastergiou et al., 2012).  
Over time, however, the lung function (FVC, FEV1) tends to decline with increasing 
adiposity. Progressive deterioration of pulmonary function in the individuals with 
excessive adiposity is supported by the CARDIA (Coronary Artery Risk 
Development in Young Adults) study that estimated 10-year FVC and FEV1 
reductions of 138ml and 47ml in non-smoker and non-asthmatic adults with baseline 
BMI ≥ 26.4 kg/m2. This multicentre cohort study revealed that ≥ 6 kg/m2 gain in 
baseline BMI of overweight or obese individuals would be respectively associated 
with 264ml and 216ml decrease in the estimated FVC and FEV1 over 10 years 
(Thyagarajan et al., 2008). Likewise, a longitudinal study of older adults found that 
over a 7-year follow-up, height-adjusted FVC and FEV1 dropped by 46 ml and 31ml 
per 1cm increment in sagittal abdominal diameter (SAD) in the elderly Caucasians 
(Rossi et al., 2008). 
Apart from the detrimental mechanical effects of increased adiposity on the static 
and dynamic lung volumes (King et al., 2005), the unfavourable inflammatory 
profile and immunometabolism of overfat adults may also worsen their respiratory 
capacity. In a long-term follow-up of the participants in the CARDIA study, higher 
serum adiponectin levels at year 15 examination were associated with higher FVC 
and FEV1 (but not FEV1/FVC) at year 20 examination, independent of obesity. 
Thus, persistently reduced adiponectin levels in centrally obese individuals may 
restrict their thoracic compliance and narrow peripheral airways. However, this 
association was no longer significant after adjustments for the homoeostasis model 
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assessment for estimating insulin resistance (HOMA-IR) and C-reactive protein 
(CRP), denoting that the adiponectin-lung function association may be mediated via 
insulin-sensitising and anti-inflammatory actions of adiponectin (Shore, 2008; 
Thyagarajan et al., 2010). Maintenance of FEV1/FVC together with concomitant 
reductions in FVC and FEV1 indicates that the airflow limitation in overweight and 
obese adults is due to restrictive abnormalities rather than the airway obstruction 
(Thyagarajan et al., 2010). 
 
2.3.2 Adiposity and Pulmonary Disease 
2.3.2.1 Obstructive sleep apnoea  
A large body of evidence supports the link between excessive adiposity and 
obstructive sleep apnoea (OSA) in both sexes. In the Sleep Heart Health Study 
(SHHS), longitudinal changes in weight were non-linearly associated with changes 
in Respiratory Disturbance Index (RDI), demonstrating a floor effect whereby those 
with a low baseline RDI did not show further reductions in the severity index of 
sleep-disordered breathing (SDB) after weight loss. In this study, men and women 
who gained 10kg or more were respectively 5 and 2.5 times more likely to 
experience large increases in the RDI (>15 events per hour) over a 5-year follow-up 
compared with the stable-weight individuals. (Newman et al., 2005).  An earlier 
cross-sectional study of the community dwelling adults enrolled in the SHHS 
exhibited that BMI and neck circumference (NC) were independent predictors of 
SDB severity. This study found that the likelihood of a high apnoea-hypopnoea 
index (AHI) increased by 1.6 and 1.5fold per 1 SD increment in BMI and NC, 
respectively. (Young, Shahar and Nieto, J, 2002). This relationship is curvilinear, 
with a greater risk of sleep apnoea or hypopnea in subjects at higher levels of 
BMI.(Newman et al., 2005).  
Of note, truncal adiposity is a stronger predictor of moderate to severe 
OSA(AHI>10) than general adiposity, with ORs of 2.6 and 1.76 being associated 
with high levels of WHR (>1 in men and >0.85 in women) and NC (>42 cm in men 
and > 37 cm in women) (Martinez-Rivera et al., 2008). A number of RCTs have also 
shown beneficial influence of diet-induced weight loss on mild as well as moderate 
to severe (Johansson et al., 2009; Tuomilehto et al., 2009).  Importantly, pharyngeal 
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fat quantity also correlates directly with the severity of OSA (Shelton et al., 1993).  
Excessive accumulation of fat around the pharyngeal airway enclosed by 
maxillomandibular bony structures causes anatomical imbalance in the upper airway 
(UA) and elevates extraluminal pressure on the upper respiratory tract to the critical 
point of closure, particularly in the retropalatal (and retroglossal) segments where 
the susceptible upper airways lacking anatomical support are overwhelmed by the 
passive intra-pharyngeal pressure and collapse during expiration at sleep (Horner, 
2007).  
In addition to the adipose tissue surrounding the upper airways, visceral fat area 
(VFA) has been shown to be a strong correlate of OSA indices (AHI and SaO2) in 
obese men independent of their BMI, %BF or subcutaneous fat area (SFA) 
(Vgontzas et al., 2000). Notably, mid and lower-face fat volume were significantly 
correlated with NC, subcutaneous adipose tissue (SAT), and (more strongly) visceral 
adipose tissue (VAT) (Sutherland et al., 2011). It is worth mentioning that visceral 
adiposity appears to be a better predictor for OSA severity than cervicofacial 
fatness. In a German study of men with suspected OSA, intraabdominal adipose 
tissue quantified by nuclear MRI as well as serum leptin levels were significantly 
correlated with AHI whereas subcutaneous cervical fat and parapharyngeal fat did 
not show significant correlations (Schäfer et al., 2002). 
Finally, dysregulated release of adipokines and pro-inflammatory cytokines from 
central depots of adipose tissue may deteriorate cyclical neuro-anatomical 
interactions involved in the feedback control of respiratory system during sleep, 
destabilising breathing pattern and increasing severity of OSA (Isono, 2009). 
Therefore, central and cervical adiposity contribute to the development and 
worsening of OSA albeit via different mechanisms. 
 
2.3.2.2 Chronic Obstructive Pulmonary Disease 
The available data are suggestive of the variable, even paradoxical, effects of obesity 
on different phenotypes and stages of COPD. In a cross-sectional analysis of the 
Function, Living, Outcomes, and Work (FLOW) study, the frequency of having a 
BMI in the obese range was two times higher in patients with early stage COPD 
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compared with the general population (Eisner et al., 2007). Earlier, the Tucson 
Epidemiologic Study of Airways Obstructive Diseases (TESAOD) had shown that 
the risk of chronic bronchitis was highest in patients with BMI≥28 kg/m2 (OR=1.80; 
95% CI:1.32 to 2.46) whereas the odds of being diagnosed with emphysema was 
highest in those with BMI<18.5 kg/m2 (OR=2.97; 95% CI: 1.33–6.68). For both 
phenotypes of COPD, the OR was lowest in the normal weight and mildly 
overweight patients (Guerra et al., 2002). 
Besides the higher prevalence of obesity in subjects with COPD compared to the 
general population (23% vs 11%), an interaction between obesity and degree of 
COPD severity was also reported in a Dutch cohort of COPD patients. In this study, 
the prevalence of obesity was inversely related to the clinical stage of COPD defined 
by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria 
(Steuten et al., 2006). However, the population-based PLATINO (Proyecto 
Latinoamericano de Investigacion en Obstruccio´n Pulmonar) study found a 
proportionally higher frequency of obesity among subjects without COPD as 
compared to those with objectively-defined COPD (32% vs 23%) (Montes de Oca et 
al., 2008). Nevertheless, a recent study of the nationally representative data from the 
Behavioural Risk Factor Surveillance System (BRFSS) that reported a dose-
response relationship between the level of obesity and COPD in lifetime non-smoker 
white adults. In this study, men and women with obesity class III (BMI≥40 kg/m2) 
were respectively 3.2 and 4 times more likely to have COPD as compared to their 
normal weight counterparts, even after adjustments for age and socioeconomic 
status (Fuller-Thomson et al., 2018). These inconsistencies may be due to 
heterogenous study population and designs as well as disparate confounders, 
comorbidities, and clinical characteristics.  
Clinical picture and functional capacity of patients with COPD are concomitantly 
influenced by their state of adiposity as well. A secondary data analysis of veterans 
with spirometry-diagnosed COPD indicated that obese subjects had poorer health-
related quality of life (measured by the higher total score on the St. George's 
Respiratory Questionnaire (SGRQ)). Moreover, they had approximately 5-fold 
higher odds of living with moderate to severe dyspnoea (MRC score ≥ 2) compared 
with their normal weight counterparts, irrespective of the severity of their airflow 
obstruction. By contrast, lung function was less impaired in obese veterans than in 
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the normal weight patients (FEV1 55% versus 44% of the predicted value). This 
contradictory finding can be explained in a few ways. Firstly, more severe 
symptoms and poorer quality of life in obese patients may prompt them to seek 
medical care at earlier stages of COPD. Excess weight of this group may also be an 
indicative of their earlier smoking cessation. Lastly, as mentioned above, obesity 
may be inversely related to more sever clinical phenotypes of COPD (Cecere et al., 
2011). 
Despite the possibility of receiving care at less advanced stages of the disease, obese 
patients with COPD suffer from deteriorated physical performance and exercise 
tolerance. In the FLOW study, 1kg increase in the BIA-estimated fat mass was 
predictive of 6% and 4% higher risk of self-reported functional limitation as well as 
13 and 11meters shorter distance of walking in 6 minutes (6MWD) in men and 
women, respectively. In addition, total physical performance score of male and 
female patients dropped respectively by approximately 0.07 and 0.1 score per 1cm 
increment in SAD (Eisner et al., 2007). In line with these observations, a 
retrospective chart review of COPD patients undergoing pulmonary rehabilitation 
displayed that, despite higher FEV1 %predicted and FEV1/FVC records, obese 
outpatients scored significantly lower on the self-reported Chronic Respiratory 
Questionnaire (CRQ-SR) and Pulmonary Functional Status Scale (PFSS). They also 
had shorted 6WD and greater fatigue as compared to their non-obese counterparts 
(Ramachandran et al., 2008). 
The abnormal ventilation and greater ventilatory demand of the chronically 
obstructed lungs (V/Q mismatch, metabolic acidosis, hypoxaemia, hypercapnia, 
increased sympathetic tone) that arise from reduced elastic recoil, airflow limitation, 
air-trapping, dynamic hyperinflation and neuromechanical dissociation are 
aggravated by the excessive fat accumulation in obese patients with COPD.  
In addition to the altered mechanics of respiration, the complex interplay of adipose 
tissue and skeletal muscle dysfunction, adiposity-fuelled and hypoxia-induced 
systemic and local inflammatory responses as well as overlapping comorbidities 
should not be overlooked in the setting of COPD (Franssen et al., 2008; Garciá-Rio 
et al., 2014). On this score, exploratory analysis of data from the multicentre 
prospective Genetic Epidemiology of COPD (COPDGene) study illuminated a dose-
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dependent relationship between obesity class and COPD-related outcomes. Adjusted 
for age, sex, ethnicity, education, FEV1/Ht
2, smoking, and comorbidity count, 
patients with obesity class III (BMI≥40 kg/m2) whose COPD had been confirmed by 
spirometry had significantly worse quality of life (QoL) (measured by the St. 
George's Respiratory Questionnaire (SGRQ) score), lower 6MWD, more severe 
dyspnoea (measured by the modified Medical Research Council (mMRC) score) and 
higher odds of moderate and severe acute exacerbation of COPD (AECOPD) 
compared to patients with other classes of obesity as well as normal-overweight 
subjects, with the largest differences observed between obese class III and referent 
groups (BMI 18.5-29.9 kg/m2).  
In contrast to the adverse effect of excessive adiposity on the symptomatology and 
QoL of COPD patients (Cecere et al., 2011), there are several lines of evidence 
suggesting an inverse relationship between obesity and mortality in these patients. In 
a prospective follow-up of the Copenhagen City Heart Study, > 3kg/m2 BMI loss 
over 5 years predicted almost 70% and 60% rise in the estimated rate ratios of all-
cause mortality in subjects with and without COPD, respectively. Furthermore, more 
than 3kg/m2 BMI loss was associated with 2-fold increase in the estimated COPD-
related relative mortality rate. In comparison, > 3kg/m2 gain in BMI did not change 
the estimated COPD-related death rate. Notably, baseline BMI had a modifying 
effect on the link between weight change and mortality in severe cases of COPD. 
While weight gain was a predictor of better survival among patients with BMI<25 
kg/m2, overweight or obese patients would have the lowest mortality rate if their 
weight remained unchanged (Prescott et al., 2002). Comparably, a Cox regression 
analysis of data from the Association Nationale pour le Traitement A Domicile de 
l'Insuffisance Respiratoire chronique (ANTADIR) Observatory, 5-year survival rate 
and the length of hospital admission among patients with severe COPD receiving 
long-term oxygen therapy was highest (59%) in obese (BMI ≥ 30 kg/m2) subjects. In 
contrast, underweight patients (BMI<20 kg/m2) had the lowest survival rate (24%) 
and longest hospitalisation (29.6 ± 40.4 days) (Chailleux, Laaban and Veale, 2003).  
The pattern of relationship between BMI and survival rate in COPD patients seems 
to be affected by the clinical stage of their disease. Whereas patients with FEV1 ≥ 
50% of the predicted value demonstrate a U-shaped association with the highest 
survival being estimated for normal-weight/overweight BMI ranges (RR for all-
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cause mortality: 0.96 and 1.24), those with severely impaired ventilatory function 
(FEV1<50% of the predicted value) exhibit a linearly negative relationship with 
highest all-cause and COPD mortality rate estimated for underweight BMI range 
(RR 1.63 and 2.20) (Landbo et al., 1999). 
These observations are in contradistinction to the epidemiological data stressing the 
harmful effect of obesity on life expectancy in the general population. The 
pathophysiological mechanisms underlying this “obesity paradox” are still poorly 
understood but differential effects of body composition phenotypes as well as 
metabolic alterations and immunoregulatory adaptations may be plausible reasons. 
This phenomenon was elegantly explored in a multicentre observational study of 
patients with COPD from the BODE (Body Mass Index, Airway Obstruction, 
Dyspnoea, Exercise Capacity) cohort registry. After a median follow up of 51 
months, BMI demonstrated inverse associations with the BODE index, 
hyperinflation, and FEV1/FVC ratio, U-shaped relationships with the mMRC scale 
and SGRQ score, and an inverted U-shaped relationship with 6MWD. The 
underweight group (BMI <21kg/m2) had the shortest Kaplan-Meyer estimated 
survival time (52 months) whereas the obese group (30 ≤ BMI<35kg/m2) had the 
longest survival (120 months), followed by very obese (BMI≥35 kg/m2) group (114 
months). Adjusted for age and obstruction severity, all-cause mortality risk ratio was 
highest in the underweight (RR:1.57) and lowest in very obese group (RR: 0.65). 
Interestingly, a proportional hazard analysis of data from the NHANES III 
elucidated that, adjusted by age, gender, ethnicity, smoking, current oral 
corticosteroid use, and degree of airway obstruction, patients with the underweight 
(BMI<18.5 kg/m2) and extreme obesity (BMI>40 kg/m2) states had the highest risk 
of death from respiratory disease (HR:7.10 and 5.78) and chronic lower respiratory 
disease (excluding asthma) (HR:14.80 and 13.69) compared to patients with other 
BMI categories. Surprisingly, extremely obese patients did not have a higher all-
cause mortality (Jordan and Mann, 2010).  
With regard to this obesity paradox in COPD, indicated by the differential clustering 
of COPD comorbidities and clinical expressions across BMI groups and the 
aggregation of respiratory-specific mortality at the extremes of BMI spectrum, it can 
be postulated that depleted lean (and fat) mass as well as excessive adiposity are 
associated with higher COPD-related morbidity and mortality via distinct 
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pathophysiological mechanisms. While undernourished individuals have more 
severe phenotypes and higher risk of short-term death, obese patients with early-
stage presentations experience a less aggressive clinical course with more frequent 
cardiovascular comorbidities and higher risk of long-term death (time differential 
hypothesis) (Divo et al., 2014). The increased risk of cardiometabolic morbidity and 
all-cause mortality in obese patients with COPD can be partly attributed to the low-
grade chronic systemic inflammatory state and abnormal metabolic profile that 
prevail in this condition. Systemic inflammation in these patients is reinforced by 
the concomitant occurrence of metabolic syndrome which has been shown to be 
more prevalent in subjects with COPD compared with the age- and sex-matched 
controls (Marquis et al., 2005; Watz et al., 2009). 
Fat depots are another source of inflammation in COPD. Overweight/obese patients 
with COPD (BMI 28.2–44.7 kg/m2), have higher interleukin (IL)-6, tumour necrosis 
factor (TNF)- α, CRP, and leptin concentration and lower adiponectin levels 
compared to normal weight subjects. In this relation, it has been suggested that FM 
is the main determinant of IL-6 and TNF- α, and CRP levels whereas BMI is the 
strongest predictor of leptin and adiponectin levels in men undergoing pulmonary 
rehabilitation for stable COPD (Poulain et al., 2008).  
Despite the presence of systemic inflammation in a large proportion of patients with 
COPD compared with control subjects, it does not differ across stages of disease. 
Hence, inflammatory responses at the adipose tissue (not the systemic) level may 
contribute to clinical expression and morbidity burden of COPD. In a prospective 
cohort study of patients who met ATS/ERS diagnostic criteria for COPD, the 
expression of hypoxia-inducible proinflammatory signalling molecules, i.e., CD40, 
MKK4 (mitogen activated protein kinase (MAPK) kinase 4)  and JNK (c-Jun NH2-
terminal kinase) was significantly higher in the abdominal SAT biopsies of subjects 
with more advanced disease (GOLD stage IV) and  significantly lower BMI, fat 
mass index (FMI), and fat-free mass index (FFMI) as compared to those with less 
severe COPD (GOLD stage I-III). In addition, the upregulation of these 
inflammatory mediators was associated with lower PaO2, BMI and adipocyte 




Although the interconnection of adiposity-incited, lung-specific, and systemic 
inflammation has yet to be proved, the role of chronic hypoxaemia, regional 
distribution and endocrine function of fat and lean mass and white adipose tissue 
(WAT) macrophage infiltration in the pathophysiology of systemic inflammation in 
COPD seem plausible (Rutten, Wouters and Franssen, 2013). 
 
2.3.2.3 Asthma  
Obesity is now recognised as a risk factor for asthma in adults and children. A large 
battery of epidemiologic studies indicate that obese patients have a higher risk of 
developing asthma.  
Progressive rise of asthma risk across the increasing levels of BMI was first shown 
in the 26-year follow-up of birth cohorts from the British Cohort Study (BCS70). 
This study indicated that young, particularly female, adults with obesity had the 
highest odds of suffering from asthma in the previous 12 months compared with 
non-overweight/obese subjects (OR:1.43; 95% CI (0.82, 2.50) in men; OR:1.84 ; 
95% CI (1.19, 2.84) in women) (Shaheen et al., 1999). A meta-analysis of large-
scale prospective studies reported a dose-response effect of BMI on the adjusted 
annual OR of incident asthma. Compared with normal-weight individuals, 
overweight and obese subjects had respectively 38% and 92% higher chance of 
being diagnosed with asthma over 1-year follow-up (Beuther and Sutherland, 2007). 
In contrast to the U-shaped association of BMI and COPD-related adverse outcome, 
the relationship between BMI and adult-onset asthma appears to follow a J-shaped 
pattern. Based on the Finnish Twin Cohort study, the risk of asthma increased by 
approximately 50% and 60% in the underweight and overweight subset of COPD-
free individuals as compared to their normal-weight counterparts. Notably, obesity 
was associated with 2-fold increase in the incidence of asthma over an 8-year period. 
During follow-up, multi-covariate adjusted odds of developing asthma was about 
40% higher in those who gained more than 10kg compared with subjects whose 
weight increased less than 10kg (OR:1.41; 95% CI (0.50, 3.98) for men and 




By contrast, some longitudinal studies have pointed to a reverse association. The 
Zurich Cohort Study of young adults revealed that the asthmatics were 4 times more 
likely to become obese over 20 years as compared to those without asthma (OR:3.9; 
95% CI (1.2, 12.2)). Also, pre-existing asthma was predictive of higher risk of 
weight gain (0.15 kg/m2 per year) and obesity (OR:3.2; 95% CI (1.3, 8.2)) later in 
life (Hasler et al., 2006). 
Notwithstanding these reports, there is substantial evidence that the aggregation of 
fat mass precedes development or deterioration of asthma in adults. The largest 
prospective study of adiposity-asthma link which followed Norwegians aged 14–59 
years for an average of 21 years found that the adjusted risk of self-reported asthma 
was significantly higher in men and women who were overweight (RR (95% 
CI):1.27 (1.13, 1.43) and 1.30(1.17, 1.45), respectively) or obese (RR(95% 
CI):1.88(1.28, 2.76) in men and 2.21 (1.75, 2.80) in women) as compared to their 
normal-weight peers. The incidence of asthma increased respectively by 7% and 
10% for each unit BMI increment in men and women subjects (Nystad et al., 2004). 
Besides BMI, body fat has been shown to be a predictor of asthma incidence. The 
assessment of birth cohorts from the Dunedin Study indicated that the odds of 
having asthma increased by 30% per 1SD increment in %BF of women. In addition, 
adiposity was found to be a contributor to the airflow obstruction. While higher 
%BF predicted greater airway obstruction in female participants, it was associated 
with less severe obstruction (higher FEV1/FVC) in males, particularly among 
smokers (McLachlan et al., 2007). 
The examination of data from the PRIT (Prevalence of Cardiovascular Risks in 
General Hospital Workers) 2001 survey showed that the likelihood ratio (LR) for 
asthma symptoms in female (but not male) Hispanic workers rose proportionally 
with increasing WC from 73.5 cm to 86 cm. WHR was not a predictor of asthmatic 
symptoms in any of these groups (Del-Rio-Navarro et al., 2003). Sex-dependent 
association between abdominal obesity and physician-diagnosed asthma was 
subsequently observed in the cross-sectional Humboldt study where abdominally 
obese women (WC ≥100 cm) had greater odds of life-time and recent asthma 
(adjusted OR (95% CI): 1.95 (1.11, 3.43)) than those with WC<100cm. Large WC 
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did not significantly increase the risk of life-time or recent asthma in men (Chen et 
al., 2005). 
Not only does excessive adiposity increase the risk of adult-onset asthma, but it 
impairs pulmonary function. Longitudinal exploration of data from the Health2006 
and the Health2006 follow-up studies illustrated a sex-dependent inverse 
relationship between 5-year changes in adiposity measures and parameters of lung 
function in a general population. In the asthmatic subgroup, 1SD increase in BMI 
from baseline to follow-up significantly predicted negative changes in FEV1 
(−96.4±16.7ml) and FVC (−109.7±24.4ml) in men. Despite declining trends in 
women, the contribution of adiposity to the worsening of lung function was not 
significant. Regardless of asthma status, changes (1SD) in all measures of adiposity 
(BMI, WC, %BF) were associated with significantly inverse changes in FEV1 
(−78.5, −66.4, and −52.0 ml for men; −25.5, −23.4, and −19.2 for women) and FVC 
(-113.6, -90.7, and -54.3ml for men; -32.6, -28.1, and -18.0 ml for women) but not  
FEV1/FVC ratio. The effect of adiposity on spirometric parameters was more than 
three times stronger in male participants than females and was not modified by 
atopy or fractional exhaled nitric oxide (FeNO) levels (Fenger et al., 2014). In a 
cross-sectional analysis of NHANES data, BMI, WC, and waist to height ratio 
(WHtR) were all related to the worsening of lung function (FEV1, FVC, FEF25-75%) 
in men and women with asthma, with WHtR being the strongest correlate of all 
indices in both sexes. Notably, WC and WHtR were significantly correlated with 
reduced FEV1/FVC ratio only in males (Sadeghimakki and McCarthy, 2019). 
In addition to pulmonary function, symptom burden, airway hyperresponsive 
(AHR), inflammation, and treatment response in patients with asthma are also 
influenced by their adiposity status. The normative aging study provided the earliest 
evidence on the relationship between obesity and AHR in asthmatic men. In this 
prospective cohort study, there was a U-shaped association between initial BMI and 
the risk of incident methacholine airway hyperresponsiveness, with the odds of a 
positive methacholine challenge test being 7.5fold greater in veterans who had the 
lowest (≤24.3 kg/m2) or highest(>29.4 kg/m2) baseline BMI as compared to other 
patients (Multivariable OR (95% CI): 7.5 (1.3, 44.7) and 7.5 (1.5, 37.8), 
respectively). Additionally, annual changes in BMI were linearly related to the odds 
of developing AHR over 4 years. Whereas 0.4-1.9 kg/m2 increase in BMI per year 
58 
 
predicted 55% higher risk of AHR, losing 0.2-1.5 kg/m2 per year decreased the 4-
year risk of AHR by 32%. Irrespective of methacholine challenge, no significant 
difference in percentage predicted values of FEV1 or FVC was observed across 
quintiles of BMI (Litonjua et al., 2002). 
In a recent prospective evaluation of severely obese patients with mild-moderate 
asthma who had undergone laparoscopic adjustable gastric banding (LAGB), 
surgically induced persistent weight loss (14.8±3.2 kg/m2) at 5-year follow-up was 
associated with significantly improved lung function (percentage predicted values of 
FEV1 and FVC), asthma control (Asthma Control Test (ACT) total score), and 
health related QoL (the Mini Asthma Quality of Life Questionnaire (Mini-AQLQ) 
score). In comparison, these outcomes remained unchanged in the control group 
from baseline to 5-year follow-up (Maniscalco et al., 2017). 
Likewise, a longitudinal study of morbidly obese (BMI>40 kg/m2) with physiologic 
evidence of asthma (determined by methacholine challenge or bronchodilator 
response) who underwent bariatric surgery showed significant improvements in 
spirometric indices (percentage predicted values of FEV1 and FVC), asthma control 
(lower scores on the Juniper Asthma Control Questionnaire (ACQ); less frequent 
use of short-acting ꞵ-agonists (SABA)), quality of life (Asthma Quality of Life 
Questionnaire (AQLQ) score), AHR (increased Methacholine PC20 estimates) at 
12-month follow-up. Importantly, clinical phenotype of asthma affected changes in 
several endpoint measures subsequent to bariatric surgery. AHR improved only in 
patients with normal IgE level (non-atopic patients). In spite of favourable changes 
in symptom severity and asthma control, markers of allergic inflammation (airway 
eosinophil count) did not increase postoperatively (Dixon, Pratley, et al., 2011). 
It should be emphasised that asthma is a heterogenous multifactorial disease with a 
multitude of clinical characteristics. The landmark Severe Asthma Research 
Program (SARP) identified 5 distinct phenotypes of asthma using agglomerative 
discriminant cluster analysis of demographic, pathobiologic, and clinical data from 
non-smoking asthmatics. Remarkably, obesity-asthma association was more 
recognisable in cluster 3 phenotype characterised by late-onset, female 
predominance, highest BMI, higher rate of hypertension, low FeNO and IgE 
concentration, high sputum neutrophil count, short duration of asthma, less 
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likelihood of atopy/allergy, mild airflow obstruction, AHR, disproportionate relation 
of symptoms to pulmonary function impairment, moderate severity, more reliance 
on medications, and frequent exacerbations requiring oral corticosteroid use (Moore 
et al., 2010). In this regard, the eosinophilic airway inflammation, assessed directly 
by quantifying eosinophil counts in induced sputum or indirectly by FeNO has not 
been found to be associated with adiposity in asthmatic obese patients (McLachlan 
et al., 2007). 
Contrary to the early-onset allergic asthma (clusters 1,2, and 4 with an increasing 
order of severity) that involves Th2-mediated lymphocytic inflammation and airway 
eosinophilia, mucus hypersecretion, and remodelling (Wenzel, 2012), the 
inflammatory responses in the adult-onset nonallergic obesity-related asthma 
(cluster 3) are predominantly mediated by Th1 cells (Sideleva and Dixon, 2014). 
This clustered phenotyping may help explain discrepant reports on the temporal 
relationship of obesity and asthma, sex differences in the adiposity-asthma 
associations, inconsistent effects of BMI and weight change on the AHR, and varied 
responses of asthma outcomes to the adiposity measures in children and adults. A 
large majority of these studies did not differentiate between early-onset Th2 allergic 
asthma and late-onset non-Th2 nonallergic asthma when explored the possible 
associations between adiposity and asthma endpoints. 
Excessive adiposity can be linked to the worsening of asthma-related outcomes via 
several potential mechanisms. From a mechanical perspective, the accumulation of 
truncal fat restricts lung capacity (TLC, FRC), diminishes ERV, and reduces lung 
compliance, leading to tidal-volume breathing, EFL, air-trapping, peripheral airway 
damage and ventilation/perfusion mismatch (Salome, King and Berend, 2010). 
Moreover, obese people have been shown to have more reactive airways due to their 
overstretched smooth muscles and reduced calibre (Dixon et al., 2010). Bronchial 
hyperresponsiveness (BHR) or impaired bronchodilation appear to be synergistically 
augmented by the co-existence of asthma and obesity (Boulet et al., 2005). Further, 
obesity is associated with inflammatory changes in the airways, including lower 
eosinophil and higher neutrophil count, Th1-polarised immune responses, IL-17 
related inflammation, and enhanced oxidative responses (Baffi, Winnica and 
Holguin, 2015).  
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Concomitant metabolic dysregulation also plays a role in the pathogenesis of 
obesity-asthma phenotype. Higher levels of plasma and airway leptin, lower L-
arginine/asymmetric dimethyl arginine (ADMA) ratio and aggravated oxidative 
stress may all contribute to the impaired lung function in obese asthmatics (Baffi, 
Winnica and Holguin, 2015). The imbalance between L-arginine, a precursor of 
nitric oxide (NO) and a substrate for inducible NO synthase (iNOS) and the ADMA, 
an inhibitor of NOS, results in the iNOS uncoupling, decreased bronchoalveolar NO 
bioavailability and impaired bronchodilatory response. This may lead to the 
worsening of pulmonary function, symptoms, and quality of life in overfat adults 
with asthma (Holguin et al., 2013). Apart from leptin, increased TNF-α may 
contribute to the AHR via TNFR-2 signalling that activates the expression of IL17‐
A, endothelin 1, and trk ꞵ, elements crucially involved in the innate airway 
responsiveness.(Williams et al., 2013). 
Along with the excessive fatness, insulin resistance (IR) is thought to be another 
culprit for the impaired pulmonary function in obese asthmatics. Recently, an 
investigation of NHANES data showed that IR strengthened the association of 
obesity and current asthma in adults by 2-fold, although the contribution of IR to the 
association between visceral adiposity and PFT values was not explored in this study 
(Cardet et al., 2016). In accord with this finding, a quantitative analysis of the 
NHANES 2009-2012 data elucidated that the absolute spirometric indices (FVC and 
FEV1) were negatively affected by IR in adults with asthma. In this study, IR 
modified the effect of central obesity (measured by WHtR) on and FVC and FEV1 
so that higher WHtR was associated with impaired lung function only in asthmatics 
who were insulin resistant (Sadeghimakki and McCarthy, 2019). 
IR and the consequent hyperinsulinemia can influence the lung function via several 
mechanisms. IGF-1 triggers airway smooth muscle proliferation and contractility 
(Dekkers et al., 2009). Insulin is a promoter of airway smooth muscle contraction 
and remodelling and a modulator of inflammatory reactions in the lung, especially in 
asthmatics with metabolic syndrome (Singh et al., 2013). Furthermore, it has been 
suggested that high insulin levels may alter the diameter of small airways via central 
neuro-hormonal mechanisms as well (MacIver, Michalek and Rathmell, 2013). The 
interplay between asthma and IR in centrally obese individuals could also be 
explained immunologically by the altered activation patterns of monocytes and T 
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helper cells (Dixon, Johnson, et al., 2011), leading to the predominance of Th1 and 
M1 adipose tissue macrophages (Lumeng and Saltiel, 2011; Gerriets and MacIver, 
2014). 
 
2.3.3 Lean mass and lung function 
As opposed to the deteriorating impact of excess fat on respiratory health and 
function, well-developed lean mass appears to improve lung physiology and protect 
against pulmonary dysfunction. Lean mass acts as a link between physical 
performance and lung function as it is related to respiratory muscle strength 
(Nishimura et al., 1995). Adjusted for by body fat, fat-free mass (FFM) and muscle 
strength have been shown to correlate significantly with lung volume and ventilatory 
capacity among healthy men and women(Enright et al., 1994; Lazarus et al., 1998). 
DXA-quantified total and segmental muscle mass are directly correlated with 
spirometric parameters (FVC, FEV1, FEF 25%–75%) in male and female Caucasians. 
Among lean mass components, leg and trunk lean mass have been shown to be the 
strongest age and BMI-matched determinants of  FEV1 and FVC in men and women, 
respectively (Martín Holguera et al., 2017). Moreover, FFM-depleted individuals 
exhibit lower respiratory (assessed by maximal inspiratory and expiratory mouth 
pressures) and peripheral muscle strength (measured by handgrip dynamometry) 
(Schols et al., 2003) even with a normal body weight (Schols et al., 1993). 
The inclusion of muscle mass or FFM components in the reference prediction 
equations for lung function, improves their accuracy (Cotes et al., 1979; Mengesha 
and Mekonnen, 1985). For instance, the inclusion of bone-free lean mass (BF-LM) 
and BMC in the regression models improved the performance of these models in 
predicting  spirometric parameters (FVC, FEV1, and PEF) as compared to the 
regression equations simply derived from age and height (Mohamed et al., 2002). 
The elevated FFMI augments IC while it diminishes ERV and FRC in both sexes. 
Because of the sex-specific association of FFM with IC, the effect of leanness on 
TLC, FVC and FEV1 is more prominent in healthy men than women (Cotes, Chinn 
and Reed, 2001). However, one should not forget the opposite effects of FM and 
FFM on the lung function. These body compartments may cancel out each other’s 
impact on spirometric parameters if not included as distinct variables in the 
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predictive models, giving the false impression that body size is not a significant 
covariate of lung function. This may be one of the reasons for the inconsistencies 
surrounding BMI-lung function associations 
Body composition might also modify the association between age and lung function. 
As men and women grow old, they tend to become physically less active, gain 
(visceral) adipose tissue and lose skeletal muscle, both contributing to the age-
related decline in pulmonary function (Hazzard et al., 2003) due to reduced elastic 
recoil, chest wall compliance and respiratory muscle function(Enright et al., 1994; 
Watsford, Murphy and Pine, 2007).The positive association between FFM (and 
muscle strength) and spirometric indices (FEV1, FVC, and FEV1/FVC) has been 
observed in the elderly men and women both cross-sectionally (Wannamethee, 
Shaper and Whincup, 2005; Karacan et al., 2008) and longitudinally (Burchfiel et 
al., 1997). Of note, a longitudinal study of older Italians showed that controlling for 
baseline lung function, smoking, renal function and sex, FVC diminished by 38ml 
(95% CI (17, 60)) per 1kg decline in DXA-measured FFM over 7 years. More 
precisely, individuals with increased SAD and decreased FFM had the highest 
probability of FEV1 and FVC decline. In comparison, those with stable FFM and 
decreased SAD had the lowest frequency of diminished  FEV1 and FVC , denoting 
the additive effect of excess fat and FFM depletion on lung function impairment in 
the setting of sarcopenic obesity (Rossi et al., 2008). In addition to the loss of 
muscle mass, the decline in muscle function (partially caused by intermuscular fat 
infiltration) may impair respiratory performance in older adults with sarcopenic 
obesity (Rossi et al., 2011). In this regard, an analysis of the Korean National Health 
and Nutrition Examination Survey (KNHANES) indicated that pulmonary function 
was most severely affected in COPD-free older adults who had concomitant low 
muscle mass and obesity (Moon, Kong and Kim, 2015).  
FFM, particularly SMM, is also a significant determinant of the exercise tolerance, 
clinical course and the prognosis of patients with pulmonary diseases. The 
prevalence of sarcopenia, defined by the European Working Group on Sarcopenia in 
Older People (EWGSOP) as low muscle mass plus low muscle strength and/or low 
physical performance (Cruz-Jentoft et al., 2010), is higher in patients with COPD 
than COPD-free individuals. In addition, frequency of sarcopenia is higher in the  
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patients with more advanced COPD as compared to those at earlier stages of the 
disease (Shimokata et al., 2018). 
COPD patients with reduced muscle quantity, quality or strength tend to be older, 
and at higher risk of cardiovascular comorbidities. The degree of airflow limitation, 
the intensity of symptoms, the frequency of exacerbations, the level of physical 
disability and impaired quality of life, as well as the severity of disease are more 
pronounced in sarcopenic patients with COPD compared to non-sarcopenic patients, 
especially among men (Jones et al., 2015). Patients with moderate-severe COPD are 
3 times more likely to have low FFMI (OR:3.5; 95% CI (2.33, 5.27)) compared to 
ever-smokers without COPD, independent of their sex or age (Grydeland et al., 
2012). FFMI declines progressively with the worsening of COPD, with subjects 
suffering from GOLD stage 4 disease having the highest prevalence of skeletal 
muscle mass depletion (Vestbo et al., 2006).  
Apart from the established detrimental effect of low BMI on the outcome measures 
of COPD in different age groups (Landbo et al., 1999; Corrada et al., 2006; 
Thinggaard et al., 2010), it has been shown that skeletal muscle mass (SMM) 
depletion, assessed by mid-thigh muscle cross sectional area (MTCSACT) and mid-
arm muscle area (MAMA), is a stronger predictor of mortality than BMI in those 
with severe COPD (Marquis et al., 2002; Soler-Cataluña et al., 2005). Akin to these 
observations, a recent study of community-dwelling older Taiwanese with 
objectively diagnosed stable COPD indicated that low (<30 cm) calf circumference 
(CC) and low (<23.5 cm) mid upper arm circumference (MUAC) were more 
effective independent predictors of 3-year multivariate mortality (HR (95% CI): 
4.40 (1.82, 10.63) and 3.09 (1.30, 7.38), respectively) than low BMI (<21 
kg/m2)(HR (95% CI): 2.78 (1.10, 7.10)) (Ho et al., 2016).  
As the lung function deteriorates, the impact of FFM depletion and skeletal muscle 
deconditioning on the physical disability of the patients also becomes more 
prominent. In the advanced course of COPD, there is universal loss of body mass 
(FM and FFM) and muscle wasting. In this context, it appears that depleted lean 
mass is the strongest correlate of ventilatory disturbance, with FFMI being the most 
important prognostic factor in moderate-severe COPD (Slinde et al., 2005). 
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Although muscle depletion may be the consequence of a more severe phenotype of 
COPD associated with heavy smoking, it could also be a causative factor. Recent 
data from the population-based BOLD (Burden of Obstructive Lung Disease) study 
indicated that thin (BMI<20 kg/m2) male and female never-smokers had higher risk 
of experiencing moderate-severe COPD (GOLD stage 2 and above) (OR (95% CI): 
13.39 (3.67, 48.84) and 2.56 (1.40, 4.71) than their normal-weight counterparts 
(Lamprecht et al., 2011). Over time, however, the slope of FFM decline in patients 
with COPD approximates that of controls irrespective of the smoking status. The 
Health ABC Study revealed striking similarities in multivariate adjusted 7-year 
trajectories of lean mass, BMC, and quadriceps strength between older adults with 
mild-moderate obstructive lung disease and smokers as well as never-smokers with 
normally functioning lungs (Van Den Borst et al., 2011). 
Besides depleted SMM, peripheral muscular weakness (measured by quadriceps 
maximal voluntary contraction force (QMVC)) is also associated with poor survival 
in patients with moderate-severe COPD (Swallow et al., 2007). In agreement with 
this finding, a posteriori analysis of the multicentre Phenotype and Course of COPD 
(PAC-COPD) study demonstrated that after adjustment for ADO (age, dyspnoea, 
obstruction) index (Puhan et al., 2009). BMI, handgrip strength below 10th centile 
of the healthy population predicted increased mortality in patients with stable COPD 
(HR:1.53; 95% CI (1.07, 2.12)) (Burtin et al., 2016).  
In patients with COPD, upper and/or lower limb muscular strength not only predict 
the quantity of life, but they also affect the quality of life. Based on the prospective 
analysis of data from the multicentre ICE-COLD ERIC (International Collaborative 
Effort on Chronic Obstructive Lung Disease: Exacerbation Risk Index Cohorts) 
study, 2-year mortality decreased by 42% and 16% per 5 more repetitions of the 1-
minute sit-to-stand (STS) and per 5kg rise in the isometric grip force. Additionally, 
1-min STS as a measure of exercise capacity was found to be a strong predictor of 2-
year survival with a discriminatory power close to ADO and BODE (BMI, airflow 
obstruction, dyspnoea, exercise capacity) indices (Muggensturm et al., 2013). It 
should also be noted that, until advanced stages, COPD patients lose 
disproportionately higher amount of muscle in lower limbs as they work the upper 
body muscles more frequently and more extensively, leading to quadriceps atrophy 
and weakness (Bernard et al., 1998). 
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Several factors contribute to the loss of lean mass and muscular dysfunction in 
patients with COPD, including muscle disuse, long-term use of oral corticosteroids, 
chronic hypoxia as well as systemic and local inflammatory responses. Depending 
on the severity of pulmonary damage, several myopathological adaptations occur in 
the skeletal muscles of COPD patients. These include progressive reduction in 
skeletal muscle capillarisation (due in part to the hypoxia-attenuated VEGF 
expression) which is related to the degree of airflow obstruction and exercise 
capacity, fibre type shifting towards an easily fatigable glycolytic profile (due to the 
impaired muscle oxygen supply) related to BMI and oxidative capacity, (Eliason et 
al., 2010) and dysregulation of skeletal muscle protein metabolism (caused by 
disturbances in ubiquitin–proteasome and myogenetic pathways) that leads to 
muscle atrophy and defective compensatory hypertrophy (Joanisse et al., 2007). 
Besides their discrete effects on the health status, functioning capacity, and survival, 
high FM and low FFM also exert compound impacts on COPD-related outcomes. 
The new approach toward the assessment of body composition in COPD sufferers is 
to classify the patients into distinct phenotypes, i.e., normal body composition, 
obesity, sarcopenia, and sarcopenic obesity (SO). Data from ECLIPSE (Evaluation 
of COPD Longitudinally to Identify Predictive Surrogate Endpoints) study shows 
that COPD patients with SO have significantly lower physical performance (-28min 
6MWD; 95% CI (-45.6, -10.4) and more intense inflammation (1.6 time greater odds 
of having more than 2 inflammatory markers, 95% CI (1.1, 2.5)) compared to those 
with normal body composition (Joppa et al., 2016). Across body composition 
phenotypes, FEV1 , physical functioning (expressed as the quadriceps strength per 
kilogram ASM) and cycle endurance time have been found to be lower in the 
sarcopenic patients with COPD  as compared to SO (Van De Bool et al., 2015). 
Better physical performance of the latter group may be secondary to the reduced 
lung volume that attenuates the static and dynamic hyperinflation in their lungs 
(Wadell et al., 2011). Static lung hyperinflation (presenting as low IC) has emerged 
as a risk factor for disease-specific and all-cause mortality in COPD patients 
(Tantucci et al., 2008). It is, therefore, conceivable that lower lung volumes and 
larger IC and IC/TLC in COPD patients with higher body weight may improve their 
ventilatory function (Casanova et al., 2005). This protection is, however, outdone by 
the increased cumulative risk of morbidity and mortality in patients with sarcopenic 
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obesity. In COPD patients with SO, depleted SMM, contractile insufficiency, 
metabolic impairment and myokine dysregulation act in synergy with excessive 
adiposity to aggravate their adverse outcomes, including insulin resistance, 
weakened antioxidant capacity, fatigue, fractures, and impaired ventilation as well 
as the greater risk of dyslipidaemia, metabolic syndrome, type 2 diabetes and 
cardiovascular disease (Biolo, Cederholm and Muscaritoli, 2014). Thus, it is prudent 
to include detailed body composition analysis in the risk estimation and 
multidisciplinary care of patients with chronic pulmonary disease. 
In the setting of asthma, recent findings suggest that lean mass may be a better 
indicator of pulmonary function than fat mass. In the multivariable analyses of data 
from the year 20 examination of the CARDIA cohort, all indices of fat and lean 
mass were significantly associated with the adjusted odds for current asthma in 
females with intermittent or mild-moderate asthma. On the contrary, none of these 
indices showed significant association with the risk of asthma in male participants 
except for lean arm muscle index. Moreover, there was a sexual dimorphism for 
asthma-lean mass association, such that highest tertile of total and regional lean 
mass indices reduced the risk of current asthma in men but increased it in women 
(Beckett et al., 2010), providing further evidence to the importance of exploring 
asthma and its covariates as phenotypic clusters. This observation can be explained 
by the fact that lean mass is not entirely formed of fat-free tissues, particularly in 
women whose DXA-measured lean mass is not an absolute measure of the skeletal 
muscle mass (Sutherland et al., 2008). The marbling of muscles is also a prominent 
finding in females, a phenomenon which does not depend on their overall fat mass 
(Miljkovic-gacic et al., 2008). Divergent effects of sex-hormones, adipokines (leptin 
and adiponectin), and other endocrine products may also be involved (Sood, 2011). 
Among female cohorts of the CARDIA study, DXA-assessed total lean mass was a 
stronger predictor of current asthma (OR (95% CI): 1.87 (1.04, 3.36)) than total fat 
mass (1.46 (0.77–2.77)). Importantly, the association of fat mass and asthma became 
nonsignificant after the addition of lean mass to the model, indicating the 
independent effect of lean mass on the asthma risk. Among regional components of 
lean mass, trunk (OR (95% CI): 2.81 (1.39, 5.69)) and leg (OR (95% CI): 0.40 
(0.19, 0.84)) mass indices remained significant predictors of current asthma after 
adjustment for regional fat components (Beckett et al., 2010). Interestingly, the ORs 
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for truncal and leg lean mass were directed oppositely, signifying the site-specific 
metabolic and inflammatory effects of lean tissues (Pelt and Schechtman, 2002; 
Olsen et al., 2005).  At the same time, the possible contributory role of the ectopic 
fat deposits in the asthma-leanness relationship cannot be ruled out (Berry et al., 
2006). It is noteworthy that women have higher physiological (subcutaneous) and 
(metabolically more active and strongly pro-inflammatory) ectopic fat content 
(including fat infiltrates in the skeletal muscle) (Kyung-Mook et al., 2011; Sood, 
2011). Despite quantitatively lower visceral fat, metabolic activity of this adipose 
depot is greater in women (Leenen et al., 1992; Rattarasarn, Leelawattana and 
Soonthornpun, 2004). By contrast, their total and regional lean mass are lower and 
contain higher intramyocellular triglycerides (Battezzati et al., 2001). 
Lean and fat mass exert similarly directed effects on pulmonary function in female 
subjects with asthma. In a study of non-smoking overweight or obese Australians 
with objectively diagnosed stable asthma awaiting weight loss intervention, DXA-
measured total and regional lean mass correlated negatively with the static (TLC, 
FRC, ERV) and dynamic lung function (FVC, FEV1, FEV1/FVC) parameters in 
women as were the overall and regional fat mass. Intriguingly, significant 
relationships were found only between lean and fat mass of the arms with FVC, total 
and arm lean mass as well as android, thoracic, and arm fat mass with ERV, and arm 
lean mass with TLC and FRC. In contrast, components of lean mass in men were 
positively related to static and dynamic lung function whilst their corresponding fat 
components were negative correlates of these parameters. In male subjects, 
significant correlations were detected only between android and arm lean mass with 
TLC and FRC, total lean mass with TLC, and android lean mass with ERV. 
Nonetheless, total and upper body (android, thoracic, and arm) fat mass in males 
were positively correlated with leptin levels. Fat content of the arms correlated 
significantly with the eosinophil count while leg lean mass was the only significant 
correlate of the systemic inflammation (CRP). In females, however, significant 
relationships were found between gynoid fat mass with eosinophilic airway 
inflammation (sputum eosinophil%) as well as lower body (gynoid and leg) lean 
mass with neutrophilic airway inflammation (sputum neutrophil% and count). In 
addition, static (ERV) and dynamic (FEV1/FVC) lung function were oppositely 
associated with android lean mass in men whilst lean and fat mass were inversely 
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associated with ERV in women (Scott et al., 2012). These findings suggest sexually 
dimorphic interplay between body composition, systemic and airway inflammation 
and pulmonary function in asthmatics, giving substance to the notion that the 
pathophysiology of asthma varies across clusters of disease. 
Cystic fibrosis (CF) is also closely related to the alterations in lean body mass.  
Adult patients with stable CF have significantly lower total FFM, BMC and regional 
FFMI than their age or sex matched healthy peers, with regional FFM loss following 
a hierarchical pattern (greatest FFMI deficit being detected in leg followed by arm 
and trunk). Furthermore, the magnitude of FFM and BMC loss in all segments is 
accentuated by the increasing severity of disease (Bolton et al., 2003). Loss of 
muscle mass and bone organic matrix are thought to be caused by the reduced 
physical activity and catabolic intermediary metabolism secondary to sustained 
inflammatory response to chronic pulmonary infection (Ionescu et al., 2002). FFM 
depletion is also a poor prognostic factor in patients with cystic fibrosis as it 
underlies reduced inspiratory muscle dysfunction and diaphragmatic thinness. 
Patients with the loss of DXA-measured FFM (<5th percentile of the reference 
population) had significantly lower static (VC and TLC) and dynamic (FEV1% 
predicted) lung function, (Enright et al., 2007). These important contributions may 
remain undetected in earlier stages of disease if only body mass and weight are 
relied upon for the nutritional evaluation of patients, partially explaining why 
nutritional support fails to improve the health status and pulmonary function of CF 
patients in spite of inducing weight gain (Thomson et al., 1995). Using serum 
creatinine as a biomarker of lean muscle mass, a study of adults patients with stable 
CF from the UK Cystic Fibrosis Registry found that FEV1 and FVC would increase 
respectively by 171 ml (95% CI (116, 227)) and 99ml (95% CI (41, 157) in males 
and by 90 ml (95%CI (46, 133) and 64ml (95%CI (19, 110)) in females per 1SD 
increment in serum creatine level in the mutually adjusted models. Additionally, 
compared to patients with normal BMI, those with BMI< 20 kg/m2 had significantly 
lower FEV1 and FVC, whereas overweight/obese (BMI≥25 kg/m
2) men and women 
exhibited significantly higher FEV1 and FVC, a trend opposite to that seen in 
healthy population (Forrester et al., 2013). These observations underscore the 




2.4 Body Composition and Systemic Blood Pressure 
2.4.1 Fatness and blood pressure 
The ascending trend in the obesity epidemic over the past 20 years has been 
paralleled by an upward shift in the prevalence of hypertension (Forouzanfar et al., 
2016). Obesity, mainly in the form of central adiposity, is a precursor for primary 
hypertension. In the Framingham study, hypertension was twice as common in 
obese men and women as normal weight individuals, with those in the highest BMI 
quartile having higher systolic (SBP) (16mmHg) and diastolic (DBP) (4mmHg) 
blood pressure than persons in the lowest quartile (Hubert et al., 1983). Likewise, in 
the second Nurses’ Health Study, the 14-year risk of incident hypertension was more 
than 2 and 4 times higher in young (27-44 years old) overweight and obese women 
with normal baseline SBP and DBP (multivariable HR (95% CI) : 2.56 (2.43, 2.7) 
and 4.70(4.45, 4.96), respectively) as compared to their age-matched leaner 
counterparts (BMI<23 kg/m2) (Forman, Stampfer and Curhan, 2009). Among the 
modifiable risk factors (physical inactivity, low DASH score, alcohol consumption, 
and BMI), BMI was the strongest predictor of hypertension incidence in this 
population, with an estimated 40% attributable risk for overweight or obese status. 
Surprisingly, adherence to other low risk behaviours (daily vigorous exercise, high 
DASH score, low alcohol intake, and minimal use of non-narcotic analgesics) did 
not reduce the HR of incident hypertension in obese women, implying the 
significantly role of weight loss in primary or secondary prevention of elevated 
systemic blood pressure. The efficacy of weight-loss as a part of lifestyle 
modification in the control of hypertension has been established by several studies. 
The results of the multicentre Trials of Hypertension Prevention (TOHP) Phase II 
showed that both SBP and DBP decrease significantly at 6 (3.7 mmHg SBP; -2.7 
mmHg DBP),  18 (-1.8mmHg SBP; -1.3mmHg DBP), and 36 months (-1.3mmHg 
SBP; -0.9mmHg DBP) in overweight or obese individuals (30 to 54 years old) with 
above-normal nonmedicated blood pressure (BP) who underwent weight-loss dietary 
interventions as compared to the control group. In particular, the relative risk (RR) 
of hypertension at 36-month follow-up was significantly lower in those who 
successfully maintained their lost weight (at least 4.5 kg) as compared to the relapse 
and no-loss group (RR (95% CI): 0.46(0.25, 0.84) and 0.31(0.18, 0.55), 
respectively) (Stevens et al., 2001). It should be noted, however, that the association 
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of adipose tissue with arterial pressure varies by ethnicity and fat distribution. 
Nevertheless, visceral adiposity has been shown to be consistently related to the rise 
in blood pressure. The multidetector CT sub-study of the Framingham Heart Study 
Offspring and Third-Generation Study cohorts revealed that in the multivariable 
adjusted models, VAT was a more powerful predictor of SBP and DBP than SAT in 
both men and women. The association between VAT and arterial pressure remained 
significant after adjustment for BMI and WC (Brion et al., 2007). Findings from the 
IRAS (Insulin Resistance and Atherosclerosis) family study also indicated that the 
odds of being hypertensive was significantly higher in Hispanic and African 
American adults in the highest tertiles of both VAT and BMI (OR:6.30 and 
OR:3.50, respectively) compared with those in the lowest collective tertile (Foy et 
al., 2008). BP-raising effect of greater central adiposity was corroborated by the 
Ohtori Study which demonstrated 5-fold increase in the risk of high-normal pressure 
or hypertension among Japanese men in the highest tertile of intra-abdominal fat 
area (IAFA) as compared to those in the lowest tertile, controlling for multiple 
confounders  including abdominal subcutaneous fat area (ASFA), total subcutaneous 
fat area (TSFA), and insulin resistance. In the multivariate models, none of these 
measures were significant predictors of the outcome (Koh et al., 2011). 
Adipose tissue interacts with the cardiovascular system through haemodynamic, 
neurohumoral, and renal mechanisms (Hall et al., 1993). Compared with lean 
people, obese subjects have higher arterial pressure, heart rate, glomerular filtration 
rate (GFR), renal sodium reabsorption, renal and muscular sympathetic activity and 
perfusion (in the uncomplicated ABCD), as well as plasma insulin levels. Moreover, 
the incidence of (eccentric and concentric) left ventricular hypertrophy (LVH) is 
higher in obese individuals. By contrast, baroreflex sensitivity, cardiac diastolic 
function, muscle blood flow reserve, cardiac sympathetic activity and insulin 
sensitivity tend to be lower in the subjects with overfatness (Hall et al., 2015). These 
abnormal changes in vasculature are due, in part, to endothelial dysfunction, 
vascular stiffening and atherosclerosis stemming from adiposity-related 
inflammation, oxidative stress, neurohumoral overactivity, hyperglycaemia, and 
lipotoxicity (Lyon, Law and Hsueh, 2003; Wildman et al., 2003). Central obesity 
has also deleterious effects on renal pressure natriuresis. The accumulation of WAT 
in visceral, retroperitoneal and perinephric areas compresses the kidneys, rising 
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intrarenal and subsequently systemic arterial pressure. Retroperitoneal and renal 
sinus fat deposition may also induce inflammation and interstitial oedema in the 
extracellular matrix of renal medulla, compressing the loops of Henle and vasa recta, 
and secondarily decreasing medullary and tubular perfusion which serves as the 
stimulus for increased renal sodium reabsorption (Hall, Brands and Henegar, 1999; 
Hall et al., 2014). Additionally, ectopic intrarenal fat may induce kidney damage 
through mitochondrial dysfunction and endoplasmic reticulum stress (Unger et al., 
2013). The other factor involved in the association  between adiposity-induced renal 
injury and hypertension is the local and systemic activation of renin angiotensin 
aldosterone system (RAAS).This escalates renal Na reabsorption, constriction of 
efferent glomerular arterioles, and intraglomerular hydrostatic pressure, 
deteriorating harmful interplay of kidney dysfunction and hypertension (Hall et al., 
2012; Landsberg et al., 2013). The activation of sympathetic nervous system (SNS), 
particularly renal sympathetic nerve activity (RSNA) is the third important 
mechanism mediating BP-raising effect of visceral adiposity. It stimulates RAAS 
and renal sodium reabsorption as well vascular tone (Lohmeier and Iliescu, 2013). 
Other factors contributing to SNS activation in the setting of obesity-induced 
hypertension include baroreflex dysfunction, OSA-triggered chemoreceptor reflexes, 
hyperinsulinemia, and increased angiotensin II.  
Recent findings also stress the pivotal role of central leptin-melanocortin pathways 
in the pathophysiology of adiposity-related hypertension. In this respect, chronic 
hyperleptinemia activates the CNS proopiomelanocortin (POMC)- melanocortin 4 
receptor (MC4R) system via Janus tyrosine kinase 2 (JAK2)- signal transducer and 
activator of transcription 3 (STAT3), insulin receptor substrate 2 (IRS2)-
phosphatidylinositol 3-kinase (PI3-K), and Src homology-2 tyrosine phosphatase 
(SHP2) mitogen-activated protein kinase (MAPK) which in turn stimulates 
vasomotor centres in the brain stem and spinal sympathetic preganglionic neurons, 
leading to increased SNS, RNSA, and BP. This hypertensive effect of central 
adiposity is amplified by the concurrent endothelial dysfunction and selective 
resistance to anorexigenic and weight-reducing actions of leptin (Hall et al., 2015). 
Thus, visceral adiposity may initiate and promote essential hypertension by inducing 




2.4.2 Leanness and blood pressure 
Unlike the clear relationship between adiposity and BP, findings on hypertension-
leanness association have been inconsistent. A study of non-underweight young men 
reported a J-shaped relationship between DXA-measured lean mass percentage and 
submaximal SBP recorded during graded exercise test, with men in 2nd to 4th 
quintiles having significantly lower submaximal SBP at various intensities of 
exercise than those in the lowest and highest quintiles (Prasad et al., 2016). In the 
Tobago Health Study, baseline and 6-year decrease in calf muscle attenuation (as an 
indication of intramuscular fat infiltration) determined by peripheral quantitative CT 
(pQCT) were significant predictors of newly developed hypertension among black 
men even after adjustment for BMI or WC and intermuscular adipose tissue 
(IMAT). This underscores the contribution of intramuscular adiposity to BP rise, 
possibly via adiposity induced RAAS activation and impaired intramuscular insulin 
action (Zhao et al., 2017). In contrast, BIA-derived MAMC and LBM were 
positively associated with SBP in Turkish university students (Vaziri et al., 2015). 
In a cohort study of postmenopausal women, DXA-measured total and regional 
(trunk, arm and appendicular but not leg) lean mass indices (LMI) were positively 
correlated with SBP and DBP, independent of age, physical activity, and total FM. 
Nonetheless, most of these indices lost their significance after adjustment for WC, 
except arm LMI. Interestingly, all lean mass indices showed significantly positive 
relationship with anthropometric and DXA-derived measures of fatness. There was a 
significant interaction between arm LMI and WC such that metabolic syndrome was 
more prevalent in women who had larger waist and higher arm LMI as compared to 
other combinations of WC and arm LMI (Peppa et al., 2014), suggesting that lean 
mass may potentially link central adiposity to cardiometabolic health in this 
subpopulation. Analogous to these observations, a large study of community-
dwelling Chinese adults found higher multivariable (including fat mass) adjusted 
risks of prehypertension and hypertension in subjects with increased total skeletal 
muscle index (SMI) measured by DXA (OR (95%CI): 1.34 (1.16,1.54) and 1.55 
(1.35,1.78), respectively). The android to gynoid fat ratio (AOI) as an indicator of 
central obesity was a very strong predictor in these models (OR (95%CI): 5.86 
(2.72,12.62) and 12.05 (5.74,25.31), respectively). Notably, high arm but not leg 
LBM was the significant predictor of elevated SBP and DBP, pointing to the BP-
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rising potential of upper-limb muscularity (Ye, 2018). One possible explanation for 
these findings can be LVH, carotid wall thickening, arterial stiffness (Leischik et al., 
2014; Moreno et al., 2015), myofiber type shift in hypertrophied muscles (DiCesare 
et al., 2017), and SNS activation (Fossum et al., 2004; Saito, Iwase and Hachiya, 
2009) in (obese or intensively exercising) individuals with elevated skeletal muscle 
mass which exert BP-increasing effects. This provides further support for the 
combined assessment of fat and lean mass in the risk evaluation of patients with 
ABCD. 
 
2.5. Blood pressure and lung function 
Although the underlying mechanisms are still incompletely understood, several 
studies have revealed significant interactions between systemic blood pressure and 
pulmonary function in across genders and ethnicities. 
In a population-based prospective cohort study of Swedish men, hypertensive men 
with impaired lung function (height-adjusted FEV1 below median) had significantly 
higher incidence of stroke, cardiac events and all-cause mortality than hypertensive 
group with high FEV1, even after adjustment for smoking and other confounders 
(Engström et al., 2001). Earlier, the Normative Age Study had demonstrated that 
residual FVC (adjusted for age and height) was inversely associated with 10-year 
incidence rate of hypertension in men (Sparrow et al., 1988). Similarly, the 
multivariate adjusted 2-year risk of incident hypertension was significantly higher in 
initially normotensive Chinese women at the lowest quintiles of FEV1 and FVC (Wu 
et al., 1998). It has also been reported that older people with reduced FEV1 display 
higher short-term beat-to-beat SBP variability (Engström et al., 2009). Nevertheless, 
there is uncertainty over long-term association of impaired lung function and blood 
pressure variability. As indicated by the Jackson Heart Study, after multivariable 
adjustment, sex-specific quartiles of FVC and FEV1 were not associated with day-
night standard deviation and average real variability of SBP and DBP in African 
Americans (Booth III et al., 2016).  
Besides baseline records, the rate of FVC decline is a predictor of developing 
hypertension later in life. The prospective Coronary Artery Risk Development in 
Young Adults (CARDIA) Study showed that, controlling for sociodemographic, 
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SBP, and BMI data, young adults with greatest FVC decline from the peak recorded 
value were respectively 37% (HR:1.37 (1.05–1.80)) and 49% (HR:1.49 (1.07–2.07)) 
more likely to develop hypertension at year 10 and 20 follow-ups. Further, the risk 
of incident hypertension increased by 15% (HR:1.15 (1.06–1.26)) and 28% (HR: 
1.28 (1.16–1.42)) per 1SD decrement of FVC from peak to years 10 and 20, 
respectively(Jacobs Jr et al., 2012). 
In this setting, one of the most plausible explanations would be the concomitant but 
not necessarily interconnected changes in the physiology of respiratory and vascular 
systems induced by or associated with adiposity and insulin resistance. 
Multidimensional influences of adiposity on respiratory function and systemic blood 
pressure were explored in previous sections.  
With respect to insulin resistance, insulin can trigger polarisation of the effector T 
cells towards a Th2 phenotype, a key contributor to the pathogenesis of asthma. This 
hormone also induces mast cell-mediated bronchoconstriction by activating 
phosphoinositide 3-kinase (PI3K) pathway. As seen in patients with diabetes who 
had been administered inhaled insulin formulations, these substantial local effects 
may decrease FEV1.  
By synergistic interaction with insulin-like growth factor (IGF)-1 receptor, insulin 
may increase airway smooth muscle mass via mitogen-activated protein kinase 
(MAPK) - extracellular signal-regulated kinases (ERK) and PI3-K/Akt signalling 
pathways. Insulin also affects contractility of airway smooth muscles in a Rho 
kinase and PI3-kinase-dependent fashion. Rho-kinase pathway results in the 
production of contractile prostaglandins in airway smooth muscles. On this basis, 
insulin contributes to the formation of stiff and hypercontractile airways. 
Alternatively, insulin may modulate lung morphogenesis prenatally and airway 
remodelling postnatally via activation of Wnt / Beta-Catenin signalling (Singh et al., 
2013).Finally, it has been revealed that central hyperinsulinemia may increase 
hyperreactivity of both proximal and distal airways via activation of ERK but not 
PI3K/Akt pathway in parasympathetic pre-ganglionic nerves at the dorsal vagal 
complex (DVC) which convey outflow signals down to richly innervated small 
diameter airways where maximum contraction occurs (Leiria et al., 2015). 
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Regarding the link between IR and systemic BP, there is compelling evidence that 
IR induces vascular dysfunction by impairing NO synthesis, activating MAPK-
related vasoconstriction, inflammation, and sodium retention, and raising 
intracellular ICAM and VCAM levels following excessive release of prothrombotic 
and pro-inflammatory factors (Ormazabal et al., 2018). In addition, IR is associated 
with the overactivity of SNS and RAAS, promoting myocellular hypertrophy and 
remodelling of the vessel wall (Landsberg, 1999). 
Apart from the potential role of adiposity, systemic inflammation, and insulin 
resistance associated with abnormal changes in pulmonary function and systemic 
blood pressure, It could be postulated that diminished elastic recoil, airway 
remodelling and inflammatory reactions in lung parenchyma are directly associated 
with parallel nonatherosclerotic decline in elasticity and increased stiffness of the 
vessels together with endothelial dysfunction, and subsequently essential 
hypertension (McAllister et al., 2007; Mills et al., 2008).  
Although the bulk of evidence points to the precedence of reduced lung function 
over hypertension, some studies have suggested a reverse relationship. In the 
ECRHS-I (European Community Respiratory Health Survey) Erfurt study, after 
adjustment for confounders, medically treated patients with uncontrolled 
hypertension had significantly lower FVC (-190ml) and FEV1 (-150ml) compared to 
normotensive subjects or patients who did not receive antihypertensive medication 
(Schnabel, Nowak, et al., 2011). Longstanding elevated BP causes LVH and raises 
the arterial and pulmonary venous pressure. This, in turn, leads to the interstitial 
fluid accumulation in lung parenchyma, reducing lung volume and compliance. 
Broncho-constrictive effects of ꞵ-blockers and angiotensin converting enzyme 
inhibitors (ACEI) may also aggravate the deterioration in lung function. This 
complies with the results of the Cardiovascular Health Study which showed that 
never-smoking elderly people free of pulmonary disease but with systolic 
hypertension had significant anthropometrically adjusted decrements in FEV1 (-40 
to -100-ml) and FVC (-50 to -150ml) as compared to their normotensive 
counterparts. Importantly, LVH is associated with significant declines in FVC and 
FEV1 (Enright et al., 1995). Arterial stiffness may also play a role in the association 
between elevated BP and reduced lung function. As revealed in the Multi-Ethnic 
Study of Atherosclerosis (MESA), multivariable adjusted FVC increased by 40±5 
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ml per 1SD increment in small arterial elasticity (SAE). Remarkably, endothelial 
(soluble intercellular adhesion molecule (sICAM-1), haemostatic (fibrinogen), and 
general inflammatory (hs-CRP and IL-6) biomarkers were all predictors of reduced 
SAE and FVC in men and women (Duprez et al., 2013).  
Altogether, it can be construed that there should be a common process linking 



























3.1. Study design and population 
This research project was a cross-sectional study of community dwelling adults (19-
65 years old) living in London. It was conducted in the Nutrition Physiology 
Laboratory at London Metropolitan University from November 2016 to October 
2018. Ethical approval was taken from the School of Human Sciences ethics panel, 
London Metropolitan University (Appendix A). The study was not funded by any 
internal or external sources.  
Recruitment process (Figure 3.1) involved advertisements on bulletin boards, the 
official website of the university, social networking sites. The project was also 
advertised in the student support services, the centre for education and learning, and 
the Science Centre. In addition, flyers (Appendix B) were distributed across the 
campuses (notice boards, cafeterias and outside lecture rooms, international student 
office, and the student hub). There were negotiations with the student union to notify 
student academic representatives, success coaches, society members, student council 
and related committees both internally and externally; communication with the 
schools and course leaders to inform their colleagues and students of this project. 
Promotion of the study was also undertaken across Barnet -Enfield-Haringey NHS 
services as well as minority ethnic communities. The recruitment process also 
included snowballing whereby the interested volunteers were asked to pass on 
details of the study to others via spoken word, email, or social networks. Induction 
sessions were held at the Tower Building, North Campus, London Metropolitan 
University where the potential participants were briefed about the project and the 
information sheets were distributed among them (Appendix C) to give the attendees 
a better understanding of the study. The interested volunteers (n=134) were given 
specific numbers. Then, 50% of the volunteers were selected randomly using 
random number generation. Selected individuals were contacted to arrange the 
measurements. Afterwards, supplementary information and preparatory instructions 
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about the tests were emailed to them three days before their appointments. A number 
of selected subjects (n=11) missed the appointment for different reasons (did not 
agree to perform the tests, did not show up, cancelled the appointment, developed 
one of the conditions precluding accurate measurements, could not access the site, 
rescheduled but failed to attend the session). In total, 56 adult men (n=25) and 
women (n=31) from students and staff of London Metropolitan University as well as 
the external volunteers took part in the study. The estimated sample size based on a 
priori calculation for hierarchical multiple linear regression was 83. Each participant 
was examined and tested during a pre-booked one-hour six-component session. The 
study consisted of sphygmomanometry, anthropometry, handgrip dynamometry, 
bioelectrical impedance analysis (BIA), air displacement plethysmography (ADP), 
and spirometry, carried out in a sequential order. At the beginning of the session, a 
brief description of the study and measurement techniques was given to the study 
participant (SP) and a written consent form was taken (Appendix D).  
All procedures were done in accordance with national and/or international 
guidelines and the calibration, maintenance, quality control, cleaning, disinfection, 










































134 volunteers attended the induction sessions  
 
67 volunteers were selected using simple 
random sampling and scheduled for 
measurements 
56 participants attended the appointments and 
their data were collected 
11 volunteers did not take part in 
measurements  
 
6 participants were excluded 
because they had completely 
missing data on at least one of 
the measurements 
Recruitment involved advertisements, flyer 
distribution, and promotion across university 
campuses, minor ethnicity communities, and 
NHS services 
Data analysis was performed on data from 50 
participants 
Ethical approval obtained 
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3.2 Study instruments and protocols 
3.2.1 Anthropometry  
General notes 
The examiner explained the procedure to the SP before measuring any part. All 
circumference (except arm circumference) measurements were performed by SECA 
201 ergonomic girth measuring tape (SECA GmbH & Co., KG, Hamburg, 
Germany), with eyes looking straight ahead. Measurements were taken with the 
examiner standing on the right side of the SP. At all times, the tape was kept parallel 
to the ground, perpendicular to the long axis of the SP’s body part and pulled snugly 
without compressing the skin. The SP was instructed to turn in the direction needed 
for a given measure not the examiner. Before recording the value, it was ensured 
that the zero end of the tape was placed underneath the measured section. Parallax 
was avoided by reading the measurement in a line of sight directly in front of the 
value. All measurements were recorded to the nearest 1 centimetre. All 
circumference and height measurements were done two times and the average was 
used in the data analysis. A third measurement was undertaken if there was ≥ 1cm 
discrepancy between records. 
Mid upper arm circumference and waist to hip ratio were determined by the BIA 
equipment. 
Height  
Height (Ht) was measured by Marsden HM-250P Portable Leicester Stadiometer 
(Marsden Weighing Machine Group Ltd., Rotherham, UK) in erect posture. At the 
beginning of each measurement, the stadiometer was calibrated by a 100cm rod. SP 
was asked to remove the shoes as well as any hair ornaments, braids, or buns from 
the top of the head. SP stood up straight against the vertical scale with the body 
weight evenly distributed, shoulders relaxed, arms hanging loosely by the side of 
body, legs straight, both feet flat on the floor plate, knees and heels together and toes 
apart, pointing 60 degrees outward. Care was taken to ensure the back of the head, 
shoulder blades, buttocks, and heels were in contact with the vertical scale. Then, 
the head was positioned in the Frankfort plane (a craniometric reference plane 
passing from the external auditory meatus to the inferior orbital margin), parallel to 
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the floor and perpendicular to the vertical backboard. During deep inspiration, the 
stadiometer headpiece was lowered to rest firmly on top of the participant’s head 
whilst a gentle upward pressure was applied on the mastoid prominence. After 
recording the value, the subject released the breath. Measurement was considered 
non-straight (NS) if the SP had kyphoscoliosis, neck lesion, upper body weakness or 
any other problems that precluded an upright standing posture (Centre for Disease 
Control and Prevention, 2007). 
Neck circumference  
Neck circumference (NC) was measured in the midway of the neck between mid-
cervical spine and mid-anterior neck (superior border of the tape just below the 
thyroid cartilage and perpendicular to the long axis of the neck) during inspiratory 
apnoea with the SP standing upright and the head positioned in the Frankfurt 
horizontal plane. The presence of any scars or swelling was noted and the history of 
neck surgery and thyroid disease was checked.  
Waist circumference  
Waist circumference (WC) was measured in the midabdominal location (midpoint 
between subcostal margin and superior border of iliac crest in midaxillary line) 
according to WHO protocol (World Health Organization, 2000). The examiner stood 
to the right side and behind the SP, with tape in his left hand. The examiner passed 
the tape around the SP’s body with right hand, giving attention to the horizontal 
position of the tape. The SP was informed that the clothing could be lifted, and the 
trousers might be lowered to slightly below the waist. The measurement value was 
recorded at the end of the normal expiration. Ethnicity and sex specific thresholds 









Table 3.1 Waist Circumference Thresholds for Abdominal Obesity as recommended by the 
international diabetes federation (IDF)(Alberti, Zimmet and Shaw, 2007) 
Population  Men  Women  
Europid  ≥ 94 cm ≥ 80 cm 
Middle East or East 
Mediterranean* 
≥ 94 cm ≥ 80 cm 
Black (African and African-
Caribbean) * 
≥ 94 cm ≥ 80 cm 
Asian (including Chinese 
and South Asian) 
≥ 90 cm ≥ 80 cm 
Non-black Central and South 
American ** 
≥ 90 cm ≥ 80 cm 
*European data until more specific data are available 
**South Asian recommendations until more specific data are available 
 
Thigh circumference 
Thigh circumference (TC) was measured according to the National Institute for 
Health Research (NIHR) Southampton Biomedical Research Centre (BRC) Standard 
Operating Procedures. TC measurements were taken on the non-dominant side in 
mid-thigh area (at the mid-point between the anterior superior iliac spine and the 
lateral superior margin of the patella). The SP stood facing the examiner, with most 
of the weight on the dominant side. The SP held the non-dominant leg slightly 
flexed at knee joint and the soles of both feet flat on the floor. The tape was 
positioned perpendicular to the long axis of thigh, resting firmly on skin without 
indenting it (NIHR Southampton Biomedical Research Centre, 2015). 
Calf circumference 
Calf circumference (CC) was measured according to the NIHR Southampton BRC 
standard operating procedures on the non-dominant calf while the SP stood relaxed 
with the feet shoulder-width (about 25cm) apart and the body weight evenly 
distributed on both feet. The tape was extended horizontally around the calf at the 
widest part in a plane perpendicular to the long axis of the calf. As defined by WHO 
expert committee, a cut-point of 31cm was considered to be an indicator of low 




Body mass index (BMI) was calculated as Wt(kg)/ Ht (m)2. Ethnicity-specific cut-
off points were utilised for BMI classification (Table 3.2) 
Table 3.2. WHO classification of body mass index (World Health Organization, 
1995; 2004). 
BMI classification  International   Asian  
Underweight  <18.5 <18.5 
Normal weight 18.5–24.9 18.5–22.9 
Overweight  25-29.9 23-27.4 
Obesity class I 30-34.9 27.5-32.4 
Obesity class II 35-39.9 32.5-37.4 
Obesity class III >40 >37.5 
Values are presented in kg/m2 
Waist to height ratio (WHtR) was calculated as WC/Ht to adjust for the variability in 
WC attributable to height. This measure has been shown to be a strong predictor of 
early health risks associated with excessive central adiposity (Ashwell and Gibson, 
2016). 
Neck to height ratio (NHtR) was calculated as NC/Ht. This ratio has been reported 
to be a predictor of sleep apnoea (Ho, Moul and Krishna, 2016) and metabolic 
syndrome (Selvan et al., 2016). 
Waist to calf ratio (WCR) was calculated as WC/CC. This ratio has been suggested 
to be a predictor of carotid atherosclerosis (Kim et al., 2011). 
Waist to thigh ratio (WTR) was calculated as WC/TC. This ratio has been suggested 
to be a predictor of hyperglycaemia and all-cause mortality (Mason, Craig and 
Katzmarzyk, 2008). 
The new BMI (NBMI) was calculated as 1.3 × weight (kg)/height (m)2.5 (van Vugt et 
al., 2015), with 1.3 being the squared root of an assumed height (1.69 meter) for an 
average-sized adult. This formula can capture the gravity -related proportionality of 
transverse versus vertical growth more accurately because the body does not grow 
equally in all dimensions.  
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Overall, the squares of weight correspond to fifth powers of the height at different 
age. Switching to this new formula could be mathematically translated to 1unit BMI 
change per 30 cm of height if body weight remains unchanged (Trefethen, 2013). 
Thus, the revised equation may improve the discriminatory power of BMI equation 
(Amirabdollahian and Haghighatdoost, 2018). 
Conicity index (CI) was calculated as WC(m)/0.109 * √(weight(kg)/ height (m)). 
This index adjusts WC by body size and has been proposed to be a predictor of long-
term cardiovascular events (Valdez et al., 1993). 
A body shape index (ABSI) was calculated as WC/ (BMI 0.66× height (m)0.5. This 
index accounts for the sublinear relationship between WC and BMI, along with its 
non-linear association with height, minimising the regression inflation caused by the 
multicollinearity of WC and BMI. ABSI has been shown to be associated with 
biochemical metabolic markers in young and healthy men with sedentary lifestyle 
(Malara, Anna and Tkaczyk, 2015) and a predictor of mortality risk in the general 
population (Krakauer and Krakauer, 2012). 
 
3.2.2 Sphygmomanometry 
Systolic and diastolic blood pressure were measured by OMRON M7 (HEM-780-E) 
automated oscillometric blood pressure monitoring device (OMRON Healthcare 
Co., Kyoto, Japan) in accordance with the American Heart Association (AHA) 
recommendations (Muntner et al., 2019). 
Exclusion criteria: both arms with skin lesions, dressings, plaster, major swelling or 
atrophy, open sores, or hematomas; the affected arm in SPs with a history of 
ipsilateral axillary nodal biopsy or resection. 
Blood pressure (BP) was measured in the right arm. It was ascertained that SP had 
not taken caffeine or nicotine and had not exercised for at least 30 minutes before 
the measurement. SP rested quietly for 5 minutes prior to BP measurement; then BP 
was taken in a comfortable seated position, with legs uncrossed, back supported, 
arm bared (sleeve rolled up gently) and relaxed, the midpoint of the upper arm 
(halfway between the olecranon and acromion) kept at heart level (lower left sternal 
border in the fourth intercostal space), elbow slightly flexed, palm facing up, and 
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both feet flat on the floor. A properly sized cuff (cuff bladder encircling ≥80 and 
40% of arm length and width, respectively) was wrapped snuggly around the arm 
(2cm above the antecubital fossa), with marked edging turned medially, and the air 
tube running parallel to the medial side of the forearm. Two successive 
measurements were done 3 minutes apart. SP sat still whilst SBP and DBP were 
being recorded automatically by the unit attached to the cuff). If two recordings 
differed by more than 20mmHg, an additional BP measurement was done. 
Computed parameters  
The mean arterial pressure (MAP) was calculated as (SBP+2DBP)/3 as a predictor 
of cardiovascular health (Sesso et al., 2000). 
Pulse pressure (PP) was calculated as (SBP -DBP) as an indicator of arterial 
stiffness (Jankowich, Taveira and Wu, 2009). 
 
3.2.3 Dynamometry 
The isometric grip strength was measured in both hands by Takei 5001 Analogue 
Grip Dynamometer (Takei Scientific Instruments Co., Niigata, Japan). 
SPs with visible limitations or lesions on the hands (missing finger or phalange, 
congenital anomalies, broken or casted finger, wrist or hand, hand lesion, open sore, 
distal motor neuropathy or myopathy) or those with a history of hand or wrist 
surgery during a three-month period prior to test were excluded from the 
measurement. The history of wrist or hand arthritis, tendinopathy or tenosynovitis, 
or pain, aching or stiffness in hands in past 7 days was recorded.  
The dynamometer was adjusted for grip size until the proximal interphalangeal (PIP) 
joint of the fingers were at 90˚ flexion, with the hand being in line with the wrist and 
forearm. If the second joint of the index finger was flexed less than 90 degrees, the 
adjustment knob was turned clockwise to increase the grip size. If the joint flexion 
was greater than 90 degrees, the grip size was decreased by turning the knob 
anticlockwise.  
In compliance with the National Centre for Health Statistics (NCHS) protocol 
(National Center for Health Statistics, 2011), the test was performed in the upright 
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standing position. Having been explained the proper technique for the test, the SP 
grasped the dynamometer between the fingers and the palm at the base of the thumb. 
Holding the dynamometer in line with the forearm at the thigh level, the SP was 
asked to squeeze the dynamometer tightly and forcefully while breathing out, with 
shoulders, back and chest straightened, eyes straight ahead, shoulder abducted about 
10 degrees, elbow fully extended, and wrist in neutral position. When the peak hold 
needle stopped rising, the reading was recorded in kilogram force units rounded to 
the nearest 1kg. The SP rested for 5 minutes between successive measurements. 
Grip strength was defined as normal, intermediate and weak according to cut-points 
(Alley et al., 2014) recommended by the Foundation for the National Institutes of 
Health (FNIH) Sarcopenia Project for the identification of clinically relevant 
weakness (Table 3.3). 
 
Table 3.3. Grip strength thresholds for clinical weakness adopted from (Alley et al., 2014) 
Cut-off point Men  Women  
Normal  ≥32 kg ≥20 kg 
Intermediate  ≥26 but <32kg ≥16 but <20kg 
Weak  <26kg <16kg 
 
3.2.4 Body composition assessment 
Body composition was assessed by air displacement plethysmography and 
bioelectrical impedance direct segmental multifrequency body composition analysis 
(DSM-BIA) methods. 
3.2.4.1 Bioelectrical impedance analysis  
Bioelectrical impedance analysis (BIA) was conducted by Tanita MC 980 MA 
(Tanita Co., Inc, Tokyo, Japan) and InBody 720 (InBody Co., Ltd., Seoul, Korea), 
each operating on a tetrapolar 8-point tactile electrode system that measured the 
impedance (resistance and reactance) in the limbs and trunk and, as explained earlier 
in the literature review, determined total body water (TBW), fat-free mass (FFM), 
and fat mass (FM) as well as segmental lean and fat mass from impedance, height, 
and weight included in patented prediction equations. 
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Exclusion criteria: Any metallic part (e.g., pacemaker, defibrillator, nerve 
stimulator), prosthetic joints or pins, catheters, renal failure, serious life‑limiting 
comorbid situations (such as malignancy, uncontrollable infection, and end‑stage 
heart, lung, or liver disease), pregnancy or lactation, taking diuretics or lipid-
lowering agents, active oozing hand and foot skin lesions, hyperhidrosis, generalised 
oedema. 
Cautions before measurements: 
A few days prior to the appointment, the SP was advised not to have a meal less than 
2 hours before the test, to avoid the test during menses, not to exercise or bath before 
the test. The SP was also instructed to use the bathroom, wear light clothes, remove 
jewellery or other ornamental objects, and not sit down or stand up before starting 
the measurement.  
Protocol  
The SP stepped on the foot electrode barefooted and stood still comfortably with 
hands hanging down and heel and the ball of the feet touching the foot electrodes. 
After the record of body weight and personal information was completed, the SP 
held the hand electrodes gently. Attention was given to make sure palms, fingers and 
soles correctly touched the electrodes and heels landed on the circular-shaped foot 
electrode before the forefoot hit the front electrode without any piece of clothing 
getting in between the heels and electrodes. The shoulders were relaxed, arms 
abducted about 15 degrees, elbows and fully extended, and knees not flexed. If the 
SP’s feet or hands were too dry, or had crusts, the palms and soles would wet with 
electrolyte tissue.  
Computed parameters: 
To examine relative contribution of fatness and leanness to the outcomes, fat mass to 
fat-free mass ratio was calculated as FM/FFM for both analysers. 
To understand the comparative influence of limb fat and lean tissues on the 
outcomes, fat and muscle(lean) contents of 4 extremities were integrated to the 
composite appendicular fat mass (AFM) and appendicular muscle mass (ASM) or 
lean mass (ALM) as the sum of the corresponding values for each limb (right arm, 
left arm, right leg, and left leg).  
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To compare the associations of upper versus lower extremity fat, lean and skeletal 
muscle mass with the outcomes, corresponding terms were created as follows: 
Upper limb fat mass (UFM) was calculated as the sum of right arm and left arm FM 
(RAFM+LAFM) 
Upper limb lean mass (ULM) was calculated as the sum of right arm and left arm 
LM(RALM+LALM) 
Upper limb skeletal muscle mass (USM) was calculated as the sum of right arm and 
left arm SMM (RAMM+LAMM) 
Lower limb fat mass (LFM) was calculated as the sum of right leg and left leg FM 
(RLFM+LLFM) 
Lower limb lean mass (LLM) was calculated as the sum of right leg and left leg LM 
(RLLM+LLLM) 
Lower limb skeletal muscle mass (LSM) was calculated as the sum of right leg and 
left leg SMM (RLMM+LLMM) 
To investigate the combined contributions of truncal versus appendicular fat and 
skeletal muscle masses to the outcomes, relative ratios were calculated as 
AFM/ASM, and truncal FM(TFM)/ truncal SMM(TSM),  
To adjust for the variations in height the following indices were constructed: 
Fat mass index (FMI) was calculated as FM/Ht2 (kg/m2) for both analysers. 
Skeletal muscle mass index (SMI) was calculated SMM/ Ht2 (kg/m2) for Tanita MC 
980 MA. 
Corresponding indices were also computed for appendicular and truncal parameters 
as follows: 
AFM index (AFMI)= AFM/ Ht2 (kg/m2) 
ASM index (ASMI)= ASM/ Ht2 (kg/m2) 
TFM index (TFMI)= TFM/ Ht2 (kg/m2) 




3.2.4.2 Air displacement plethysmography 
Whole body densitometry was performed by the air displacement plethysmography 
(BODPOD) system (Life Measurement, Inc, Concord, CA, USA). 
A few days prior to testing, the SP was advised to be dry and to refrain from shower 
for at least 1 hour before testing and not to grow facial hair or beard, not to wear 
“Boxer” or running shorts, and not to eat or exercise for 3-4 hours before testing 
(Fields, Higgins and Radley, 2005).  
The BODPOD was warmed up for 30 minutes and the environment stability was 
verified, especially with respect to room temperature. Then the integrated digital 
weighing scale was calibrated by using two gold calibration weights (19.99 to 20.01 
kg) to keep the reading precision at 0.01 kg of the weights. Then, the BODPOD was 
calibrated using a 50L cylinder. It was ascertained that the SP wore no jewellery or 
eyeglasses and was minimally clothed (tight-fitting or Spandex swimsuit or single-
layer compression shorts and sport bras (without padding or wires)) and put on tight-
fitting acrylic swim cap, ensuring that all hair was hidden under the cap. Any air 
pockets were released from under the cap. Having weighed the SP, the procedure 
was fully described. In addition to the exclusion criteria described for the BIA, the 
possibility of claustrophobia was ruled out before the test. The SP was assured that 
the test could be cancelled anytime by pressing the magnet release button. The SP 
sat comfortably in the BODPOD, hands in lap, breathing normally without talking or 
laughing. The test lasted approximately 40 seconds and was repeated one more time 
with 30-second intervals between tests. The system measured the uncorrected body 
volume based on volume changes inside the chambers (explained earlier in the 
literature review). In the event of disagreement between measurements (>150mls as 
set by the manufacturer), another measurement was carried out. After the 
completion of the test, the mean of the two closest measurements was used to 
determine the corrected body volume, body density (Db), %BF, FM, and FFM. The 
actual body volume was calculated by the system software after adjustment for the 
predicted lung volume (Collins and McCarthy, 2003) and body surface area artefact. 
The calculated Db (actual volume/body weight) was used to determine %BF 
according to Siri equation (Siri, 1961).  
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3.3 Spirometry  
Lung function was evaluated by the COSMED Quark PFT modular system 
(COSMED s.r.l, Rome, Italy). This system consists of a Quark unit, a turbine 
flowmeter, breathing valve, and additional external sensors and devices. The expired 
gas is analysed by using an infrared optoelectronic reader counting the light 
interruptions caused by the spinning vanes of the bidirectional turbine. Technical 
features and accuracy specifications of the equipment comply with the ERS/ATS 
standards (Table 2.1). 
Exclusion criteria (Miller, Crapo, et al., 2005) 
• Current painful ear infection 
• Thoracic or abdominal surgery in the last 3 months 
• Brain, eye, or ENT surgery in the last 3 months 
• Pneumothorax  
• Bronchial marked hypersensitivity 
• Severe gas exchange impairment 
• Myocardial infarction  
• Aortic aneurysm  
• Haemoptysis  
• Pulmonary embolism 
• Retinal detachment 
• Acute diarrhoea  
• Stroke or angina in the last 3 months  
• Severe hypertension (systolic >200 mm Hg, diastolic >120 mm Hg) 




Lung function testing was conducted according to the ATS/ERS task force 
recommendations (Miller, et al., 2005). Prior to spirometry, the SP was asked to 
loosen any tight clothing and to remove dentures if they were not secure. 
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Spirometric testing was performed in the standing position but a stool was 
positioned behind the SP. Having been demonstrated the proper technique, the SP 
was instructed to lift the chin and extend the neck slightly. The flowmeter was 
attached to the handle to connect the turbine to Quark unit. Then the antibacterial 
filter was mounted onto the turbine. First, a trial test was practiced in the following 
manner: after deep inspiration, the SP put the disposable filter into the mouth, 
between teeth, and on top of tongue, bit on the filter lightly and sealed the lips 
tightly around it, applied nose clip, blasted out the air as hard and fast as possible, 
and continued forced expiratory manoeuvre for at least 6 seconds or until the SP 
could not carry on. The adequacy of the attempt was decided by the pattern of 
volume-time and flow-volume curves to detect submaximal inhalation, excessive 
extrapolated volume due to hesitated initiation, submaximal blast due to insufficient 
expiratory effort, jagged interruption due to coughing, early termination, dipped 
flow-volume curved due to variable exhalatory effort, abrupt cessation due to glottis 
closure or breath holding, curve descent after plateau or back-tracking toward zero 
due to air leak, stepped curve due to extra breath(s), or zero-flow errors due to 
incorrectly set flow references (for details see Chapter 2) (Beeckman-Wagner and 
Freeland, 2012). Three best attempts were considered for the analysis. The 
spirometric indices (FVC, FEV1, FEV1/FVC, FEF25-75%) were expressed in absolute 
values to avoid the inaccuracies of using percentage of the predicted values. 
 
3.3 Statistical analysis 
The sample size (n=83) was calculated using a priori power analysis by the 
statistical software package G*Power 3.1 (Faul et al., 2009). The F test procedure 
was chosen to determine sample size based on the r2increases in a multiple linear 
regression model given the alpha level of 0.05 and power of 80%, with 7 predictors 
and an estimated effect size (partial r2) of 0.16. 
Statistical analyses were performed using the Statistical Package for the Social 
Sciences (SPSS) version 25.0 (SPSS Inc., Chicago, IL, USA). Because of 14% 
(>10%) missingness and the small sample size, even though the data were missing 
completely at random, multiple imputation was carried out to replace the missing 
values by the simulated values (predicted from the observed cases) with the highest 
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possible similarity to the available data to reduce bias in parameter estimations 
(Sterne et al., 2009). First, monotonicity of the missing values was ruled out in the 
pattern analysis chart where concentrations of missing datapoints touching to the 
upper left and lower right were interspersed by patches of non-missing datapoints, 
indicating a random pattern of missingness and low chance of bias. Then the random 
seed settings were determined by Mersenne Twister method to initialise random 
number generator. Subsequently, all variables with missing values were entered in 
the imputation model (5 simulations per sequence of missing data) to create a new 
complete data set with the average of newly imputed values replacing corresponding 
missing values by the fully conditional specification (Markov Chain Monte Carlo 
(MCMC)) imputation method(Rubin and Schenker, 1991). Due to the small size of 
the study sample (n≤50) and mild missingness (≤20%), predictive mean matching 
(PMM) method was chosen as the preferred type of the regression model (Barnes, 
Lindborg and Seaman Jr, 2006) as it could provide imputed values consistent with 
observed values 
The imputed data were almost normally distributed (as checked by Shapiro-Wilk 
test of normality, skewness statistics and visual inspection of histograms). Body 
composition phenotypes were created by transforming raw values into tertiles and 
by constructing composite variables that integrated corresponding total and 
segmental fat and lean mass. The presence of outliers was inspected graphically 
(Box plots) as well as statistically (using the interquartile range formula). The 
significance value was set at p<0.05. To create composite variables, syntax codes 
were utilised. Bivariate relationships among anthropometric, body composition and 
spirometric measures were examined by Pearson’s correlation test. The association 
between body composition and lung function across levels of systemic blood 
pressure was explored using general linear models meeting the assumptions of 
linearity and normality of residuals. The assumption of homoscedasticity (equality 
of residual variances) was examined by the modified Breusch -Pagan test (Breusch 
and Pagan, 1979) and heteroscedasticity consistent standard errors were estimated 
using SPSS macros (Hayes and Cai, 2007) when required. Statistical significance 
was set at a p-value<0.05. Post-hoc analyses were done by Tukey’s honest 
significant difference (HSD) test (Tukey and Cleveland, 1984). The effects of the 
moderators on the association between the predictors and outcomes were 
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investigated in the PROCESS macro version 3.2 (Hayes, 2012) using simple 
moderation analysis (in the form of an ordinary least squares (OLS) regression) 
whereby the outcome would be estimated as a weighted function of the predictors 
and their interaction. Bias-corrected 95% confidence intervals were also generated 
by bootstrapping. The heteroscedasticity consistent standard error estimator 
developed by MacKinnon & White was chosen to yield robust inferences on the 
OLS parameter estimates (Hayes and Cai, 2007). To probe the significant 
interactions, the conditional effect of the independent variable on the outcome 
variable was estimated at various (low, medium, and high) levels of the moderating 
predictor operationalised respectively as 16th, 50th and 84th percentiles. To 
demarcate regions of significance of the effect of predictors on the outcomes along 
the continuum of the moderators, the Johnson-Neyman technique (Hayes and 
Matthews, 2009) was utilised. This technique delineates the values of moderator 
where the conditional effect transitioned from significance to non-significance as 
well as the confidence interval bands for the regression slopes. The conditional 
effects of the predictors on the outcomes at three discrete percentiles of the 
moderator were visually depicted as the interaction plots using the output table for 
data visualisation generated by the PROCESS. 
 
3.4 Descriptive Characteristics 
The main characteristics of the study population are presented in Tables 3.3 to 3.6. 
In total, 22 men and 28 women aged 22 to 61 years took part in the study. 
Participants were ethnically diverse (10 British white, 27 non-British white, 3 black, 
6 South Asian, 2 Asian, 1 Hispanic, and 1 white-Asian), predominantly non-smoker 
(32 never-smokers, 13 ex-smokers, and 2 current-smokers), physically active (37 
moderately active, 7 vigorously active, 5 lightly active, and 1 sedentary lifestyle), 
and healthy/overfat (20% under-fat, 40% healthy, 40% overfat) with normal grip 
strength (100%) and no history of pulmonary, cardiovascular or neuromuscular 
diseases . In general, female SPs had lower BMI, NC, AC, WC, TC, CC, WHR, and 
WHtR as well as total (FFM, LBM, SMM) and segmental (ALM, ASM, ULM, 
USM, LLM, LSM) lean mass. In comparison, total fat (%BF and FM) and 
appendicular fat (AFM and LFM) were proportionally higher in females while their 
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centrally distributed fat was significantly lower than males. However, UFM was not 
significantly different between sexes. Male SPs had stronger grips, higher SBP, 
wider pulse pressure, larger LV and higher FVC, FEV1, and FEF25-75%. FEV1/FVC 
ratio was lower in males; there was no significant difference in DBP between male 
and female SPs. 
 
Table 3.4. Age and anthropometric measures 
 Male  Female  Total  
Age  38.00±13.13 35.21±8.90 36.44±10.93 
















































Wt (kg)  
BMI (kg/m2)  
NC (cm)  
AC (cm)  
WC (cm)  
TC (cm)  









    
Values are presented as mean ± SD 
For all variables in male, female, and total participants, n=22, 28, and 50, respectively. 
Wt: body weight(kg); BMI: body mass index; NC: neck circumference; AC: arm circumference; WC: 
waist circumference; TC: thigh circumference; CC: calf circumference; WHR: waist to hip ratio; 
WHtR: waist to height ratio. NBMI: new BMI; WTR: waist to thigh ratio; WCR: waist to calf ratio; 








Table 3.5. Sex and ethnicity-specific adiposity status 
 Male  Female  Total  
BMI-defined      
Underweight  0 2 (7%) 2 (6%) 
Normal weight  11 (50%) 20 (71%) 31 (62%) 
Overweight   8 (36%) 6 (21%) 14 (38%) 
Obesity  3 (14%) 0 3 (4%) 
 
WC-defined  
   
No abdominal obesity 16 (73%) 25 (89%)  41 (82%) 
Abdominal obesity  6 (27%) 3 (11%) 9 (8%) 
 
BODPOD-defined 
   
Underfat  1 (4%) 9 (32%) 10 (20%) 
Healthy  9 (41%) 11(39%) 20 (40%) 
Overfat/obesity 12 (55%) 8 (29%) 20 (40%) 
Values are presented as frequency (%) 
BMI definition follows WHO criteria for general and Asian population (World Health Organization, 
1995; 2004) 
WC definition follows IDF ethnicity-specific thresholds for abdominal obesity (Alberti, Zimmet and 
Shaw, 2007) 
Fatness status is defined according to BMI, age, sex, and ethnicity-specific body fat ranges 















Table 3.5. Body composition measurements 
Values are presented as mean ± SD 
For all variables in male, female, and total participants, n=22, 28, and 50, respectively. 
FFM: fat free mass; SLM: soft lean mass; LBM: lean body mass; SMM: skeletal muscle mass; TSM: 
trunk muscle mass; ASM: appendicular skeletal muscle mass; USM: upper limb skeletal muscle 
mass; LSM: lower limb skeletal muscle mass; BF: body fat; FM: fat mass; VFA: visceral fat area; 
VFR: visceral fat rating; TFM: trunk fat mass; AFM: appendicular fat mass; UFM: upper limb fat 














Body composition  Male  Female  Total  
FFM Tanita (kg)  62.56±8.94 45.86±5.05 53.21±10.88 
FFM InBody (kg)  63.58±7.36 45.93±5.15 53.70±10.78 
FFM BODPOD (kg)  61.50±7.56 45.27±5.82 52.41±10.46 
SMM InBody (kg)  35.43±5.39 26.00±3.67 30.15±6.49 
TSM (kg) *** 32.72±3.78 25.76±2.36 28.82±4.63 
ASM (kg) *** 27.19±1.45 19.10±.2.52 22.66±5.28 
USM (kg) *** 7.03±1.29 4.28±0.73 5.49±1.71 









%BF InBody 20.44±8.48 24.39±6.66 22.65±7.69 
%BF Tanita 19.58±6.76 24.33±5.19 22.24±6.33 
%BF BODPOD 22.29±8.43 25.36±6.45 24.01±7.47 
FM InBody (kg) 16.76±8.02 14.78±5.15 15.65±6.57 
FM Tanita (kg) 15.63±6.42 15.19±4.55 15.38±5.40 
FM BODPOD (kg) 18.01±7.89 15.26±4.76 16.47±6.41 
VFA (cm2) * 86.63±56.67 61.16±30.59 72.37±45.33 
VFR* 6.64±4.75 3.12±2.17 4.67±3.92 
TFM (kg)  9.49±4.50 6.94±2.80 8.06±3.83 
AFM (kg)  5.96±2.27 8.36±2.13 7.31±2.48 
LFM (kg)  4.42±1.75 6.76±1.78 5.73±2.11 




Table 3.6. Grip strength, measures of blood pressure, and spirometric indices 
 Male  Female  Total  
Grip R (kg)  44.00±12.00 30.50±3.75 33.19±12.63 
Grip L (kg)  41.50±7.00 30.00±6.00 33.00±10.25 
Grip M (kg)  42.25±8.63 30.00±4.38 33.25±11.28 
SBP (mmHg)  118.07±10.38 108.25±12.67 112.62±12.59 
DBP (mmHg) 74.98±11.14 75.50±11.50 74.84±11.22 
PP (mmHg)  43.09±9.33 35.50±8.51 37.83±9.97 
MAP (mmHg) 89.34±9.96 86.08±11.26 87.51±10.73 
LV (L)  4.06±0.36 3.36±0.35 3.67±0.50 
FVC (L)  4.81±1.21 3.31±0.63 3.97±1.19 
FEV1 (L)  4.35±0.85 3.14±0.51 3.67±0.91 
FEV1/FVC 88.59±5.46 94.17±4.58 91.72±5.67 
FEF25-75% (L/s)  5.08±1.24 4.31±0.90 4.65±1.12 
Values are presented as mean ± SD 
For all variables in male, female, and total participants, n=22, 28, and 50, respectively. 
Grip strength records are presented as median ± IQR; measures of blood pressure are presented as 
mean ± SD. Grip M: average grip strength of both hands; SBP: systolic blood pressure; DBP: 
diastolic blood pressure; PP: pulse pressure; MAP: mean arterial pressure. LV: lung volume; FVC: 
forced vital capacity; FEV1: forced expiratory volume in 1 s; FEF25-75%: forced expiratory flow at 25–
















Anthropometric Measures and Body Composition 
 
To understand which anthropometric measures are better indicators of fat-free mass 
and/or fat mass at total and segmental level, the anthropometric measurements were 
divided into conventional and non-conventional categories. Conventional 
anthropometric measures included BMI, NC, AC, WC, TC, CC, WHR, and WHtR. 
Non-conventional anthropometric measures included NBMI, WTR, WCR, NHtR, 
CI, and ABSI. The relationships between these measures and body composition data 
derived from segmental BIA and the BODPOD system were examined using 
Pearson’s correlation test. BIA-derived parameters included FFM, SMM, TSM, 
ASM, USM, LSM as well as %BF, FM, VFA, TFM, AFM, UFM, LFM. Body 
composition parameters determined by the BODPOD system included FFMADP, 
%BFADP, and FMADP. These parameters (except %BF) were also divided by the 
square of height to create stature-adjusted indices of total and segmental body 
composition to account for the contribution of height to the variability in FM and 
FFM. The expression of fatness and leanness as the indices normalised for body size 
has been shown to provide more accurate information about the nutritional and 
health status of the individuals of different age, sex and body size as compared to the 
expression of FM and FFM as absolute or relative (percentages of weight) values 
(Schutz, Kyle and Pichard, 2002).  
 
Results 
4.1 Total Lean mass and anthropometric measurements 
As shown in Table 4.1, NC and AC were the strongest conventional anthropometric 
correlates of FFM, FFMADP, and SMM followed by WC, CC and BMI in the entire 
study population. In male SPs, AC was significantly correlated with FFM and SMM 
but not FFMADP. NC showed significant correlations with SMM. No significant 
correlation was found between other indices and total lean mass.  
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Conventional anthropometric measures 





FFM  0.37 0.48* 0.68*** 0.26 0.31 0.45 0.17 0.04 
FFMADP 0.13 0.36 0.42 0.03 0.08 0.32 -0.05 -0.19 
SMM  0.13 0.43 0.58** 0.01 0.27 0.42* -0.11 -0.27 
TSM 0.42 0.57** 0.73*** 0.34 0.32 0.47* 0.26 0.10 
ASM 0.27 0.35 0.57** 0.17 0.21 0.39 0.05 -0.04 
USM 0.28 0.38 0.61** 0.12 0.36 0.29 0.06 -0.07 






FFM  0.02 -0.08 0.11 -0.14 -0.06 -0.17 -0.01 -0.11 
FFMADP 0.16 0.33 0.26 0.36 0.35 0.40* 0.15 0.16 
SMM  -0.05 0.42* 0.19 0.03 -0.23 -0.07 0.14 -0.07 
TSM 0.11 -0.02 -0.05 -0.02 .01 -0.08 0.02 -0.05 
ASM -0.08 -0.17 -0.19 -0.23 -0.15 -0.27 -0.08 -0.21 
USM 0.02 -0.09 -0.12 -0.05 -0.04 -0.06 0.01 -0.07 






FFM  0.57*** 0.68*** 0.64*** 0.58*** 0.32* 0.51*** 0.37* 0.35* 
FFMADP 0.52*** 0.72*** 0.64*** 0.59*** 0.36* 0.59*** 0.36* 0.32* 
SMM  0.45** 0.73*** 0.66*** 0.49*** 0.25 0.50*** 0.32* 0.22 
TSM 0.59*** 0.69*** 0.66*** 0.59*** 0.34* 0.52*** 0.39* 0.36* 
ASM 0.53*** 0.64*** 0.60*** 0.54*** 0.28 0.49** 0.33 0.31* 
USM 0.54*** 0.66*** 0.62*** 0.55*** 0.34* 0.49** 0.35* 0.32* 
LSM 0.50*** 0.62*** 0.57*** 0.52*** 0.27 0.49** 0.31 0.28 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
BMI: body mass index; NC: neck circumference; AC: arm circumference; WC: waist circumference; 
TC: thigh circumference; CC: calf circumference; WHR: waist to hip ratio; WHtR: waist to height 
ratio; FFM: fat free mass; SMM: skeletal muscle mass; TSM: trunk muscle mass; ASM: 
appendicular skeletal muscle mass; USM: upper limb skeletal muscle mass; LSM: lower limb skeletal 
muscle mass;  
The only significant findings in female SPs were the correlations of CC with 
FFMADP and AC with FFM (Table 4.2), ABSI and CI were stronger correlates of 
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FFM, FFMADP, and SMM in the total population. Of note, the ABSI was the only 
significant non-conventional correlate of FFM, FFMADP, and SMM in male SPs. It 
showed a consistently negative relationship with all measures of total lean mass in 
men and women.  




Non-conventional anthropometric measures 





FFM  0.25 -0.10 -0.25 -0.09 -0.11 -0.79*** 
FFMADP  0.02 -0.12 -0.17 -0.13 -0.13 -0.78*** 
SMM  -0.01 -0.10 -0.24 0.01 -0.10 -0.80*** 
TSM 0.29 0.17 0.10 0.25 0.17 -0.46* 
ASM 0.16 0.08 -0.05 0.03 0.05 -0.52* 
USM 0.17 -0.03 -0.04 0.08 -0.03 -0.54* 






FFM  0.02 0.24 0.11 0.11 0.20 -0.42* 
FFMADP  0.07 0.24 0.13 0.12 0.20 -0.37 
SMM  -0.09 0.19 0.07 0.31 0.07 -0.19 
TSM 0.09 -0.05 0.01 -0.06 -0.14 -0.23 
ASM -0.06 -0.15 -0.08 -0.14 -0.28 -0.17 
USM 0.08 -0.05 -0.04 -0.12 -0.11 -0.16 





FFM  0.44** 0.41** 0.31* 0.38** 0.55** -0.63*** 
FFMADP  0.38** 0.40** 0.37* 0.37* 0.53** -0.62*** 
SMM  0.31* 0.40** 0.30* 0.45** 0.46** -0.58*** 
TSM 0.46** 0.46** 0.41** 0.45** 0.55** -0.47** 
ASM 0.40** 0.44** 0.37* 0.39** 0.53** -0.46** 
USM 0.41** 0.41** 0.38* 0.41** 0.52** -0.47** 
LSM 0.37* 0.42** 0.33 0.35* 0.53** -0.49*** 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
NBMI: new BMI; WTR: waist to thigh ratio; WCR: waist to calf ratio; NHtR: neck to height ratio; 
CI: conicity index; ABSI: a body shape index. FFM: fat free mas; SMM: skeletal muscle mass; TSM: 
trunk muscle mass; ASM: appendicular skeletal muscle mass; USM: upper limb skeletal muscle 




4.2 Segmental lean mass and anthropometric measurements 
AC and NC were the strongest conventional anthropometric correlates of truncal, 
appendicular, lower limb, and upper limb lean/skeletal muscle mass in total 
population whereas TC, WHtR and WHR demonstrated weakest correlations. AC 
and NC were most strongly correlated with TSM, respectively. Stratified by sex, AC 
was the only conventional measure that showed significant correlations with the 
abovementioned indicators of segmental lean mass in male SPs. AC was most 
strongly correlated with TSM (Table 4.1). WHtR and WHR displayed negative (but 
weak) correlations in both sexes. Among the non-conventional anthropometric 
indices (Table 4.2), NBMI and ABSI showed the strongest correlations with all 
segmental measures of lean mass in total population, albeit in opposite directions. 
WTR and CI where equally correlated with segmental lean mass. Split by sex, the 
ABSI was the only significant non-conventional anthropometric correlate of 
segmental lean mass in men. It exhibited inverse relationships with measures of 
segmental lean mass. Compared with commonly used anthropometric indices, the 
ABSI was a stronger correlate of lower body lean mass in men. In women, non-
conventional anthropometric indices were weakly correlated with segmental lean 
mass. The ABSI exhibited the most consistent negative relationship with segmental 
lean mass in both sexes. 
Collectively, AC and NC were the strongest anthropometric correlates of total 
leanness together with total, truncal and appendicular muscularity whilst ABSI was 
the only anthropometric index which was inversely and significantly related to total 
and segmental leanness/muscularity in the entire study population. Thus, large arm 
and neck circumferences may indicate expanded lean or muscular tissues better than 
other anthropometric measures in free-living healthy adults. It is worth mentioning 
that the anthropometric measures commonly used as the indicators of fatness had 
directly significant relationships with BIA-derived fat-free mass and skeletal muscle 
mass, underscoring the contribution of lean compartments to the associations 
observed between these measures (BMI, WC, WHR, WHtR) and metabolic risk 
factors. In this regard, increased ABSI (as an index of body-size adjusted WC) could 
be an indicator of depleted lean mass. 
102 
 
As the study was underpowered for subgroup analysis, it is difficult to make 
inferences about the sex-specific relationships between anthropometric indices and 
measures of leanness.  
 
4.3 Total body fat and anthropometric indices 
In total, WHtR, BMI, and WC were the strongest conventional anthropometric 
correlates of total fat mass whereas WHtR and BMI were stronger correlates of 
%BF. After sex stratification, WHR, WHtR, WC and BMI were strongly correlated 
with FM and %BF in male SPs. No significant relationship was found between 
either %BF or FM with TC, AC, and NC in total and male SPs. NC showed the 
weakest correlation with %BF while TC was the weakest correlate of FM. In female 
SPs, however, BMI, AC, WC, and WHtR were strong correlates of FM and %BF. 
Although, %BF by the BODPOD was significantly correlated with BMI and WHtR. 
TC was the weakest correlate of total body fat in this group (Table 4.3).  
Among the non-conventional measures, NBMI was the only significant 
anthropometric correlate of total body fat in total SPs. This index was the strongest 
correlate of FM and BF% in men and women too. WTR and CI also demonstrated 
moderate to strong relationships with total body fat in men. The strength of 
correlation was lower in women. The ABSI did not show any significant correlation 
with FM or %BF in female SPs (Table 4.4). Taken together, NBMI and BMI were 
comparably correlated with FM and BF% in both sexes. 
4.4 Segmental body fat and anthropometric indices 
In the entire study population, visceral fat was most strongly related to WHtR, WC, 
WHR, and BMI. WC, BMI, WHtR and WHR were respectively the strongest 
correlates of truncal fat. Upper limb fat mass was most strongly correlated with BMI 
and WHtR followed equally by WC and WHR. All these measures showed 
comparably strong relationships with VFA. None of the conventional 
anthropometric measurements had significant correlation with the fat content of the 
lower limb. In men, the strongest correlates of VFA were WHR, WHtR, and WC, 
while in women BMI, AC, and WHtR exhibited the strongest correlations. WHR 
and WC were equally correlated with VFA in females. For TFM, WC and WHR 
103 
 
were the strongest correlates in male SPs. In female SPs, BMI, WC and WHR were 
the only significant correlates of TFM. While AFM was most strongly correlated 
with BMI, WHR and WC and in men, it showed the strongest correlations with BMI 
and WC in women. Relatively similar sex-specific patterns were detected for the 
correlations of UFM and LFM with the conventional anthropometric measures, with 
BMI, WC and WHR being the strongest correlates in male SPs and BMI, WC and 
WHtR being the strongest correlates in female SPs (Table 4.3). 
As shown in Table 4.4, NBMI was the strongest non-conventional correlate of 
segmental body fat in total, male and female SPs. WTR and CI followed NBMI in 
men while WTR and WCR held the next highest ranks of correlations in total 
population as well as in women. Higher WCR in both sexes was more strongly 
correlated with visceral fat and lower appendicular than with truncal fat. Again, 
NBMI and BMI were comparably correlated with segmental fatness. 
Altogether, WHtR, WHR, WC, BMI, and new BMI all were strong correlates of 
total, visceral and truncal adiposity in the entire population. Although adjustments 
for calf or thigh perimeters reduced the strength of associations between WC and 
measures of total, truncal and visceral fatness, these relationships remained strong. 
Thus, WC and BMI can be good indicators of fatness in healthy adults; however, 
they cannot differentiate fat depots accurately. In contrast, ABSI was not strongly 












Table 4.3. Conventional anthropometric measures and fatness 
Total and 
regional fatness 
Conventional anthropometric measures 





%BF  0.70*** 0.19 0.30 0.73*** 0.11 0.39 0.80*** 0.79** 
%BFADP 0.76*** 0.32 0.44* 0.72*** 0.18 0.45* 0.72*** 0.71*** 
FM  0.81*** 0.36 0.44* 0.84*** 0.13 0.56** 0.88*** 0.83*** 
FMADP 0.81*** 0.46* 0.60** 0.83*** 0.17 0.59** 0.78*** 0.74*** 
VFA (cm2) 0.79*** 0.43 0.38 0.84*** 0.08 0.48* 0.90*** 0.84*** 
TFM (kg) 0.79*** 0.49* 0.50* 0.83*** 0.01 0.70*** 0.82*** 0.74*** 
AFM (kg) 0.92*** 0.58* 0.66* 0.83** 0.17 0.66** 0.83** 0.72** 
UFM (kg) 0.86*** 0.55* 0.63** 0.83*** 0.14 0.74*** 0.81*** 0.73*** 






% BF  0.81*** 0.40* 0.68*** 0.60** 0.30 0.29 0.64** 0.63*** 
% BFADP 0.77*** 0.08 0.28 0.34 0.20 0.30 0.23 0.45* 
FM  0.91*** 0.51* 0.80*** 0.75*** 0.30 0.42* 0.69** 0.73*** 
FMADP 0.81*** 0.17 0.38 0.51* 0.31 0.49* 0.32 0.54** 
VFA (cm2) 0.90*** 0.53** 0.83*** 0.77*** 0.16 0.27 0.77** 0.79*** 
TFM (kg) 0.72*** 0.27 0.47 0.53* 0.06 0.21 0.49* 0.42 
AFM (kg) 0.92*** 0.49* 0.67** 0.81*** 0.32 0.43* 0.58** 0.73** 
UFM (kg) 0.90*** 0.40 0.58* 0.67* 0.24 0.31 0.54* 0.62* 





%BF  0.42**- -0.01 0.21 0.32* 0.10 0.15 0.48** 0.50*** 
%BFADP 0.37* -0.01 0.15 0.29* 0.11 0.21 0.29 0.43** 
FM 0.73*** 0.38 0.54 0.69*** 0.23 0.49*** 0.70*** 0.76*** 
FMADP 0.68*** 0.37 0.50 0.66*** 0.27 0.56*** 0.53*** 0.68*** 
VFA (cm2) 0.75*** 0.50*** 0.58*** 0.77*** 0.18 0.46** 0.77*** 0.82*** 
TFM (kg) 0.68*** 0.48** 0.54*** 0.72*** 0.12 0.55*** 0.64*** 0.66*** 
AFM (kg) 0.33* -0.01 0.19 0.25 0.07 0.18 0.34* 0.36* 
UFM (kg) 0.62*** 0.32 0.47** 0.56** 0.18 0.44* 0.56*** 0.60** 
LFM (kg) 0.22 -0.11 0.10 0.13 0.05 0.08 0.25 0.26 
Values are presented as r. For all correlations in male, female, and total participants, n=22, 28, and 
50, respectively. *p<0.05; **p<0.01; ***p<0.001 
BMI: body mass index; NC: neck circumference; AC: arm circumference; WC: waist circumference; 
TC: thigh circumference; CC: calf circumference; WHR: waist to hip ratio; WHtR: waist to height 
ratio; BF: body fat; FM: fat mass; VFA: visceral fat area; TFM: trunk fat mass; AFM: appendicular 
fat mass; UFM: upper limb fat mass; LFM: lower limb fat mass. 
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Table 4.4. Non-conventional anthropometric measures and fatness 
Total and 
regional body fat  
Non-conventional anthropometric measures 





%BF  0.74*** 0.61** 0.56* 0.40 0.58* 0.64** 
%BFADP 0.76*** 0.57* 0.55* 0.44* 0.57* 0.48* 
FM  0.81*** 0.70** 0.58** 0.50* 0.64* 0.54* 
FMADP 0.77*** 0.67** 0.57** 0.49* 0.64** 0.37 
VFA (cm2) 0.81*** 0.72*** 0.64** 0.59** 0.67** 0.60** 
TFM (kg) 0.76*** 0.75** 0.49* 0.51* 0.65** 0.35 
AFM (kg) 0.89*** 0.68* 0.51* 0.57* 0.59* 0.25 
UFM (kg) 0.82*** 0.63** 0.46* 0.58* 0.55* 0.23 






% BF  0.81*** 0.39* 0.48** 0.46* 0.22 0.14 
%BFADP 0.77*** 0.19 0.18 0.23 0.01 0.20 
FM 0.88*** 0.53** 0.55** 0.51* 0.36 0.13 
FMADP 0.77*** 0.28 0.24 0.22 0.19 0.15 
VFA (cm2) 0.89*** 0.65*** 0.68*** 0.57** 0.44* 0.29 
TFM (kg) 0.63** 0.48* 0.46* 0.14 0.34 -0.09 
AFM (kg) 0.87*** 0.57** 0.61** 0.41 0.50* 0.09 
UFM (kg) 0.84*** 0.55** 0.53* 0.37 0.50* 0.07 





% BF  0.50*** 0.27 0.33* 0.21 0.16 0.47** 
%BFADP 0.45** 0.23 0.25 0.17 0.13 0.39** 
FM  0.76*** 0.60** 0.59*** 0.48*** 0.49** 0.31* 
FMADP 0.68*** 0.55** 0.54*** 0.41** 0.49** 0.20 
VFA (cm2) 0.76*** 0.71** 0.71*** 0.60*** 0.61** 0.35* 
TFM (kg) 0.64*** 0.68** 0.62*** 0.43** 0.58** 0.06 
AFM (kg) 0.39* 0.22 0.20 0.14 0.12 0.29 
UFM (kg) 0.64*** 0.49** 0.49** 0.39* 0.38* 0.19 
LFM (kg) 0.29* 0.11 0.12 0.04 0.02 0.29* 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
NBMI: new BMI; WTR: waist to thigh ratio; WCR: calf to waist ratio; NHtR: neck to height ratio; 
CI: conicity index; ABSI: a body shape index. BF: body fat; FM: fat mass; VFA: visceral fat area; 




4.5 Height-adjusted leanness indices and anthropometric measures 
When BIA-estimated measures of leanness/muscularity were adjusted by height to 
control for the influence of stature on the variability in lean compartments (Table 
4.5), all indices except SMI showed stronger relationships with AC, BMI, NC and 
WC than with other conventional anthropometric measures in total SPs (Table 4.5). 
AC was the strongest correlate of FFMI; BMI was the strongest correlate of TSMI 
and LSMI while NC was the strongest correlate of FFMIADP in total SPs. USMI 
correlated equally with AC, BMI, and NC. In male SPs, significant correlations were 
as follows: FFMI with AC and TC; SMI with WHtR, WHR, WC and BMI; USMI 
and LSMI with NC and ASMI with AC, BMI, and TC. In female SPs, only SMI and 
FFMIADP correlated significantly with the conventional anthropometric measures, 
most strongly with BMI and WC. SMI demonstrated consistently negative 
relationships with all anthropometric measures in both sexes. 
Among the non-conventional anthropometric measures (Table 4.6), NBMI was the 
strongest non-conventional correlate of height-adjusted leanness indices in total SPs, 
most strongly with TSMI, followed by NHtR. ABSI also showed negative 
relationships with all leanness indices but ASMI. NHtR was the strongest non-
conventional anthropometric correlate of SMI.  
 
Overall, AC and NC were found to be the strongest anthropometric indicators of 
stature-normalised total leanness and muscularity in the entire population. BMI and 
new BMI were the strongest correlates of truncal muscularity whilst AC, NC, BMI 
and WC were comparably strong indicators of appendicular muscularity. Again, 
ABSI was the only negative correlate of leanness/muscularity in total population. 
The magnitude of associations was, however, lower than the figure observed for 
stature-unadjusted leanness/muscularity measures These observations lend support 
to the previous notion that the measures widely known as the markers of fatness may 
be influenced by changes in the lean compartments too. Also, correlation of 










Conventional anthropometric measures 





FFMI 0.39 0.41 0.67** 0.12 0.48* 0.33 0.12 -0.01 
FFMIADP 0.28 0.35 0.35 0.15 0.16 0.13 0.23 0.13 
SMI 0.38 0.46* 0.68*** 0.10 0.46* 0.37 0.10 -0.04 
TSMI  0.46* 0.46* 0.73*** 0.49* 0.59* 0.34 0.58** 0.46 
ASMI 0.55* 0.20 0.61** 0.26 0.54* 0.32 0.27 0.20 
USMI 0.32 0.60** 0.59** 0.21 0.45 0.16 0.24 0.15 






FFMI 0.30 0.28 0.55* 0.20 0.01 0.02 0.26 0.18 
FFMIADP 0.51* 0.27 0.47 0.35 0.41* 0.24 0.15 0.40* 
SMI 0.08 0.31 0.15 -0.02 -0.22 -0.22 0.09 0.09 
TSMI  -0.14 -0.03 0.04 0.04 0.09 -0.07 -0.07 0.22 
ASMI 0.02 -0.19 -0.28 -0.16 -0.07 -0.15 -0.18 -0.03 
USMI -0.16 -0.11 -0.09 -0.08 -0.04 0.01 0.01 0.05 





FFMI 0.59** 0.67** 0.76*** 0.53*** 0.36* 0.46* 0.40* 0.34* 
FFMIADP 0.61*** 0.63*** 0.59*** 0.58*** 0.42** 0.47*** 0.40* 0.47** 
SMI 0.47*** 0.63*** 0.59*** 0.41** 0.21 0.32* 0.31* 0.28* 
TSMI  0.68** 0.53** 0.58** 0.56** 0.41* 0.38* 0.38 0.51** 
ASMI 0.60*** 0.61*** 0.57*** 0.57*** 0.35* 0.46* 0.35 0.42* 
USMI 0.58*** 0.57*** 0.57** 0.51*** 0.34* 0.37* 0.37* 0.39* 
LSMI 0.50** 0.41* 0.42** 0.39** 0.22 0.25 0.27 0.34* 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
BMI: body mass index; NC: neck circumference; AC: arm circumference; WC: waist circumference; 
TC: thigh circumference; CC: calf circumference; WHR: waist to hip ratio; WHtR: waist to height 
ratio; FFMI: fat-free mass index; SMI: skeletal muscle index; TSMI: truncal skeletal muscle index; 
ASMI: appendicular skeletal muscle index; USMI: upper limb skeletal muscle index; LSMI: lower 











Non-conventional anthropometric measures 





FFMI 0.31 -0.10 -0.04 0.21 -0.12 -0.49* 
FFMIADP 0.36 0.07 0.08 0.28 -0.06 -0.10 
SMI 0.30 -0.11 -0.08 0.25 -0.15 -0.53* 
TSMI  0.69** 0.19 0.36 0.52* 0.16 0.05 
ASMI 0.53* 0.68* 0.10 0.57* 0.59* 0.25 
USMI 0.40 0.01 0.14 0.26 -0.03 -0.19 






FFMI 0.28 0.19 0.20 0.26 0.03 -0.09 
FFMIADP 0.40 0.08 0.22 0.24 0.06 -0.20 
SMI 0.13 0.12 0.12 0.46* -0.12 0.20 
TSMI  0.39 -0.05 0.12 0.10 -0.22 0.22 
ASMI 0.07 -0.13 -0.09 -0.02 -0.26 0.12 
USMI 0.18 -0.09 0.01 0.02 -0.25 0.13 





FFMI 0.49** 0.38* 0.38* 0.49* 0.37* -0.43** 
FFMIADP 0.55*** 0.41* 0.43** 0.54*** 0.45** -0.16 
SMI 0.41** 0.33* 0.31* 0.56*** 0.26 -0.28 
TSMI  0.65** 0.38* 0.47** 0.51* 0.35* -0.09 
ASMI 0.52** 0.22 0.42** 0.14 0.12 0.29 
USMI 0.50** 0.37* 0.41** 0.45** 0.35* -0.26 
LSMI 0.47** 0.30* 0.32* 0.37* 0.23 -0.13 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
NBMI: new BMI; WTR: waist to thigh ratio; WCR: waist to calf ratio; NHtR: neck to height ratio; 
CI: conicity index; ABSI: a body shape index; FFMI: fat-free mass index; SMI: skeletal muscle 
index; TSMI: truncal skeletal muscle index; ASMI: appendicular skeletal muscle index; USMI: upper 







4.6 Height-adjusted fatness indices and anthropometric measures 
In total population (Table 4.7), WHtR and BMI displayed the highest level of 
correlation with height-adjusted total, truncal and upper limb fatness, followed by 
WHR and WC. No significant relationship was found for the appendicular and lower 
limb fat indices. WHtR, BMI and WC were equally correlated with TFMI. For FMI 
and UFMI, BMI and WHtR were respectively the strongest correlates. In men, 
WHR exhibited the strongest correlations with all indices, with LFMI being the 
most closely related index, followed by FMI and UFMI. For all fatness indices, 
relationships were stronger in male than in female SPs. In women, BMI showed the 
closest relationships with height-adjusted total and segmental body fat. WHtR and 
WC were almost equally correlated with the appendicular fat indices. TC did not 
show any significant relationship with the height-adjusted body fat indices in total, 
male or female SPs. 
In men and women, NBMI was the strongest non-conventional anthropometric 
correlate of all height-adjusted fat indices (Table 4.8). 
Thus, for a given height, new BMI, BMI and WHtR appear to be stronger indicators 
of total and upper limb fatness in otherwise healthy adults as compared to WC and 
WHR. In contrast, all four anthropometric measures demonstrate equally strong 
correlations with truncal fatness. It is noteworthy that none of these measures related 
significantly to lower limb fatness. Instead, WTR, NHtR, conicity index and ABSI 
correlate significantly to lower appendicular adiposity and may be used as surrogate 















Conventional anthropometric measures 





FMI 0.80*** 0.45* 0.52* 0.81** 0.18 0.65** 0.87** 0.78* 
FMIADP 0.78*** 0.40 0.56* 0.83*** 0.20 0.51* 0.83*** 0.80*** 
TFMI 0.73** 0.40 0.42 0.78** 0.02 0.61** 0.80** 0.74** 
AFMI 0.80** 0.45 0.59* 0.73* 0.33 0.59** 0.82* 0.70* 
UFMI 0.85*** 0.49* 0.58* 0.83*** 0.18 0.65** 0.86*** 0.80*** 






FMI 0.83** 0.33 0.57 0.69** 0.13 0.25 0.53* 0.65* 
FMIADP 0.67** 0.09 0.36 0.45* 0.29 0.38* 0.30 0.57* 
TFMI 0.61* 0.29 0.53* 0.60** 0.13 0.26 0.51* 0.53* 
AFMI 0.79* 0.42* 0.61* 0.75*** 0.31 0.37 0.50 0.74* 
UFMI 0.75* 0.34 0.57 0.63* 0.23 0.24 0.52* 0.65* 





FMI 0.65*** 0.16 0.33* 0.47** 0.10 0.31 0.51** 0.57** 
FMIADP 0.61*** 0.20 0.38* 0.53*** 0.23 0.40** 0.47** 0.65*** 
TFMI 0.67*** 0.40** 0.50*** 0.67*** 0.14 0.49* 0.63*** 0.67*** 
AFMI 0.25 -0.12 0.09 0.13 0.10 0.08 0.24 0.30 
UFMI 0.53** 0.14 0.33* 0.41* 0.14 0.27 0.48** 0.55** 
LFMI 0.14 -0.24 -0.01 0.01 0.01 -0.05 0.17 0.21 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
BMI: body mass index; NC: neck circumference; AC: arm circumference; WC: waist circumference; 
TC: thigh circumference; CC: calf circumference; WHR: waist to hip ratio; WHtR: waist to height 
ratio; FMI: fat mass index; TFMI: truncal fat mass index; AFMI: appendicular fat mass index; 











Table 4.8. Non-conventional anthropometric measures and height-adjusted fatness indices  
Height-adjusted 
fatness indices  
Non-conventional anthropometric measures 





FMI 0.82*** 0.65** 0.61** 0.55* 0.57* 0.41 
FMIADP 0.77*** 0.65** 0.63** 0.54* 0.62** 0.51* 
TFMI 0.71** 0.68* 0.50* 0.61** 0.57* 0.45 
AFMI 0.79** 0.62** 0.45 0.63** 0.54* 0.38 
UFMI 0.84*** 0.58** 0.51* 0.29 0.41* 0.11 






FMI 0.81** 0.44 0.52** 0.40 0.27 0.20 
FMIADP 0.69** 0.52** 0.25 0.44* 0.40* 0.25 
TFMI 0.56* 0.65** 0.51* 0.55* 0.57* 0.41 
AFMI 0.75* 0.65** 0.59** 0.54* 0.62** 0.51* 
UFMI 0.73** 0.68* 0.53* 0.61** 0.57* 0.45 





FMI 0.71*** 0.43** 0.48*** 0.28 0.31* 0.31 
FMIADP 0.67*** 0.43** 0.42** 0.36* 0.34* 0.39* 
TFMI 0.66*** 0.35 0.54** 0.32* 0.22 0.35* 
AFMI 0.34* 0.08 0.12 0.08 0.01 0.36* 
UFMI 0.60*** 0.43** 0.34* 0.28 0.31* 0.31 
LFMI 0.25 0.43** 0.05 0.36* 0.34* 0.39* 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
NBMI: new BMI; WTR: waist to thigh ratio; WCR: waist to calf ratio; NHtR: neck to height ratio; 
CI: conicity index; ABSI: a body shape index; FFMI: fat-free mass index; FMI: fat mass index; 
TFMI: truncal fat mass index; AFMI: appendicular fat mass index; UFMI: upper limb fat mass 












This is the first study that comprehensively explores the relationships between 
conventional and non-conventional anthropometric measures with absolute and 
height-normalised parameters of total and segmental leanness and fatness in free-
living healthy adults.  
In the entire study population, NC and AC were found to be the closest conventional 
anthropometric correlates of total FFM as well as total and segmental skeletal 
muscle mass followed by WC, BMI and CC whilst ABSI was the only strong but 
negative correlate of these parameters. The absolute effect size of ABSI was 
comparable to AC for total parameters but it was inferior to NC, AC, BMI and WC 
for segmental parameters. Of note, the strength of association of all anthropometric 
measures was slightly greater for total and truncal than appendicular parameters of 
lean mass. Also, the adjustment of FFM as well as total and segmental skeletal 
muscle mass for height weakened change their relationship with anthropometric 
measurements but did not substantially altered the pattern of these associations 
except for ABSI which was no longer a significant correlate of segmental muscle 
mass. AC has been suggested as a reliable measure of muscle mass in the evaluation 
of sarcopenia and nutritional status across different groups of population (Al-Gindan 
et al., 2014). As compared to BMI and CC, AC has also been shown to be a stronger 
negative predictor of long-term survival in the elderly (Wijnhoven et al., 2010); 
however, it cannot be overemphasised that upper arm circumference is anatomically 
related to bone, skeletal muscle and subcutaneous adipose tissue. For this reason, 
like other limb circumferences, the association of AC with health outcomes may 
stem from changes in the quality and quantity of these three tissues. Another 
interesting observation was that TC, WHR and WHtR exhibited similar trend of 
relationship with BIA-derived measures of leanness. These anthropometric indices 
were more strongly related to FFM and upper body skeletal muscle mass than total 
skeletal muscle mass and leg muscle content (the main metabolic constituent of the 
musculature), suggesting that mid-thigh circumference may be reflect subcutaneous 
fat tissue better than muscle tissue in adults with less muscular body built.. The 
established independent and oppositely directed link between insulin sensitivity and 
waist versus thigh and hip circumference in men and women (Snijder et al., 2003) 
lends more support to the view that improved metabolic profile of individuals with 
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larger thighs and hips can be due to the more favourable metabolism of their 
subcutaneous adipocytes (Van Pelt et al., 2002). Of particular interest was the 
relationship of NC and WC with total and regional muscularity as well as total 
leanness which indicates these anthropometric measures may not exclusively reflect 
the adiposity status of healthy adults and their role as the predictors or indicators of 
altered metabolic processes can be ascribed to the underlying adaptive and 
maladaptive changes in fat and fat-free components of body composition. Notably, 
when the contribution of BMI to WC was discounted by creating ABSI, the 
direction of association between waist circumference and leanness/muscularity was 
reversed. This was opposite to the observed association between CI, another body 
size adjusted index of WC, and BIA-estimated FFM and skeletal muscle mass. 
Hence, ABSI discloses depleted lean mass better than CI as it indicates the residual 
WC after controlling for body mass and height. Therefore, individuals with high 
ABSI have a greater fraction of visceral fat and a smaller fraction of appendicular 
lean tissue at a given BMI and height. The inverse relationship between ABSI (as a 
measure of body shape) and lean tissue mass is supported by the findings from a 
secondary analysis of the NHANES 1999-2004 data (Krakauer and Krakauer, 2012). 
This study showed negative correlation between ABSI and DXA-estimated lower 
limb lean mass adjusted for height. Also, in a cross-sectional study of 200 Italian 
and Slovenian adults with elevated BMI, men and women with higher ABSI had 
significantly lower FFMI (Biolo et al., 2015). Given the inverse association of total 
and appendicular muscle mass with physical disability, increased morbidity and 
mortality risk (Chang and Lin, 2016), ABSI may be used as a surrogate measure of 
reduced lean and muscle tissue to predict adverse outcomes in adults. This supports 
the hypothesis that the consistently observed link between general, upper-body, and 
abdominal adiposity (determined anthropometrically by BMI, NC, and WC) and 
metabolic abnormalities may also be influenced by concomitant changes in the 
quantity and regional distribution of lean mass.  
In accord with this notion, Takai et al. reported that WHtR and body mass to WC 
ratio were independent predictors of DXA-measured FFM in Japanese male athletes 
(Takai et al., 2018). Thus, the combined contribution of FM and FFM should be 
carefully considered when using BMI, NC, and WC in the assessment of a variety of 
clinical outcomes in otherwise healthy adults. Another noticeable observation was 
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that NC related to upper and lower-limb muscularity more strongly than AC and CC. 
MUAC and CC have been commonly applied as the proxy measures of lean or 
muscle mass in both observational and interventional studies but the potential role of 
NC as an indicator of appendicular muscularity has not been investigated so far. It is 
possible that neck circumference can be used as a measure of skeletal muscle 
content in both upper and lower extremities.  
Overall, these observations indicate that at a given height, large arm and neck 
circumferences reflect higher total and segmental muscularity better than other 
anthropometric indices in otherwise healthy adults. Also, an increased ABSI can be 
an indicator of diminished leanness in this population. Nevertheless, the association 
of AC, CC and NC with total and segmental fatness should not be overlooked. 
When stratified by sex, ABSI emerged as the strongest (yet negative) 
anthropometric correlate of total fat-free and muscle mass whilst AC was the 
strongest correlate of segmental muscle mass in men. The other significant 
indicators of total leanness and segmental muscularity were NC, CC (before height 
adjustment) and TC (after height adjustment) in male SPs. In contrast, significant 
relationships in female SPs were observed just between FFMADP and CC (directly) 
and FFM and ABSI (inversely). These were in contradiction to the significant 
correlations of all non-conventional anthropometric measures with the above 
parameters observed before sex-stratification of data. The observed discrepancy 
between total and sex-stratified correlations can be explained by the amalgamation 
paradox (Berman et al., 2012). This happens when two groups with contrasting 
patterns of binary associations between pairs of variables are aggregated. In this 
case, the overlap between data-pairs pertinent to each group improves the linearity 
of the combined group, distorting the actual relationships. The lack of significant 
relationships in female SPs may be due to their lower total and regional skeletal 
muscle mass and the higher proportion of subcutaneous fat in their trunk and 
extremities. As a result, anthropometric measurements in women may reflect total 
and segmental fat mass rather than muscle mass (Kyle et al., 2001). When the effect 
of body size is controlled (as in NBMI and ABSI), the contribution of non-muscle 
compartments to the anthropometric indices is attenuated and the direction of 
association is reversed. 
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A more plausible explanation could be the established limitation of subgroup 
analysis. Although it was attempted to improve the statistical power of sex-stratified 
analyses of the study population by having relatively equal proportions of male and 
female SPs and testing anthropometric and body composition variables along their 
continuum, the lack of prior probability estimation and sample size calculation based 
on the main effects in the entire population would result in an inadequate power and 
subsequently higher probability of false negative findings from the subgroup 
analysis (Burke et al., 2015). 
With respect to total and segmental fatness, WHtR, NBMI, WHR, BMI, WTR, WC 
and WCR were found to be strong indicators of total, visceral and truncal fatness in 
the entire population, with the relationships being stronger for visceral adiposity 
whereas ABSI represented visceral but not total or truncal adiposity. This is not 
unexpected as ABSI has been proposed to control for the dependence of WC on 
height and BMI. In this regard, an analysis of the NHANES 1999–2004 data 
(Krakauer and Krakauer, 2012), showed that WC was weakly correlated with DXA-
measured Z score of trunk fat mass adjusted for body size. When the influence of 
body size is discounted, the association of WC and subcutaneous fat depot (the main 
adipose constituent of trunk and limbs) loses significance. What remains is the 
association between the body shape (the component of WC which reflects central 
distribution of body mass) and visceral fat depot. The significant associations of 
WHtR, WC and WHR with CT-determined total and visceral fat areas have been 
established (Ashwell, Cole and Dixon, 1985, 1996; Seidell et al., 1987; Busetto et 
al., 1992).  
The effect size of these measures on appendicular (especially lower limb) fatness 
was smaller. In fact, NBMI and ABSI were the only indices which showed 
significant albeit weak relationship with the fat content of lower limbs. This 
observation demonstrates that the anthropometric measurements are not useful 
surrogates for the lower-body adiposity and should be interpreted carefully when 
used as the proxy measures of appendicular adiposity. In addition, their comparably 
close relationship with total, visceral and truncal adiposity suggests that these 
measures cannot differentiate between subcutaneous and visceral fat depots. 
Interestingly, NC and AC were related to visceral and truncal but not total fat mass, 
indicating that neck and arm perimeters reflect upper body rather than general 
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adiposity. Thus, the total and segmental quantity of lean tissues as well as the 
amount of fat stored in the truncal region of adults are jointly linked to the 
circumference of neck and arms. This is in contrast to previous reports on the strong 
associations between NC, visceral and subcutaneous adipose tissue (Sjöström et al., 
1995; Yang et al., 2010; Aswathappa et al., 2013). Nevertheless, these studies had 
been mainly conducted on obese or insulin resistant subjects. In this context, the 
established link between increased NC and metabolic risk factors (Ben-Noun and 
Laor, 2006), OSA (Katz et al., 1990) or polycystic ovary syndrome (Dixon and 
O’brien, 2002) may not be solely due to the excessive upper-body fatness. The 
influence of lean tissues on neck circumference may be an explanation for the 
superior performance of NC in predicting metabolic syndrome and obstructive sleep 
apnoea in comparison to WC or BMI, especially in men (Pływaczewski et al., 2008; 
Onat et al., 2009).  
The finding of positive correlation of AC and (less strongly) CC with absolute as 
well as height-normalised total and segmental adiposity in the present research 
suggests that the frequently observed association between low CC or AC and 
unfavourable health outcomes, including lower quality of life and higher mortality in 
different groups of population (Powell-Tuck and Hennessy, 2003; Mason, Craig and 
Katzmarzyk, 2008; Flegal and Graubard, 2009), may be due to concomitant loss of 
fat and muscle mass (Cesari et al., 2009; Huang et al., 2010). However, the lack of 
significant relationships between CC and absolute or height-adjusted measures of 
leanness in the current study in both sexes shows that the negative impact of low 
calf and arm circumferences on health outcomes is mostly attributable to the loss of 
fat rather than muscle, at least in the non-elderly healthy population.  
In contrast, TC was not significantly related to any fat component. Given the 
significant relationship between thigh circumference and total as well as segmental 
muscle mass in the entire population of the current study, it can be inferred that the 
perimeter of mid-thigh area is not indicative of total or segmental body fatness in 
healthy adults. This is conflict with the findings of Snijder et al. (Snijder et al., 
2005) who showed significant association of mid-thigh circumference with CT-
measured thigh total fat area and muscle area. That study, however, was conducted 
on well-functioning adults aged 70-79 years. BIA-related estimation error of fat 
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components especially in lean individuals may also be a reason for the observed 
dissociation of TC and fatness in the present study. 
Akin to the associations between anthropometric indices and measures of leanness, 
stature adjustment of total and regional body fat attenuated but did not change the 
pattern of associations with anthropometric measures, denoting the ability of these 
parameters to represent total and segmental leanness and adiposity.  
Close associations of WHtR, NBMI, WHR, BMI, WTR, WC and WCR with total 
and segmental adiposity were reproduced in male SPs whereas BMI, NBMI, WC 
and WHtR emerged as the strong indicators of total and regional fatness in female 
SPs. Interestingly, AC and CC indicated truncal and appendicular adiposity better 
than total and visceral adiposity ascompared to total and visceral fatness in males. In 
contrast, AC was a better indicator of total and visceral fatness in female SPs. 
Sexual disparity was also found for NC-fatness relationship. While neck 
circumference reflected non-visceral segmental adiposity in men, it had significant 
relationship with appendicular and visceral adiposity in women. In addition, ABSI 
and CI represented total and segmental fatness more consistently in men. They were 
only related to visceral fatness in women. These observations indicate a sex-specific 
relationship between anthropometric indices and body composition due to the 
differential proportion and distribution of fat and fat-free compartments in male and 
female adults (Karastergiou et al., 2012; Siervo et al., 2015). These differences can 
be explained by the fact that, adjusted for height, men have higher lean mass, greater 
arm and leg muscle mass, lower total fat mass, centrally accumulated adipose tissue, 
and less appendicular fat. On the contrary, women tend to have higher total fat and 
peripherally distributed adipose tissue (WHO, 2011). Moreover, geometric 
properties as well as soft tissue composition of neck, arms and legs play important 
parts in the sexual dimorphism in the associations of anthropometric measures and 
other clinical outcomes even among height-matched individuals (Antoszewska and 
Wolański, 1992; Vasavada, Danaraj and Siegmund, 2008). Nevertheless, inadequate 
power of the present study for subgroup analysis limits the accuracy of these results. 
Collectively, these findings suggest that both conventional and non-conventional 
anthropometric indices except TC and ABSI represent total, central and peripheral 
adiposity in male and female adults. Additionally, BMI (and/or NBMI), WHtR, 
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WHR and WC are comparably strong surrogates of total and segmental fatness in 
healthy adults. On the contrary, most of the anthropometric measures cannot be 
relied upon as the pure indicators of leanness, although ABSI, neck circumference 
and arm circumference are better indicators of total and segmental muscularity 
status. 
However, it should be remembered that these relationships were not adjusted for 
age, total quantity of fat and fat-free compartments and categories of relative body 
composition. Moreover, it is well-known that anthropometric measurements are 
subject to several limitations. They poorly distinguish between visceral and 
subcutaneous fat depots, fail to discriminate segmental lean and fat tissues, and are 
unable to make differences between muscle, bone and other components of fat-free 
mass. Repeatability and reproducibility of these measurements are not optimal. 
There is considerable intra and inter-observer variation in the recorded readings. 
Biological factors, including bony structure, hydration and prandial states, phases of 
respiration, posture, together with laxity of muscles and skin also influence the 
accuracy and precision of anthropometric measurements. Variability in anatomical 
landmarks and techniques of measurement may be other sources of error. Besides, 
age, sex, and ethnicity-specific alterations in body composition complicates the 
harmonised interpretation of the values. When absolute measurements are 
composited into ratios or indices, the propagation of error increases. Further, the 
combination of measurements would inevitably lead to the loss of information, 
causing some uncertainty about the underlying changes in fat or fat-free 
components. Notwithstanding these drawbacks, anthropometry is a valuable 
assessment tool in clinical setting because of reasonably low cost, participant  
burden, practitioner burden of data collection and analysis, information bias, and 
cognitive capacity as well as favourably high availability, practicality and inclusivity 
(MRC epidemiology unit, 2016). The estimation error inherent in the measurement 
of fat and lean compartments by BIA might have also confounded the actual 
relationships. Nevertheless, as discussed thoroughly in chapter 2, direct segmental 
multifrequency assessment of body composition using the In-Body and Tanita 
analysers has been shown to have good agreement to DXA in the quantification of 
total FFM, FM and %BF as well as truncal and appendicular lean mass in otherwise 




Body Composition and Blood Pressure 
 
SPs were divided into three groups of fatness, namely underfat, healthy-range and 
overfat/obese based on the BMI, age, sex, and ethnicity-specific body fat ranges 
recommended by Gallagher et al. (Gallagher et al., 2000). The effect of fatness 
status on the measures of systemic blood pressure (SBP, DBP and MAP) was 
analysed using univariate ANOVA with the Bonferroni-adjusted post-hoc test. 
Pearson’s correlation test was conducted to examine the relationship between 
measures of systemic BP and total as well as segmental fatness and leanness. 
Correlations were additionally stratified by sex. Sex-specific tertiles of total and 
regional relative boy composition were created and compared in relation to indices 
of BP by ANOVA with post-hoc analysis using Tukey’s HSD test. FM/FFM and 
TFM/ASM as the whole-body and segmental indicators of metabolic load-capacity 
balance were included in the linear regression models with heteroscedasticity-
consistent standard errors. Models were also adjusted for age, sex and ethnicity.  
 
Results  
5.1 Fatness and systemic blood pressure 
Fatness status had a significant effect of on SBP (F(2,47)=5.31, p=.007, ηp
2=.18), 
DBP (F(2,47)=5.26, p=.009, ηp
2=.18), and MAP F(2,47)=6.60, p=.003, ηp
2=.22). 
Thus, fatness status explained 18% of SBP and DBP total variance and 22% of MAP 
total variance among SPs. Pairwise comparisons indicated that SBP in overfat SPs 
was significantly higher than underfat (MD=12.86mmHg, p=.031) and normal-fat 
(MD=10.59mmHg, p=.020) SPs. Overfat SPs also had higher DBP than their 
underfat (MD=8.35, p=.12) and normal-fat (MD=10.38, p=.009) counterparts. 
Similarly, MAP was higher in overfat than underfat (MD=8.20, p=.10) and normal-












5.2 Total and segmental body composition and systemic blood pressure 
In the entire study population, total and segmental skeletal muscle mass correlated 
significantly with SBP and PP (Table 5.1). Additionally, DBP correlated negatively 
but non-significantly with total and segmental skeletal muscle mass. Notably, the 
magnitude of relationship between total quantity of skeletal muscle and parameters 
of systemic BP was comparable to that of truncal and appendicular muscle mass. 
None of the skeletal muscle compartments correlated with mean arterial pressure. 
This may indicate a greater influence of general and regional muscularity on systolic 
rather than diastolic pressure; therefore, otherwise healthy individuals with larger 
quantity of skeletal muscle may have higher SBP and slightly lower DBP, and 
consequently wider pulse pressure as compared to their less muscular counterparts. 
In contrast, total, truncal and appendicular fat mass showed comparably significant 
relationships with DBP and MAP in the entire population. In addition, total and 
truncal fat mass correlated significantly with SBP. All segmental fat compartments 
showed negative but non-significant associations with pulse pressure. The only 
observed significant correlation was between UFM and PP in total population. As a 
result, in free-living healthy adults, general and central adiposity relate positively to 
systolic and diastolic BP, with slightly greater influence on the diastolic component. 
In comparison, peripheral adiposity is mostly related to the diastolic component of 
systemic BP. It does not, however, seem that fat component (except upper-limb fat 
compartment) of body composition could be a major correlate of pulse pressure.  
In the entire population, SBP and PP had stronger relationships with muscular 
compartments than adipose compartments, whereas DBP and MAP correlated more 













Lean compartment Fat compartment 




SBP 0.13 0.17 0.07 0.09 0.07 0.49* 0.45* 0.50* 0.41 0.54* 
DBP -0.30 -0.27 -0.31 -0.32 -0.35 0.55* 0.56* 0.51* 0.46* 0.52* 
MAP -0.18 -0.15 -0.20 -0.20 -0.23 0.58** 0.58** 0.56* 0.49* 0.57* 





SBP -0.13 -0.08 -0.15 -0.05 -0.20 0.36 0.17 0.43 0.33 0.37 
DBP -0.10 -0.06 -0.13 -0.06 -0.18 0.52* 0.37 0.52* 0.42 0.49 
MAP -0.12 -0.07 -0.14 -0.06 -0.20 0.49* 0.32 0.52* 0.41 0.48 





SBP 0.31* 0.32* 0.30* 0.33* 0.28 0.38* 0.38* 0.19 0.11 0.32 
DBP -0.11 -0.10 -0.11 -0.11 -0.13 0.53*** 0.45** 0.45** 0.41** 0.43* 
MAP 0.05 0.05 0.04 0.05 0.02 0.52*** 0.46** 0.39* 0.33* 0.43* 
PP 0.52*** 0.52*** 0.51*** 0.53*** 0.52*** -0.11 -0.02 -0.27 -0.32* -0.09 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
All compartments were measured by Tanita SEG-MF Bioelectrical Impedance Analyser. 
FFM: fat-free mass; TSM: trunk skeletal muscle mass; ASM: appendicular skeletal muscle mass; 
USM: upper limb skeletal muscle mass; LSM: lower limb skeletal muscle mass TFM: trunk fat mass; 
AFM: appendicular fat mass; UFM: upper limb fat mass; LFM: lower limb fat mass; SBP: systolic 









5.3 Body composition phenotypes and systemic blood pressure 
To investigate the relative contribution of fatness and leanness to the parameters of 
systemic blood pressure, total, truncal and appendicular body composition 
phenotypes were created based on the tertiles of the corresponding fat and lean 
compartments. 
Across sex-specific body composition phenotypes, only DBP and MAP were found 
to have significantly different mean values (Figures 5.2 and 5.3). For total body 
composition phenotypes, High-FM/High-FFM phenotype had significantly higher 
DBP than Low-FM/Mid-FFM (MD=23.25 mmHg, p<0.05) and Mid-FM/High FFM 
(MD=21.33 mmHg, p<0.05) phenotypes. With respect to MAP, the significant 
difference was observed between High-FM/High-FFM and Low-FM/Mid-FFM 
phenotypes (MD=22.81 mmHg, p<0.05). Consequently, healthy adults with the 
highest degrees of total fatness and leanness had at least 20mmHg higher diastolic 
and mean arterial pressures than those with the lowest levels of fatness and mid-
range leanness. By contrast, DBP and MAP of individuals who had the lowest level 
of leanness did not differ significantly by their fatness status. This may imply that 
potentially harmful effects of general adiposity are exerted on diastolic and mean 
arterial pressure when the lean compartment is expanded. A similar trend was 
observed across truncal phenotypes where DBP was significantly higher in SPs with 
high truncal fat and high skeletal muscle mass than those with low fat but high 
skeletal muscle mass in truncal region (MD=23.98 mmHg, p<0.05) although MAP 
did not differ significantly between truncal phenotypes.  
On the contrary, DBP rose steadily across levels of appendicular fat irrespective of 
the corresponding muscularity status. Nevertheless, the magnitude of effect exerted 
by the increased fat content of the limbs on diastolic pressure was greater when the 
concomitant muscle content was also increased. Among appendicular phenotypes, 
SPs with Low-AFM/High-ASM phenotype had significantly lower DBP than those 
with Mid-AFM/Low-ASM (MD=-16.72 mmHg, p<0.05), High-AFM/Mid-ASM 
(MD=-19.72 mmHg, p<0.05) and High-AFM/High-ASM (MD=-24.01 mmHg, 
p<0.01) phenotypes; DBP was also lower in Mid-AFM/High-ASM SPs than those 
with High-AFM/High-ASM phenotype (MD=-22.25 mmHg, p<0.01).  
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A comparable association was observed between MAP and appendicular body 
composition phenotypes where MAP was significantly lower in Low-AFM/High-
ASM SPs than those with Mid-AFM/Low-ASM (MD=-16.66 mmHg, p<0.05), 
High-AFM/Mid-ASM (MD=-16.80 mmHg, p<0.05) and High-AFM/High-ASM 
(MD=-24.60 mmHg, p<0.01) phenotypes; SPs with Mid-AFM/High-ASM 
phenotype had also lower MAP than High-AFM/High-ASM SPs (MD=-21.83 
mmHg, p<0.01).  
Once again, the largest difference in the mean arterial pressure (approximately 
25mmHg) was observed between adults with the lowest and highest appendicular fat 
mass only if both groups had high degrees of appendicular muscularity, reinforcing 
the possibility that the quantity of total and segmental skeletal muscle may augment 
the unfavourable influence of excessive adiposity on the diastolic component of 
systemic pressure. 
Despite significant effects on DBP and MAP, total and segmental body composition 

















Figure 5.2 Diastolic blood pressure across body composition phenotypes; a) total, b) 











5.4 Relative Body composition and systemic blood pressure 
In order to explore the association between metabolic homeostasis and arterial 
function, fat mass to fat-free mass ratio and truncal fat mass to appendicular skeletal 
muscle mass ratio were created as the proxy measures of whole-body and segmental 
metabolic balance. 
FM/FFM was significantly associated with DBP (ꞵ=17.61±6.4, p<0.001) but not 
SBP and pulse pressure. In contrast, TFM/ASM showed significant relationships 
with all three measures of blood pressure. Each 0.1point increase in TFM/ASM was 
respectively associated with 1.6mmHg (ꞵ=15.94±4.9, p<0.01) and 2.7mmHg 
(ꞵ=27.47±4.2, p<0.001) rise in SBP and DBP and 1.1mmHg (ꞵ=-11.38±4.01, 
p<0.01) decrease in pulse pressure (Figure 5.4). Hence, adults with segmental 
metabolic overload may have higher systolic and diastolic pressures as well as 
narrower pulse pressure even if their whole-body metabolic overload only affects 



















Figure 5.4. Systemic Blood Pressure relationship with a) total, b) segmental body 
composition phenotypes. 
*significant relationship between measures of systemic pressure and relative body composition 
TFM/ASM: truncal fat mass to appendicular skeletal muscle ratio; DBP: diastolic blood pressure; 





In this study, overfat SPs had higher SBP, DBP and MAP than SPs in the underfat 
and healthy-range categories of %BF. Both general and central obesity are well-
known modifiable risk factor for hypertension. There is a large battery of literature 
on the independently positive association between adiposity and systolic as well as 
diastolic BP. Large-scale longitudinal studies also indicate that overweight or obese 
individuals are more likely to develop elevated SBP and DBP than normal or 
underweight individuals (Kannel et al., 1987; Stevens et al., 2001; Forman, 
Stampfer and Curhan, 2009; Koh et al., 2011).  
The observed sex-specific differences in the preceding correlations may stem from 
the higher intramuscular and ectopic fat infiltration in women (Miljkovic‐Gacic et 
al., 2008). It may also be speculated that the lower quantity of total and regional 
muscle mass affects BP-leanness association in females. Differential endocrine and 
metabolic actions of skeletal muscle tissue in the neurohormonal regulation of blood 
pressure cannot be ruled out too. It should not be forgotten that the study was 
underpowered for subgroup analysis and these observations may not accurately 
reflect the actual sex-specific relationships in the general population. 
 
Another finding of this study was the significantly positive relationships of total and 
truncal fat mass with SBP, DBP and MAP and their negative relationship with PP. 
In contrast, the appendicular fatness was significantly related to DBP and MAP but 
not SBP. 
There is compelling evidence on the associations of SBP and DBP with total, truncal 
and appendicular adiposity (Van Pelt et al., 2002; Kim et al., 2008; Hunter et al., 
2010; Park et al., 2014; Ye et al., 2018). As discussed thoroughly in the literature 
review, excessive (visceral) adiposity may induce hypertension via impaired renal 
pressure natriuresis due to the enhanced sodium reabsorption caused by renal 
compression and reduced tubular perfusion, metabolically intensified endothelial 
dysfunction, formation and progression of the atherosclerotic plaques and vascular 
stiffening, systemic and renal activation of sympathetic nervous system triggered by 
the altered sensitivity of mechano- and chemoreceptors (especially in the presence 
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of obstructive sleep apnoea), and BP-raising effects of the central leptin-
melanocortin pathway and activation of renin-angiotensin-aldosterone system (Hall 
et al., 2015). With regards to the leptin-melanocortin pathway, longstanding leptin 
resistance and hyperleptinaemia stimulates proopiomelanocortin (POMC) neurons in 
hypothalamus, brain stem, and spinal cord via leptin receptors and JAK-STAT, 
PI3K and MAPK signalling pathways, releasing α-melanocyte–stimulating hormone 
(α-MSH) which in turn activates melanocortin 4 receptors (MC4R) in sympathetic 
preganglionic neurons; this results in increased SNS activity and elevated arterial BP 
(do Carmo et al., 2017).  
Differential association of trunk and extremity adiposity with metabolic risk factors 
has been stressed in previous studies. In the Pennington Centre Longitudinal Study 
(PCLS), white and black American adults with high DXA-measured trunk and leg 
adiposity were respectively more and less likely to have 2 or more cardiometabolic 
risk factors, including elevated SBP or DBP (Hu et al., 2011). As reported by 
Alexandersen et al., truncal fat mass and peripheral lean mass were oppositely 
associated with aortic calcification in older Danish men. Severity of calcification 
was lower at highest tertile of DXA-measured appendicular lean mass in this 
population (Alexandersen et al., 2006). Kim et al., also showed that for any given 
%BF, higher DXA-determined arm and leg fat percentages were associated lower 
SBP in non-elderly women with abdominal adiposity. In contrast, higher trunk fat 
percentage predicted higher SBP in them (Kim et al., 2008). 
It was interesting to note that the distribution of fat mass changed the magnitude of 
the adiposity effect on the components of arterial BP. The lack of significant 
relationship between appendicular adiposity and SBP indicates that centrally 
distributed fat could be the main driver of the dynamic alterations in determinants of 
systolic pressure, including stroke volume, heart rate and arterial compliance. The 
significant association between total and segmental fatness and the mean arterial 
pressure can be mathematically explained by the greater contribution of diastolic 
pressure to the calculation of MAP; therefore, changes in the mean arterial pressure 
may be the reflection of the underlying changes in diastolic pressure. Comparable 
association of total as well as segmental fat mass with DBP and MAP demonstrates 
that central and peripheral adiposity may have similar adverse effects on the 
perfusion pressure and resistance of the peripheral arteries ( Brzezinski, 1990). 
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Because PP was mathematically calculated as the difference between SBP and DBP, 
mostly non-significant relationships between pulse pressure and components of fat 
mass may be explained by the comparable effects of these components on SBP and 
DBP, with slightly greater influence on the diastolic component. and.  
On this basis, it can be inferred that adiposity primarily contributes to the steady 
component of systemic blood pressure (as determined by cardiac output and 
vascular resistance) rather than the pulsatile component (influenced by the ejection 
fraction, compliance of the large arteries and wave reflections)(Darne et al., 1989). 
Contrary to the close relationship of adiposity with diastolic and mean arterial 
pressures, total leanness and segmental muscularity had significantly positive 
relationships with systolic pressure and pulse pressure. Higher SBP in the 
individuals with larger lean, particularly skeletal muscle, compartment may be due 
to the increased cardiac output to sustain adequate perfusion of this expanded site of 
metabolic activities. Over time, this augmented mechanical stress would induce 
remodelling of the vasculature, leading to the thickening and reduced elasticity of 
the large arteries (Leischik et al., 2014). This cycle of increased cardiac output and 
arterial stiffness could manifest as elevated systolic BP (Martyn and Greenwald, 
1997). Owing to the concomitant decrease in peripheral resistant of the muscular 
arteries (caused by the endothelium-dependent and endothelium-independent 
relaxation of resistant arteries), diastolic pressure may drop or remain unchanged 
(Rowell, 1993). The counterbalancing effects of changes in SBP and DBP may 
result in the maintenance of the mean arterial pressure and subsequently perfusion 
pressure. This can explain no significant relationship of muscle mass with diastolic 
or mean arterial pressures.  The same logic can be offered for the association 
between pulse pressure and skeletal muscle mass.  
The widening of pulse pressure in more muscular SPs could reflect the opposite 
changes in systolic and diastolic components of the arterial pressure (Homan and 
Cichowski, 2018). In addition, pulse pressure has been suggested as a measure of 
pulsatile hemodynamic stress and a marker of arterial stiffness (Dart et al., 2001). 
Thus, it could be postulated that leanness, more specifically skeletal muscle mass, is 
more related to the pulsatile component of systemic pressure and higher degrees of 
muscularity may indicate the increased arterial stiffening, disruption in the 
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propagation of the forward pressure wave and reflection of the backward pressure 
wave, attenuation of central to peripheral pressure amplification, and dissipation of 
the stiffness gradient. In this setting, the wave reflection occurs earlier during systole 
rather than diastole and reflected waves run into the forward waves, amplifying 
systolic pressure and diminishing diastolic pressure (London and Pannier, 2010). It 
is worth mentioning that peripherally measured pulse pressure may not be an 
accurate indicator of pulse pressure and elastic properties of the aorta and conduit 
arteries (Izzo Jr, 2014). 
The evidence surrounding the effect of lean mass on BP is conflicting. Cross-
sectional studies suggest the protective role of skeletal muscle mass against adverse 
cardiometabolic outcomes, including hypertension and arterial stiffness (Atlantis et 
al., 2009; Ochi et al., 2010; Prasad et al., 2016). On the contrary, recent studied on 
the predominantly young and healthy subjects have revealed positive associations of 
total and regional lean mass indices with SBP and the risk of hypertension across 
different ethnicities (Wang et al., 2009; Prasad et al., 2016; Zhao et al., 2017; Ye, 
2018). Importantly, these associations are modified by adiposity. Peppa et al., in a 
study of non-smoking postmenopausal women found a significant synergistic effect 
of lean mass index and WC on the metabolic risk factors, including SBP and DBP 
(Peppa et al., 2014). Similarly, in a study of urban Chinese adults, when the effect of 
total skeletal muscle on the risk of hypertension and the association of appendicular 
lean mass indices with SBP and DBP became significantly positive after controlling 
for %BF and AOI (Ye et al., 2018). As a more concrete evidence of muscle-fat 
interaction, Zhao et al., showed that progressive attenuation in calf muscle increased 
the risk of incident hypertension in black men after adjustment for insulin resistance, 
WC and IMAT (Zhao et al., 2017). This underscores the crucial role of global and 
regional metabolic crosstalk between lean and fat compartments in the regulation of 
BP.  It should also be noted that the studies which pointed to a beneficial impact of 
leanness on the measures of vascular function did not include a heterogenous 
population, used anthropometric proxies for leanness, or did not partial out the 
confounding effect of adiposity. In addition to the putative role of intramuscular fat 
infiltration in inducing insulin dysregulation (Eastwood et al., 2014) and RAAS-
mediated vascular dysfunction (Gastaldelli and Basta, 2010), muscle-specific 
mechanisms suggested to be involved in the BP-rising effects of muscularity include 
133 
 
LVH and carotid wall thickening, arterial stiffness (Leischik et al., 2014; Moreno et 
al., 2015), myofiber type shift in hypertrophied muscles (DiCesare et al., 2017) and 
SNS activation (Saito, Iwase and Hachiya, 2009). 
In addition, appendicular fat and lean mass have been shown to be significantly 
associated with the calibre, compliance and stiffness of the peripheral arteries 
(Ferreira et al., 2004). In hypertensive and normotensive individuals, pulse pressure 
as a surrogate measure of arterial stiffness and LV afterload, exhibits inverse 
association with endothelial function in conduit and resistance vessels (Ceravolo et 
al., 2003; Nigam et al., 2003; Wiesmann et al., 2004; Mceniery et al., 2006) and 
thereby is directly related to the risk of atherosclerosis and CHD (Schächinger, 
Britten and Zeiher, 2000; Perticone et al., 2001). Thus, the positive relationship 
between muscle mass and PP the study population may be translated into a higher 
long-term cardiometabolic risk. 
A major finding of this research was the significant difference of DBP and MAP 
across total, truncal, and appendicular body composition phenotypes. Whereas SPs 
with high total and truncal fatness and leanness had higher diastolic pressure than 
SPs with other total and truncal body composition phenotypes. Also, SPs with lower 
fat but higher muscle content in their limbs had lower diastolic pressure as compared 
to other SPs.  
When examined in the context of metabolic load - metabolic capacity model, 
FM/FFM ratio as a measure of whole-body metabolic balance was only significantly 
associated with diastolic pressure whilst TFM/ASM as a measure of segmental 
metabolic balance demonstrated significant associations with SBP, DBP and pulse 
pressure. This finding suggests that adults with metabolic overload at whole-body 
level may have more resistant muscular arteries whereas those with segmental 
metabolic overload (with greater quantity of truncal fat as compared to appendicular 
muscle) may have developed haemodynamic alterations in both steady and pulsatile 
determinants of arterial pressure. 
Relative contribution of skeletal muscle and adipose tissues, as determinants of 
metabolic balance, to haemodynamic changes has been identified in adults. In the 
Korean Sarcopenic Obesity Study (KSOS), skeletal muscle to visceral fat ratio was 
inversely related to cardiometabolic risk factors and brachial pulse wave velocity 
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(baPVW), denoting a link between the favourable segmental balance between 
metabolic load-metabolic capacity and arterial stiffness (T. N. Kim et al., 2011). The 
independent but opposite effects of visceral fat mass and appendicular muscle mass 
on baPVW has also been demonstrated in postmenopausal women with diabetes 
(Tanaka, Kanazawa and Sugimoto, 2016). Such effect may be mediated by the 
dominance of pro-inflammatory adipokines and myokines, reduced insulin 
sensitivity and impaired lipid and glucose metabolism, oxidative stress that lead to 
structural and dynamic changes in vascular system (Giudice and Taylor, 2017; Li et 
al., 2017; Chen et al., 2019). Therefore, metabolic homeostasis can be linked to 
haemodynamic properties of the cardiovascular system via reciprocal effects of 
adipose and lean tissues.  
Although this research is the first study that quantitatively explores the association 
between total and segmental body composition phenotypes and systemic blood 
pressure in healthy adults from the perspective of metabolic homeostasis and 
haemodynamic stability, it has several limitations. Firstly, it has a cross-sectional 
design and small sample size; this limits the generalisability of the findings, 
evaluation of the causal relationship, statistical power and the accuracy of subgroup 
analysis. Moreover, the use of BIA in the assessment of body composition may 
introduce some level of estimation error, granted that the segmental multifrequency 
method improves the accuracy of estimation. Additionally, the analysis of 
associations did not include an exhaustive set of potential confounders.  
 Further research is warranted to determine the nature of these associations and the 
potential role of body composition phenotyping in the assessment and management 
of haemodynamic abnormalities by employing more direct measures of endothelial 
function, arterial stiffness, intima-media thickness and vascular resistance as well as 









Body Composition and Lung Function 
 
The relationships between spirometric indices and anthropometric as well as body 
composition measures were examined using Pearson’s correlation test. Overlay 
scatterplots were drawn to display reciprocal correlations of spirometric parameters 
with appendicular lean versus fat compartments of body composition. To identify 
significant covariates of spirometric indices, multiple liner regression with back-
ward elimination was undertaken using heteroscedasticity-consistent standard error 
estimators (Hayes and Cai, 2007). The main and interaction effects of stature-
normalised fat and lean body compartments on pulmonary function were analysed in 
the PROCESS using OLS regression models adjusted for age, sex, ethnicity, height, 
neck circumference, calf circumference, grip strength as well as systolic and 
diastolic pressures. The smoking status was not considered in the prediction models 
as a large number of participants were not current smokers (48 out of 50 SPs). The 
quality of predictive models was measured by the mean standard error (MSE). For 
all models, lean component was set as the moderator and the values of the moderator 
wherein the main effect of fat component on the spirometric outcome shifted from 
non-significant to significant were defined. The conditional influence of total and 
segmental fat mass on measures of lung function was probed at three levels, i.e., 
16th, 50th, and 84th percentiles of the corresponding lean mass. The effects of total 
and segmental fat on lung function parameters were plotted at low, medium, and 
high levels of the corresponding lean components using visualisation data output 
from the PROCESS.  
 
Results  
6.1 Anthropometric measures and lung function 
Among lung function parameters, FEF25-75% did not show any significant 
relationship with anthropometric measures. In total population, NC, AC, WC and 
ABSI were the only significant anthropometric correlates of spirometric indices. In 
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this regard, ABSI was the strongest correlate of FEV1 (r=-.52, p<0.001), and FVC 
(r=-.49, p<0.01), whilst FEV1/FVC (r=.36, p<0.05) was most closely related to WC 
(r=-.45, p<0.001)   
Both ABSI and WC demonstrated significant relationships with all spirometric 
indices albeit in the opposite directions. Larger waist and neck circumferences and 
greater conicity index correlated significantly with higher FEV1 (r=.38, p<0.01; 
r=.38, p<0.01; r=.34, p<0.05) and FVC (r=.36, p<0.01; r=.40, p<0.01; r=.36, 
p<0.05). AC was only significantly related to FEV1 (r=.30, p<0.05). BMI, CC, 
WHR and WHtR did not display significant correlations. (Figure 6.1).  
Notably, the relationships between ABSI and spirometric parameters were in the 
opposite direction to those of other anthropometric measures. SPs with higher ABSI 
had lower FEV1 and FVC but higher FEV1/FVC ratios. Conversely, SPs with higher 
NC, WC and CI had higher FEV1 and FVC but lower FEV1/FVC ratios.  
This may indicate a positive association between upper body fatness (even after 
adjustment by height and body weight) and vital capacity and expiratory airflow in 
otherwise healthy adults, with greater influence of fatness on FVC than FEV1. When 
the influence of body size and BMI on WC is controlled in the ABSI, the association 
of the adjusted WC (as a measure of visceral adiposity) and dynamic lung function 
is reversed. As shown in previous chapters, increased ABSI could be a good 
indicator of depleted lean and muscle mass.  
In addition, the increased neck circumference and unadjusted waist circumference 
could reflect expanded fat and lean mass, with NC being a better indicator of 
leanness and WC being a stronger measure of fatness. Hence, higher FVC and FEV1 
in SPs with larger perimeters of neck and abdomen may also be linked to increases 
in their fat-free mass and skeletal muscle mass.  
To clarify this, the relationship of BIA-derived quantities of both total and regional 




Figure 6.1. Significant anthropometric correlates of the spirometric parameters. FEV1: forced 


















6.2 Absolute body composition and lung function 
BIA-derived estimates of total and segmental lean mass exhibited significant 
correlations with all spirometric parameters in total SPs (Table 6.1) although FEV1 
and FVC showed closer relationships than FEV1/FVC and FEF 25-75%. Unlike other 
indices, FEV1/FVC correlated negatively with all measures of lean mass, denoting 
that changes in leanness associates with larger changes in FVC than FEV1.  
Concerning measures of fatness, however, significant relationships were observed 
only between FEV1 (r=-.51 and -.57, p<0.01) and FVC (r=-.48 and -.53, p<0.01) 
with AFM and LFM.  
This observation lends further support to the previously addressed possibility that 
direct relationship of FVC and FEV1 as well as the inverse relationship of 
FEV1/FVC with neck circumference and unadjusted waist circumference in healthy 
adults may actually represent the correlation between dynamic lung function and the 
status of lean compartments rather than the adiposity status. Relevantly, the 
previously observed opposite association of ABSI with spirometric parameters as 
compared to other anthropometric measures was replicated for BIA-estimated fat 
mass and skeletal muscle mass.  
While measures of muscularity all correlated positively with FVC and FEV1, 
measures of adiposity showed negative correlations with these spirometric indices. 
Among measures of fatness, only appendicular fat mass was found to be 











Table 6.1. Lung function and body composition 
Spirometric 
parameter  
Lean compartment Fat compartment 




FEV1 (L) 0.39 0.34 0.44* 0.34 0.48* -0.39 -0.35 -0.44* -0.34 -0.49* 
FVC (L) 0.29 0.24 0.34 0.18 0.38 -0.27 -0.23 -0.34 -0.25 -0.36 
FEV1 /FVC 0.03 0.09 -0.09 0.06 -0.15 -0.16 -0.15 -0.12 -0.11 -0.06 
FEF 25-75% 
(L/s) 





FEV1 (L) -0.36 -0.35 -0.33 -0.17 -0.23 -0.16 -0.11 -0.17 -0.21 -0.14 
FVC (L) -0.41 -0.35 -0.37 -0.20 -0.29 -0.24 -0.21 -0.22 -0.33 -0.16 
FEV1 /FVC 0.17 -0.01 0.13 0.08 0.15 -0.03 0.04 -0.06 0.08 -0.07 
FEF 25-75% 
(L/s) 





FEV1 (L) .60*** .57*** .63*** .61*** .64*** -.23 .01 -.51** -.22 -.57** 
FVC (L) .56*** .53*** .58*** .55*** .60*** -.18 .04 -.48** -.21 -.53** 
FEV1 /FVC -.33* -.32* -.39* -.34* -.40* -.09 -.20 .15 .00 .21 
FEF 25-75% 
(L/s) 
.34* .34* .29* .34* .30* -.14 -.02 -.25 -.09 -.25 
Values are presented as r. 
For all correlations in male, female, and total participants, n=22, 28, and 50, respectively. 
*p<0.05; **p<0.01; ***p<0.001 
All compartments were measured by Tanita SEG-MF Bioelectrical Impedance Analyser. 
FFM: fat-free mass; TSM: trunk skeletal muscle mass; ASM: appendicular skeletal muscle mass; 
USM: upper limb skeletal muscle mass; LSM: lower limb skeletal muscle mass TFM: trunk fat mass; 
AFM: appendicular fat mass; UFM: upper limb fat mass; LFM: lower limb fat mass; FEV1: forced 








Stratified by sex, significant correlations were found only between FEV1 and 
appendicular, more specifically, the lower limb skeletal (r=.44 and .48, p<0.05) and 
fat mass (r=-.44 and -.49, p<0.05) in male SPs (Figure 6.2). There was no significant 
relationship between spirometric indices and body composition compartments in 
female SPs. For any given lung function parameter, all components of lean and fat 
compartments demonstrated oppositely directed relationships. 
 
 
Figure 6.2. Equally significant but oppositely directed relationship between FEV1 and 
appendicular as well as lower limb lean versus fat mass in male SPs. 
ASM: appendicular skeletal muscle mass; LSM: lower limb skeletal muscle mass AFM: appendicular 










6.3 Stature-normalised body composition and lung function 
To explore the association of total and segmental fatness and leanness with dynamic 
lung function more thoroughly, the effect of potential confounders was analysed in 
multiple linear regression models by using backward elimination method. As a large 
proportion of SPs were not current smokers, smoking status was not used in the 
models. Subsequently, the explanatory variables with significant contributions, i.e., 
age, sex, height, ethnicity, neck circumference, calf circumference, grip strength, 
and systemic blood pressure were included in the predictive models.  
Regression models for all pairs of stature-normalised fat and lean components 
significantly explained variations in FEV1(R
2=.77 to .79, p<0.001), FVC (R2=.72 to 
.74, p<0.001) and FEF 25-75% (R
2=.32 to .34, p<0.001). For all spirometric parameters, 
stature-adjusted total and segmental fat mass indices demonstrated opposite effects 
on FEV1 and FEF 25-75% at low versus high levels of their corresponding lean mass 
indices. 
As shown in Table 6.2, total fat and lean mass indices contributed significantly to 
the prediction of FEV1 (ꞵ=.46 and 0.10, p<0.001) and FEF 25-75% (ꞵ=.90 and 0.37, 
p<0.001) but not FVC. White ethnicity (ꞵ=-.051, p<0.001), sex (ꞵ=-.901, p<0.001), 
height (ꞵ=.047, p<0.001), calf circumference (ꞵ=.051, p<0.01), grip strength (ꞵ=-
.017, p<0.01) and DBP (ꞵ=-.016, p<0.001) were significant covariates of FEV1 
whereas age (ꞵ=.038, p<0.001), sex (ꞵ=-.529, p<0.05), height (ꞵ=.042, p<0.001), 
grip strength (ꞵ=-.044, p<0.001)  and SBP (ꞵ=-.018, p<0.01) were significant 










Table 6.2. Main and interaction effects of stature-normalised total fat and lean mass indices 





R2 (MSE) Significance 
region(s) 
FEV1 (L) 0.46*** (0.23,0.68) 0.10** (0.03,0.16) 0.000 0.78***(0.19) 17.55 
FVC (L) 0.21 (–0.13, 0.53) -0.03 (-0.13,0.07) 0.083 0.73***(0.39) 19.8 
FEF 25-75% (L/s) 0.90*** (0.43,1.35) .37*** (0.22, 0.52) 0.000 0.34***(0.86) 14.73, 18.6 
Values are presented as ꞵ(95% CI). 
*p<0.05; **p<0.01; ***p<0.001 
All compartments were measured by Tanita SEG-MF Bioelectrical Impedance Analyser. 
OLS regression models were adjusted for age, sex, height, ethnicity (white vs. non-white), neck 
circumference, calf circumference, grip strength, and systemic blood pressure. 
Regions of significance are defined as the values of the lean mass index where the association 
between total or segmental fat mass and spirometric indices transitioned from non-significant to 
significant. 
MSE: mean squared error; FFMI: fat-free mass index; FMI: fat mass index; FEV1: forced expiratory 

















To investigate the combined effect of regional fat and lean components on 
pulmonary function, the interaction effect of total fat mass and fat-free mass as well 
as truncal and appendicular fat mass and skeletal muscle mass were explored using 
the moderation analysis via PROCESS. 
As portrayed in Figure 6.3, the moderation analysis revealed that FMI associated 
significantly with FEV1 only at FFMI values above 17.5 kg/m
2. Thus, FMI was a 
significantly negative predictor of FEV1 in SPs with high (84
th percentile) FFMI 
(ꞵ=-.12; 95%CI (-.18, -.07), p<0.001).  
Notwithstanding the absence of significant main effects, height-adjusted total fat and 
fat-free mass demonstrated significant interaction on FVC. Each 1kg/m2 increase in 
FMI was significantly predictive of 108ml decrease in FVC at 84th percentile of 
FFMI (ꞵ=-.108; 95%CI (-0.043, -0.214), p<0.05). 
With regards to FEF 25-75%, significant interactions occurred at FFMI values below 
14.7 kg/m2 and above 18.6 kg/m2. Nevertheless, the effect of FMI on FEF 25-75% was 
mainly conditioned at 84th percentile; therefore, increased total fat mass index 












Figure 6.3. Interactions of stature-normalised total lean and fat mass indices on (a) FEV1, 
(b) FVC, (c) FEF 25-75%.  
*lean index level with significant effect of fat index on spirometric parameters.  
16th, 50th and 84th percentiles of FFMI respectively represent FFMI values of 15.77 kg/m2, 17.39 
kg/m2, and 20.17 kg/m2. 
FFMI: fat-free mass index; FMI: fat mass index; FEV1: forced expiratory volume in 1 s; FVC: forced 
vital capacity; FEF 25-75%: forced expiratory flow at 25–75% of FVC. 
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As reflected in Table 6.3, stature-adjusted truncal fat (ꞵ=0.92, p<0.001) and skeletal 
muscle indices (ꞵ=0.10, p<0.05) demonstrated significant associations with FEV1. 
For FVC, only truncal fat mass index was a significant predictor (ꞵ=0.94, p<0.001).  
Conversely, only truncal skeletal mass index could significantly predict FEF 25-75% 
(ꞵ=0.47, p<0.01) (Table 6.3). Significant covariates of FEV1 were sex (ꞵ=-0.998, 
p<0.001), ethnicity (ꞵ=-0.062, p<0.001), NC (ꞵ=-0.030, p<0.05), and DBP (ꞵ=-
0.019, p<0.001) while FVC associated significantly with sex (ꞵ=-1.461, p<0.001), 
ethnicity (ꞵ=0.286, p<0.001), height (ꞵ=0.050, p<0.001), NC (ꞵ=-0.046, p<0.01), 
CC (ꞵ=0.057, p<0.05), and DBP (ꞵ=-0.029, p<0.001).  
 
Table 6.3. Main and interaction effects of stature-normalised truncal fat and lean mass 





R2 (MSE) Significance 
region(s) 
FEV1 (L) 0.92*** (0.48,1.35)  0.14* (0.02,0.25) 0.000 0.78*** 
(0.19) 
8.07,9.97 





0.74 (-0.33,1.80)  0.47** (0.16,0.77) 0.093 0.32*** 
(0.88) 
9.67 
Values are presented as ꞵ(95% CI) 
*p<0.05; **p<0.01; ***p<0.001 
All compartments were measured by Tanita SEG-MF Bioelectrical Impedance Analyser. 
OLS regression models were adjusted for age, sex, height, ethnicity, neck circumference, calf 
circumference, grip strength, and systemic blood pressure. 
Regions of significance are defined as the values of the lean mass index where the association 
between total or segmental fat mass and spirometric indices transitioned from non-significant to 
significant. 
MSE: mean squared error; TSMI: truncal skeletal mass index; TFMI: truncal fat mass index; FEV1: 
forced expiratory volume in 1 s; FVC: forced vital capacity; FEF 25-75%: forced expiratory flow at 






Furthermore, TFMI and TSMI interacted significantly on spirometric indices such 
that high TFMI values predicted decreased FEV1 (ꞵ=-.184; 95%CI (-.268, -.101), 
p<0.001) in SPs with high TSMI (>9.97 kg/m2). At TSMI values below 8.60 kg/m2, 
higher TFMI predicted higher FVC (ꞵ=.132; 95%CI ( -.002, .26), p>.05) while it 
was a predictor of lower FVC (ꞵ=-.093; 95%CI (-.203, .017), p>.05) at TSMI values 
above 11.31 kg/m2 (Figure 6.4). TSMI also moderated the influence of TFMI on 
FEF 25-75%. At high level of TSMI, FEF 25-75%., declined by about 280ml/s per 1 kg/m
2 

















Figure 6.4 Interaction effects of height-normalised truncal lean and fat mass indices on (a) 
FEV1, (b) FVC, (c) FEF 25-75%.  
*lean index level with significant effect of fat index on spirometric parameters. 
16th, 50th and 84th percentiles of TSMI respectively represent TSMI values of 8.64 kg/m2, 9.65 kg/m2, 
and 11.10 kg/m2. 
TSMI: truncal skeletal muscle index; TFMI: trunk fat mass index; FEV1: forced expiratory volume in 
1 s; FVC: forced vital capacity; FEF 25-75%: forced expiratory flow at 25–75% of FVC. 
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As presented in Table 6.4, appendicular fat and muscle mass indices had significant 
main and interaction effects on FEV1 (ꞵ=1.21 and .31, p<0.001), FVC (ꞵ=.94, 
p<0.01; and .17, p>0.05), and FEF 25-75% (ꞵ=1.88 and .68, p<0.001). Sex (ꞵ=-.857 
and -.1.225, p<0.001), ethnicity (ꞵ=.276, p<0.001 and ꞵ=.230, p<0.01), height 
(ꞵ=0.046 and .056, p<0.001), NC (ꞵ=-.026, p<0.05 and ꞵ=-.057, p<0.001), CC 
(ꞵ=.041, p<0.05 and ꞵ=.078, p<0.05) and DBP (ꞵ=-.019 and -.023, p<0.001) also 
made significant contributions to the prediction of variations in FEV1 and FVC, 
respectively. Age (ꞵ=.034, p<0.001), height (ꞵ=.049, p<0.001) and grip strength 





















Table 6.4. Main and interaction effects of stature-normalised appendicular fat and lean mass 





R2 (MSE) Significance 
region(s) 
FEV1 (L) 1.21*** (0.78,1.65)  0.31*** (0.18,0.45)  0.000 0.79*** 
(0.18) 
6.18,7.49 





1.88***(0.88,2.89)   0.68***(0.31,1.06)  0.000 0.33*** 
(0.87)  
6.89,8.81 
Values are presented as ꞵ(95% CI) 
*p<0.05; **p<0.01; ***p<0.001 
All compartments were measured by Tanita SEG-MF Bioelectrical Impedance Analyser. 
OLS regression models were adjusted for age, sex, height, ethnicity, neck circumference, calf 
circumference, grip strength, and systemic blood pressure. 
Regions of significance are defined as the values of the lean mass index where the association 
between total or segmental fat mass and spirometric indices transitioned from non-significant to 
significant. 
MSE: mean squared error; ASMI: appendicular skeletal mass index; AFMI: appendicular fat mass 
index; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF 25-75%: forced 















The effect of AFMI on lung function depended upon the values of ASMI (Figure 
6.5). In SPs with high ASMI (84th percentile), FEV1 decreased by approximately 
390ml per 1kg/m2 increase in AFMI (ꞵ=-0.386; 95%CI (-.524, -.249), p<0.001) 
while in those with low ASMI (16th percentile), it increased by 86ml per unit 
increase in AFMI (ꞵ=.086; 95%CI (-.206,.033), p>0.05). A similar pattern was 
observed for the conditional effect of AFMI on FVC, with high AFMI being 
associated with impaired FVC at 84th percentile of ASMI (ꞵ=-.39; 95%CI (-.70, -
.07), p<0.05). Two regions of significance were found for the interaction effect of 
AFMI and ASMI on FEF 25-75%. At ASMI values above 8.81 kg/m
2, AFMI acted as a 
negative predictor (ꞵ=-.342; 95%CI (-.644, -.041), p<0.05) whereas at ASMI values 
below 6.89 kg/m2, it showed a positive association with FEF 25-75% (ꞵ=.315; 95%CIs 

















Figure 6.5 Interaction effects of height-normalised appendicular lean and fat mass indices 
on (a) FEV1, (b) FVC, (c) FEF 25-75%.  
*lean index level with significant effect of fat index on spirometric parameters. 
16th, 50th and 84th percentiles of ASMI respectively represent ASMI values of 6.41 kg/m2, 7.20 kg/m2, 
and 9.09 kg/m2. 
ASMI: appendicular skeletal muscle index; AFMI: appendicular fat mass index; FEV1: forced 




In a more interpretive sense, FEV1 and FEF 25-75% declined with increasing FMI and 
AFMI at high levels of FFMI and ASMI. The opposite associations were observed at 
low values of FFMI and ASMI. In comparison, FEV1 and FVC were negatively 
associated with TFMI at high TSMI values while the association was positive at low 
TSMI values. It is also worth mentioning that the gap in the absolute values of FEV1 
and FVC among SPs with lowest versus highest ASMI and TSMI levels widened 
progressively with increasing AFMI and TFMI. Thereby, SPs with the highest 
appendicular or truncal fat to muscle ratio had the highest FEV1 and (to a lesser 
extent) FVC while those with the lowest segmental body composition ratios had the 
lowest FEV1 and FVC. Additionally, at high levels of total fat-free mass the slope of 
FEV1 and FVC associations with fat components became steeper when the 
corresponding fat mass level exceeded the middle range. In contrast, the rate of 
AFMI-related FEV1 and FVC reductions at high ASMI level declined when the 
appendicular fat mass approached the higher range. Conversely, the FEF 25-75% gap 
among SPs with low versus high FFMI or ASMI became considerably narrower 
with increasing total and appendicular fat mass. As a result, participants with low 
FMI or AFMI exhibited the fastest mid-expiratory rates (highest FEF 25-75% ) at the 
highest FFMI or ASMI levels.  
Therefore, it could be conjectured that the deleterious impact of incremental total, 
truncal and appendicular fat accumulation on FVC, FEV1 and mid-expiratory flow 
rate in healthy adults would appear or heighten only if the respective lean or muscle 












The first noticeable finding of this study about the link between body composition 
and pulmonary function was the oppositely directed association of ABSI versus all 
other anthropometric measures with spirometric indices. Whereas all other 
anthropometric measures showed inverse relationships with FEV1 /FVC and direct 
relationships with FEV1 and FVC in the entire population, ABSI was inversely 
related to FEV1 and FVC and directly related to FEV1 /FVC. This trend was 
replicated when BIA-estimated measures of fat and lean compartments were used. 
Whilst total and appendicular fatness demonstrated direct relationship with FEV1 
/FVC and inverse relationships with FEV1 and FVC similar to the pattern observed 
for ABSI, total leanness as well as truncal and appendicular muscularity showed a 
reverse pattern comparable to all other anthropometric measures. An interesting 
finding was the direct significant relationship of total, truncal and appendicular 
lean/muscle mass with FEF 25-75% in the entire population. 
The above findings indicate that anthropometric measures mostly represent the 
effect of lean rather than fat compartments on the dynamic lung function in 
otherwise healthy adults. In addition, ABSI may be only anthropometric index that 
could be used as a surrogate of the adiposity status in the assessment of respiratory 
performance among adults who are not in the extremes of body mass.  
These observations also demonstrate that adults without clinically apparent 
pulmonary disease who have lower degrees of overall leanness or smaller amounts 
of skeletal muscle in their trunk or limbs could have restricted lung expansion, 
airway distensibility or elastic recoil as well as narrowed small airways due to 
reduced respiratory muscle strength, increased airway resistance, altered anatomical 
and physiological properties of the respiratory system and a pro-inflammatory status 
in the lung tissue. This would manifest as lower FEV1, FVC and FEF 25-75% as well as 
an increased FEV1 /FVC, denoting some degrees of upper airway restriction with the 
possibility of coexisting small airway obstruction. The independently positive 
association between total and segmental leanness or muscularity and lung function 
in apparently healthy young to middle-aged adults has been reported by previous 
studies (Martín Holguera et al., 2017; Park et al., 2018). As fully explained in 
chapter 2, the expansion of lean, particularly muscle compartment has a favourable 
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impact on lung volume and ventilatory capacity, due in part to the augmented 
strength of respiratory muscles , improved mechanics of respiration and more 
efficient ventilation  in individuals with or without lung disease (Muggensturm et 
al., 2013; Aliverti, 2016). 
On the contrary, as extensively discussed in chapter 2, excessive fatness exerts 
detrimental effects on several aspects of respiratory physiology (lung volume, lung 
compliance, airway resistance, ventilation and gas exchange) even in otherwise 
healthy adults (Salome, King and Berend, 2010), leading to significant declines in 
FEV1 and FVC together with no change or slight increases in FEV1 /FVC 
(Sutherland et al., 2016). It is unclear why appendicular fat mass was the only fat 
compartment which showed significant relationship with spirometric parameters; 
however, a similar observation has been reported by Scott et al. who found a 
significantly negative correlation between arm but not leg fat mass and FVC in 
overweight/obese female Australians with stable asthma (Scott et al., 2012). In that 
study, arm but not leg fatness was associated with serum leptin and bronchoalveolar 
eosinophil percentage in male patients 
In accord to the findings from the present research, Martín Holguera et al found 
significantly positive association between DXA-derived total, truncal and leg lean 
mass were significantly related to  FEV1, FVC, PEF (a spirometric indicator of 
expiratory muscle strength) and FEF 25-75% (an indicator of the small airway patency) 
(Martín Holguera et al., 2017).  Also, the PROOF study (Costes et al., 2016) 
provided the evidence that truncal lean mass was a predictor of respiratory muscle 
strength (measured as the maximum inspiratory pressure (MIP)) in older women.  
These observations suggest that the effect of body composition on pulmonary 
function is exerted via segment-specific mechanisms that involve respiratory muscle 
function, lung compliance and peripheral airway dynamics. The potential cross-link 
between appendicular adiposity, metabolic homeostasis and inflammatory markers 






Although the present study was underpowered for subgroup analysis, some 
observations are worth mentioning. 
In men, body shape and body size both showed significant negative correlations 
with FEV1 and FVC but not FEV1 /FVC, denoting proportional changes in FEV1 and 
FVC per changes in body mass (BMI and New BMI) and the body size adjusted 
surrogate measures of fatness (WHR, WHtR, and ABSI). A similar yet non-
significant trend was observed in women, perhaps because of the sex disparities in 
the anatomy and physiology of respiratory tract as well as the varied regional 
distribution of fat depots and differential proportionality of fat and lean 
compartments in male and female subjects. Sex-dependent association between lung 
function and anthropometric measures have been reported previously in the 
population-based cross-sectional and prospective studies (Chen et al., 2012; 
Karastergiou et al., 2012; Fenger et al., 2014). Another factor that can contribute to 
these associations is the baseline adiposity status. Although the SPs were not 
stratified by their fatness status, several studies have underscored the greater impact 
of body mass changes on the respiratory capacity and airflow among obese 
individuals (Thyagarajan et al., 2008; Santamaria et al., 2011; Fenger et al., 2014). 
It is worth mentioning that WC would not relate significantly to spirometric indices 
unless it was adjusted for the variations in height, hip circumference, or BMI. This 
underlies the confounding effect of body size on the associations between WC, as a 
proxy measure of the abdominal adiposity, and various outcomes (Malara, Anna and 
Tkaczyk, 2015; Ashwell and Gibson, 2016). This is in line with the results of the 
British Regional Heart Study (Wannamethee, Shaper and Whincup, 2005) and the 
Humboldt Study (Chen et al., 2007) which demonstrated BMI or height-adjusted 
inverse associations between adiposity (WHR and WC) and spirometric parameters 
(FEV1 and FVC) in healthy adult males. While in men, measures of central adiposity 
correlated more strongly with FEV1 and FVC, measures of general adiposity showed 
closer relationships with these spirometric parameters in women. A similar trend of 
relationship was observed for the BIA-derived measures of fatness in both sexes. In 
contrast, the observed relationships between BIA-estimated leanness/muscularity 
and lung function in men and women were in opposite directions.  
Whereas female SPs with higher levels of total and segmental leanness/muscularity 
had lower FEV1 and FVC, male SPs with larger quantities of total and segmental 
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lean/muscle mass had higher FEV1 and FVC. Interestingly, the only significant 
relationships were between FEV1 and appendicular (particularly lower limb) fat and 
skeletal muscle mass in men. (). This means that the striated muscle in legs may 
influence the airway resistance and the expiratory flow rate more significantly than 
lung compliance and vital capacity. it is worth noting that, both sets of segmental 
body compositions were equally related to FEV1 and FVC albeit in the opposite 
directions. Thus, ameliorating effects of leg muscles appear to be counteracted by 
comparably deteriorating effects of adipose tissue in lower extremities. Equal but 
oppositely directed associations of fat and lean compartments with spirometric 
parameters have been observed in healthy adults. In a study of Brazilian birth 
cohorts, %FM and %FFM determined by the BODPOD or DEXA had quantitatively 
similar multivariable-adjusted effects on FEV1 at 18 and 30 years though in reverse 
directions (De Oliveira et al., 2016). Besides, DXA-measured %TFM, %AFM and 
% LFM were significantly negative predictors of FEV1 in their study. However, the 
researchers did not investigate the contribution of segmental lean mass to pulmonary 
function. Leg lean mass has been found to be a significant predictor of FEV1 and 
FVC in healthy male and female Caucasians (Martín Holguera et al., 2017) and 
Asians (Lim et al., 2011). It is also related to handgrip strength which has been 
identified as a positive predictor of  FEV1 and FVC in healthy adults (Lazarus et al., 
1998; Sillanpää et al., 2014). 
The finding of non-significant and similarly directed relationships of lean and fat 
compartments with FEV1 and FVC in female SPs of the present study can be 
partially attributed to the lower proportion of FFM in them and the smaller effect of 
female FFM on the IC and subsequently FEV1 and FVC (Cotes, Chinn and Reed, 
2001). Also, the use of absolute values of body composition might have rendered the 
observed relationships prone to the confounding effect of height. It is not clear why 
components of muscle mass exhibited negative associations with FEV1 and FVC in 
female SPs. This accords with the findings of Sutherland and his colleagues who 
reported negative correlations between DXA-derived and height-adjusted total and 
thoracic lean mass and FEV1 and TLC in young female New Zealanders free of 
respiratory disorders (Sutherland et al., 2008). This trend disappeared after 
adjustment for corresponding fat components. In line with the observations in the 
current research, they found that total and truncal lean mass were positively but not 
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significantly correlated with spirometric indices in male participants. Similarly, 
Scott and his co-workers observed that DXA-determined total and segmental fat and 
lean mass were negative predictors of FEV1 and FVC in overweight/obese female 
asthmatics.  
There are, however, some conflicting studies which show positive relationships 
between measures of respiratory function and leanness in women. For instance, 
Lazarus and colleagues noticed steady increases in FVC across quintiles of FFM 
(estimated from skinfold-thickness) in male and female subjects participating in the 
1990 Pilot Survey of the Fitness of Australians which reached significance level 
after adjustment for body fat (Lazarus et al., 1998). One reason could be that muscle 
bulk is not fully represented by DXA and probably BIA in women. Another 
possibility could be the greater accumulation of inter or intra-muscular fat or 
muscle-specific secretion of substances that act upon lung tissue (Sood et al., 2011).  
With respect to fat components, differential distribution and function of the adipose 
tissue, anatomical and physiological dissimilarities of the pulmonary structures, and 
sex-specific metabolic profile of (Chen et al., 2012; Karastergiou et al., 2012) may 
explain the observed weaker spirometric correlations. 
When the absolute measures of fat and lean mass were replaced by the stature-
adjusted indices, total fat-free mass as well as truncal and appendicular muscle mass 
retained their significant associations with FEV1 and FEF 25-75% , independent of the 
corresponding fat components in the entire population of study, controlling for 
demographic, anthropometric, BP and grip variables. This is in concordance with the 
results of previous studies which showed independently significant associations of 
depleted FFMI with the severity of COPD (Tkacova et al., 2011; Grydeland et al., 
2012) as well as the regional loss of stature-normalised leg and trunk lean mass 
indices with the risk of asthma (Beckett et al., 2010) and the severity of CF (Bolton 
et al., 2003). However, none of the BIA-estimated measures of leanness/muscularity 
showed significant associations with FVC. Thus, it could be speculated that the 
effect of lean/muscle compartments may be primarily exerted on the airflow and the 




Another important finding of this research was the significant interaction of height-
normalised total and segmental fat and skeletal muscle mass on the variability in the 
spirometric parameters. To the best of the author’s knowledge, this is the first report 
on the moderating role of the leanness status in the association between fatness and 
lung function among healthy adults. Whereas the main effects of height-adjusted 
total and regional fatness on spirometric indices were positive, their interaction with 
the equivalent lean mass indices imparted negative effects. In SPs with high levels 
of total fat-free mass and appendicular muscle mass, FEV1 and FEF 25-75% declined 
steadily with incremental changes in total and appendicular fat mass. Comparatively, 
incremental changes in truncal fat mass of SPs with high levels of truncal muscle 
mass was associated with steady declines in FEV1 and FVC. As a consequence, total 
and segmental body composition phenotypes may determine the respiratory pattern 
of the adults with no clinically apparent lung disease. Whilst individuals with high 
fat-high lean whole-body composition and/or high fat-high muscle appendicular 
composition may exhibit obstructive respiration, those with high fat – high muscle 
truncal composition may experience a restrictive respiratory pattern. Thus, it appears 
that at the lower range of fatness, total lean mass and appendicular muscle mass 
exert beneficial effects on the expiratory flow rate and the calibre and resistance of 
airways in healthy adults. As the accumulation of fat becomes excessive, however, it 
takes over the striated muscles and acts as the major body compartment determinant 
of lung function, mainly affecting the lung compliance. 
Distinctive contributions of fat and lean compartments to the mechanics of lungs, 
respiratory performance, ventilatory capacity, and pulmonary function in men and 
women have been extensively discussed in Chapter 2. However, the combined 
impact of fat and muscle mass merits further illumination.  
As no study has explored these interactive effects yet, it is very difficult to offer 
plausible explanations for the relationships found in this research. Nevertheless, the 
findings signify the interplay between fat and lean (especially muscle) compartments 
of body composition as the independent determinants of pulmonary function. There 
is an established crosstalk between skeletal muscle and adipose tissue via common 
IL-6, TNF-α) and tissue-specific myokines (myostatin, IL-8, IL-15, irisin, fibroblast 
growth factor 21 (FGF21), and myonectin) and adipokines (leptin, adiponectin, 
resistin, chemerin, visfatin, and monocyte chemotactic protein-1 (MCP-1))  (Li et 
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al., 2017). Moreover, early life experiences may shape the repertoire of 
adipomyokines during adult life (Joung et al., 2014). These muscle and fat-derived 
factors are involved in glucose homeostasis, adipogenesis and lipid metabolism, 
regulation of cardiovascular system, bone turnover, muscle growth and 
degeneration, immune function and energy balance (Giudice and Taylor, 2017). 
Therefore, communication between fat and muscle tissue is largely dependent on the 
complex and incompletely understood interactions across a wide range of adipokines 
and myokines. It is conceivable that the adipo-myokine profile of the individuals is 
an important regulator of the balance between their metabolic load and metabolic 
capacity, manifesting as total and segmental body composition ratios. This may play 
a major role in metabolism and function of various organs including cardiovascular 
and respiratory systems. 
IL-6 and TNFα have been shown to be significantly correlated with grip strength 
and SMI in sarcopenic COPD patients (Byun et al., 2017). Compared with normal 
individuals, levels of these adipo-myokines are also higher in COPD patients 
regardless of their current smoking status(Gan et al., 2004; Watz et al., 2009). These 
patients also have higher leptin and lower adiponectin concentrations (Poulain et al., 
2008). In fact, the ECLIPSE  (Evaluation of COPD Longitudinally to Identify 
Predictive Surrogate Endpoints) study discovered a subgroup of COPD patients 
characterised by a distinct inflammome (elevated CRP, IL-6, IL-8, TNFα and 
fibrinogen) and adipokinome (increased leptin and decreased adiponectin) who had 
poor outcomes (Agustí et al., 2012; Faner et al., 2014). This landmark study 
identified a novel phenotype of COPD characterised by persistent systemic 
inflammation (≥2 abnormal inflammatory markers, both at baseline and after 1-year 
follow-up), obesity, and poor clinical outcomes (severe symptoms, worse functional 
capacity and QoL, higher cardiovascular morbidity and greater non-COPD related 
death)(Agustí et al., 2012). This biomarker expedition provided solid evidence on 
the different systemic inflammome (consisted of WBC, CRP, IL-6, IL-8, TNFα and 
fibrinogen) and adipokine profile (leptin and adiponectin) of this subgroup of COPD 
patients (Faner et al., 2014). 
Elsewhere, improvements in asthma symptoms, spirometric indices and airway 
hyperresponsiveness of patients has been documented to parallel improvements in 
markers of non-allergic airway inflammation (reduced bronchoalveolar lavage 
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(BAL) fluid neutrophil and eosinophil) and adipokine profile (decreased leptin and 
increased adiponectin levels in BAL fluid and serum) 12 months after bariatric 
surgery (Dixon, Pratley, et al., 2011). In a similarly designed intervention, at 12-
month follow-up, BAL concentration of IL-8 and MCP-1 and TNFα increased while 
the level of IL-6, IL-8, MCP-1, and TNFα in SAT decreased in women with adult-
onset asthma who had undergone bariatric surgery. In addition, leptin and 
adiponectin level in BAL correlated with their corresponding levels in SAT and 
VAT, respectively. Because of the impaired function of the alveolar macrophages 
and decreased levels of bronchoalveolar pro-inflammatory cytokines in obese 
patients, it has been postulated that peripherally secreted leptin and pro-
inflammatory cytokines may impact the pulmonary function of asthmatics via direct 
and non-inflammatory effects on the AHR and airway remodelling. The role of 
locally released leptin in the airways of patients with late-onset asthma has yet to be 
deciphered (Sideleva et al., 2012) 
As leptin, adiponectin and their specific receptors are expressed in airway 
epithelium (Holguin et al., 2011), alterations in body composition ratio may affect 
trafficking and actions of these adipokines in respiratory tract. Although the studies 
on the associations between adipokines and lung disease are inconsistent and 
sometimes contradictory, there is evidence that they should be linked via several 
inflammatory and non-inflammatory mechanisms (Sood, 2011). In vitro studies 
show that leptin stimulates TNFα, MCP-1, and IL-6 production by adipocytes. It 
also modulates T-cell responses, angiogenesis, and vascular permeability and 
epithelial cell proliferation in lung parenchyma and, possibly airway remodelling 
(Shin et al., 2008). Greater bronchial expression of leptin in COPD patients 
correlates negatively with unadjusted FEV1 and FEV1/FVC ratio. High serum leptin 
levels also increased the risk of asthma in premenopausal women (Sood, Ford and 
Camargo, 2006). Furthermore, Holguin et al., observed that overweight or obese 
adults had greater leptin levels in the BAL than lean asthmatic or control groups. 
Besides, plasma leptin level was higher in overweight or obese asthmatics than 
BMI-matched controls (Holguin et al., 2011). 
Conversely, adiponectin suppresses the production of inflammatory TNFα, IL-6, and 
vascular cell adhesion molecules while it stimulates the synthesis of anti-
inflammatory cytokines IL-10 and IL-1 receptor antagonist(Wolf et al., 2004). 
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Although unexplored in humans, adiponectin deficiency may result in uncontrolled 
production of TNFα and matrix metalloproteinases (MMPs) by the alveolar 
macrophages, leading to emphysematous changes in animals. Adiponectin 
deficiency also promotes airway inflammation, alveolar smooth muscle proliferation  
and vascular remodelling (Summer et al., 2008; Medoff et al., 2009). Lower 
unadjusted serum adiponectin concentration has also been reported in asthmatic 
women and the BMI-adjusted prevalence of asthma is lower in premenopausal 
women with high serum adiponectin concentration (Sood et al., 2008). There is, 
however, conflicting evidence that suggests adiponectin may act as a 
proinflammatory factor in bronchoalveolar tree, in the individuals with airflow 
limitation (Miller et al., 2009). In the COPDGene cohort, increased plasma 
adiponectin level was significantly associated with reduced FVC and FEV1, 
decreased post-bronchodilator changes in the percentage predicted value of FEV1, 
lower BMI, and CT-assessed emphysema among middle-aged current/ex-smoker 
adults with stable COPD (Carolan et al., 2013). Paradoxically, high adiponectin 
level is associated with lower rate of metabolic syndrome and adverse 
cardiovascular outcomes in individuals with COPD (Minas et al., 2011; Yoon et al., 
2012). This discrepancy can be explained by distinct phenotypes of COPD. While 
undernourished individuals (with higher adiponectin and lower leptin 
concentrations) have more severe phenotypes and higher risk of short-term death, 
obese patients with early-stage presentations (and higher leptin to adiponectin ratio) 
experience a less aggressive clinical course with more frequent cardiovascular 
comorbidities and higher risk of long-term death (time differential hypothesis) (Divo 
et al., 2014). Interestingly, in the COPD Quantification by Computed Tomography, 
Biomarkers, and Quality of Life (CBQ) cohort study, increased adiponectin, 
decreased leptin and low leptin/adiponectin ratio were significant predictors of rapid 
annual decline in FEV1 in the individuals with airflow limitation (Suzuki et al., 
2014).  
These lines of data underscore the complex relationship between body composition, 
adipomyokines, lung function, and the clinical picture of pulmonary disease. 
Nevertheless, the role of insulin-related signalling pathways in these intricate 




The present study identified a moderating role for the skeletal muscle tissue in the 
specific associations of whole-body and segmental adiposity with dynamic lung 
function. It used a very robust quantitative statistical method to specify the absolute 
changes in spirometric parameters per changes in total and segmental fatness over 
continuous range of lean or muscle mass. The, recommended procedures for the 
assessment of body composition and spirometry were also carefully followed to 
reduce random and systematic error, improving the precision and the accuracy of the 
measurements. Importantly, the analyses were conducted on the absolute values of 
the spirometric readings instead of the percentage of the predicted values which 
have been shown to be non-accurate indicators of abnormal lung function in adults. 
Furthermore, the comparison of individual spirometric recordings to the reference 
values was based on the ATS/ERS endorsed spline-smoothed prediction equations 
proposed by the Global Lung Function Initiative (GLI) to capture the non-linear 
association of these parameters with age, height and sex. Spirometric measurements 
were additionally expressed as Z-scores to improve the accuracy and interpretability 
of the results. For the first time, the current study provided some evidence on the 
potential implication of body composition phenotyping in the pulmonary assessment 
of healthy adults. However, it is unclear whether these effects would be applicable 
to patients with respiratory problems. Also, majority of the participants in this study 
were young or middle age, non-smokers, physically active and in the mid-range of 
fatness or leanness. Again, cross-sectional design, small sample size, the use of BIA-
estimated measures of fat and skeletal muscle mass, and lack of metabolic, 
inflammatory, and dietary data limit the accuracy and generalisability of the 
findings. Since predictive models only included one set of body composition 
compartments at a time, the contribution of other two sets of compartments to the 
observed associations cannot be ruled out. For example, in the regression models 
exploring the effect of truncal fat-muscle phenotypes on spirometric indices was not 
controlled for the total fat–lean or appendicular fat-muscle phenotypes. Moreover, 
the influence of metabolic homeostasis (indicated by total fat to fat-free mass or 
truncal fat to appendicular muscle mass ratios) on respiratory performance was not 
directly examined. The intricate communication between adipose and skeletal 
muscle tissues using the appropriate biomarkers (e.g., adipokines or myokines) or 
the presence of inter- or intramuscular fat were not investigated in this study. The 
effect of other components of lean mass on the spirometric parameters could have 
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shed more light on the link between body composition and lung function. Optimally, 
direct measures of resistance, compliance, elasticity, and reactivity of the respiratory 
tract could have been used in conjunction with the systemic and intrapulmonary 
concentration of adipomyokines, and inflammatory markers. 
Nonetheless, this preliminary research may be a starting point for large-scale clinical 
studies on the interplay of adipose, striated muscle, bone and lung tissues and the 
cross-sectional and longitudinal reciprocal connection between metabolic balance 
























Body Composition Phenotypes and Lung Function by  
Blood Pressure and Muscle Strength 
 
To investigate the effect of metabolic load-metabolic capacity balance on lung 
function, measures of fat and lean compartments were composited as FM/FFM and 
TFM/ASM ratios. The former ratio was used to represent whole-body load-capacity 
model while the latter ratio was used to indicate segmental load-capacity model. 
Then, moderation analyses were carried out in the PROCESS to probe the 
modifying effect of systemic pressure as well as isometric grip strength on the 
association between spirometric indices and body composition phenotypes. For each 
spirometric parameter, distinct heteroscedasticity consistent OLS regression models 
adjusted for age, sex, ethnicity, height, NC, CC and TC were designed. FM/FFM 
and TFM/ASM ratios were entered separately in the corresponding models as the 
independent variables. For each model, DBP, SBP and Grip strength were added 
alternatively as the moderator. When one of these variables was defined as the 
moderator, the other two were treated as covariates. The conditional effects of the 
body composition phenotypes on spirometric parameters were plotted against low, 
medium and high levels of the moderators. 
 
Results 
7.1 Relative body composition and lung function by blood pressure 
Variations in FEV1 was predicted significantly by FM/FFM ratio at low levels of 
DBP with significant associations (Table 7.1) detectable in SPs with 
DBP<72.39mmHg. At lower values of DBP (16th percentile), 0.1point increment in 
FM/FFM ratio was associated with approximately 100ml decrement in FEV1 (ꞵ=-
.104; 95%CI (-.163, -.445), p<0.01). Similarly, significant influence of FM/FFM on 
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FVC was exerted only in the lower range of DBP values (<65.66mmHg). At 16th 
percentile of DBP, FVC dropped by 127ml per 0.1point increase in FM/FFM. 
Comparatively, FM/FFM ratio was a significant predictor of FEF 25-75% at all three 
levels of DBP, with significant associations detectable in SPs with 
DBP<75.72mmHg and >86.31mmHg. At lower values of DBP (16th percentile), 
0.1point increment in FM/FFM ratio was associated with 357ml/s decrement in FEF 
25-75% (ꞵ=-.357; 95%CI (-.47, -.24), p<0.001). Equal changes in FM/FFM also 
predicted about 120ml/s decrease in FEF 25-75% at 50
th percentile of DBP (ꞵ=-.119; 
95%CI (-.22, -.02), p<0.05). On the contrary, FEF 25-75% increased by 164ml/s per 
0.1point increment in FM/FFM (ꞵ=-.164; 95%CI (.213, .307), p<0.05) at 84th 
percentile of DBP. None of the spirometric indices showed significant relationship 
with segmental relative body composition (TFM/ASM) either directly or 
conditionally via interaction with DBP. 
By contrast, SBP moderated the influence of segmental relative body composition 
on pulmonary function (Table 7.2). TFM/ASM contributed significantly to the 
prediction of FEV1 in the middle and high range of SBP values (> 111.22mmHg). At 
50th percentile of SBP, each 0.1point increase in TFM/ASM was associated with 
69.8ml decrease in FEV1(ꞵ=-.069; 95%CI (-.135, -.005), p<0.05) while equal rise in 
TFM/ASM predicted 163ml fall in FEV1(ꞵ=-.163; 95%CI (-.252, -.074), p<0.001). 
Significant interaction between segmental relative body composition and SBP was 
also observed for FEF 25-75% which declined by 148ml/s (ꞵ=-.163; 95%CI (-.266, -
.030), p<0.05) and 349ml/s (ꞵ=-.349; 95%CI (-.504, -.194), p<0.001) per 0.1point 
increment in TFM/ASM at middle (50th percentile) and high (84th percentile) levels 
of SBP, respectively. Nonetheless, SBP and TFM/ASM did not have a significant 
interaction effect on FVC. Moreover, none of the spirometric parameters were 








Table 7.1 Relative total body composition and lung function by diastolic blood pressure 
Spirometric 
parameter 







FEV1 (L) -.104** (-.163, -.044)   -.042 (-.103, .018)   .031 (-.063, .126) 
FVC (L) -.127* (-.249, -.006)  -.070 (-199, .058) -.002 (-.165, .161) 
FEF 25-75% 
(L/s) 
-.357*** (-.469, -.244) -.119* (.220, -.018) .164* (.021, .307) 
Values are presented as ꞵ(95% CI) for FM/FFM 
*p<0.05; **p<0.01; ***p<0.001 
OLS regression models were adjusted for age, sex, height, ethnicity, neck circumference, calf 
circumference, and thigh circumference. 
FM/FFM: fat mass to fat-free mass ratio; DBP: diastolic blood pressure; FEV1: forced expiratory 
volume in 1 s; FVC: forced vital capacity; FEF 25-75%: forced expiratory flow at 25–75% of FVC. 
 




TFM/ASM by SBP percentile 
16th percentile  
(102 mmHg) 
50th percentile  
(112 mmHg) 
84th percentile  
(126 mmHg) 
FEV1 (L) -.002 (-.070, .064)   -.069* (-.134, -.005)   -.163*** (-.252, -.074) 
FEF 25-75% 
(L/s) 
.007 (-.121, .136) -.148* (-.266, -.030) -.349*** (-.504, -.194) 
Values are presented as ꞵ(95% CI) for FM/FFM 
FVC did not associate significantly with TFM/ASM at any level of SBP 
*p<0.05; **p<0.01; ***p<0.001 
OLS regression models were adjusted for age, sex, height, ethnicity, neck circumference, calf 
circumference, and thigh circumference. 
TFM/ASM: truncal fat mass to appendicular skeletal muscle mass; SBP: systolic blood pressure; 
FEV1: forced expiratory volume in 1 s; FEF 25-75%: forced expiratory flow at 25–75% of FVC. 
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7.2 Relative body composition and lung function by muscle strength 
To explore the influence of muscle strength on the association between whole-body 
and segmental metabolic homeostasis and pulmonary function, the isometric grip 
strength of the SPs was used as a moderating factor in the adjusted linear regression 
models, with total fat to fat-free mass or truncal fat to appendicular muscle mass 
ratios set as the predictive variables.  
The moderation analysis demonstrated that the impact of total body composition 
phenotype on all three measures of lung function was significantly dependent on the 
strength of grip force (Figure 7.1). In SPs with hand grips at the middle (33kg) and 
high levels of strength (46kg), FEV1 decreased respectively by 66ml (ꞵ=-.065; 
95%CI(-.129, -.002), p<0.05) and 273ml (ꞵ=-.273; 95%CI(-.367, -.179) , p<0.001) 
per 0.1point increment in FM/FFM. The association between FM/FFM and FVC 
also became significant when grip strength exceeded 35.31kg, with each 0.1point 
increase in FM/FFM significantly predicting 331ml fall in FVC (ꞵ=-.331; 95%CI(-
.552, -.111), p<0.01) at high level of grip strength (84th percentile). FEF 25-75% also 
dropped by 257ml (ꞵ=-.257; 95%CI (-.384, -.129), p<0.001) and 579ml (ꞵ=-.579; 
95%CI (-.768, -.391), p<0.001) in the middle (50th percentile) and high (84th 

















Figure 7.1. Moderating effect of grip strength on FM/FFM relationship with a) FEV1, b) 
FVC and c) FEF 25-75%.  
*grip strength level with significant effect of FM/FFM on spirometric parameters.  
Grip strength levels represent 16th, 50th and 84th percentiles. 
FM/FFM: fat mass to fat-free ratio; FEV1: forced expiratory volume in 1 s; FVC: forced vital 




Therefore, the effect of whole-body metabolic overload on reducing FEV1, FVC and 
FEF 25-75% was steadily augmented by incremental changes in grip strength. SPs with 
greater distal muscle strength had significantly lower spirometric recordings at any 
given quantity of total fat to fat-free mass ratio. Since all three indices declined, it 
could be conjectured that metabolic imbalance in otherwise healthy adults with 
stronger grips may primarily target the resistance and calibre of the bronchoalveolar 
tree rather than the compliance and elasticity of the lung.  
Similarly, isometric grip force moderated the influence of segmental metabolic 
balance on FEV1, FVC and FEF 25-75% (Figure 7.2). Significant transitions in 
TFM/ASM- FEV1 relationship occurred at grip strengths above 35.65kg. At high 
levels of strength (84th percentile), FEV1 decrease by 209ml per 0.1point increment 
in TFM/ASM (ꞵ=-.209; 95%CI (-.299, -.119), p<0.001). In a similar fashion, FVC 
declined by 179ml (ꞵ=-.179; 95%CI (-.310, -048.), p<0.01) at 84th percentile of grip 
strength. Also, FEF 25-75% fell by 419 ml/s per 0.1point rise in TFM/ASM (ꞵ=-.419; 
95%CI (-.582, -.256), p<0.001) in SPs with stronger grips (84th percentile).  
Thus, deleterious impact of excessive metabolic load on respiratory performance at 
the segmental level emerged as a function of the distal muscle strength, suggesting 
that healthy adults with stronger grips may have lower FEV1, FVC and FEF 25-75% at 
any given quantity of truncal fat to appendicular muscle ratio.  
As a result, metabolic imbalance at whole-body and segmental levels, by limiting 
vital capacity and flow rate, may create an obstructive respiratory pattern in adults 














Figure 7.2. Moderating effect of grip strength on TFM/ASM relationship with a) FEV1, b) 
FVC and c) FEF 25-75%.  
*grip strength level with significant effect of FM/FFM on spirometric parameters.  
Grip strength levels represent 16th, 50th and 84th percentiles. 
TFM/ASM: truncal fat mass to appendicular skeletal muscle ratio; FEV1: forced expiratory volume 




The present study elucidated that the combined impact of total as well as regional fat 
and skeletal muscle mass on the respiratory capacity was modified by the systemic 
blood pressure and the isometric grip strength. 
 
7.3 Modifying roles of blood pressure in the association between body 
composition phenotype and lung function  
A very interesting finding of the present study was the faceted connection between 
systemic blood pressure, body composition and lung function. While diastolic 
pressure moderated the negative influence of whole-body metabolic overload on all 
spirometric indices, systolic pressure was a moderator of the deleterious impact 
exerted by segmental metabolic overload over lung function. Increased FM/FFM 
ratio as an index of whole-body metabolic load could predict diminished FEV1, FVC 
and FEF 25-75% at lower DBP values. By contrast, increased TFM/ASM ratio, as an 
index of segmental metabolic load, predicted decreased FEV1 and FEF 25-75% at 
higher levels of SBP. Although the underlying mechanisms are not clear, it can be 
speculated that earlier in the process of metabolic imbalance, when concomitant 
physiologic derangements have contributed to the increases in systolic pressure, 
moderate to small-sized airways are narrowed and bronchial smooth muscles are 
hyperresponsive, increasing airway resistance especially at high gas flow rates 
during forced expiration. This may limit FEV1 and mid-expiratory flow rate without 
impairing vital capacity. With the progression of the imbalance to the point where 
diastolic pressure is negatively affected by the stiffened arteries, elastic recoil and 
respiratory compliance are impaired, reducing vital capacity and FVC. This 
hypothesis may be supported if variations in the corresponding spirometric indices 
can be predicted from changes in SBP and/or DBP. This speculative association will 
be tested in the next two chapters. 
It is worthwhile to stress the importance of the local regulators of regional vascular 
resistance, i.e., metabolic activity, myogenic mechanisms, and flow-mediated 
dilation of peripheral vessels (that adjusts the rate of diastolic runoff in the 
vasculature) as well as the elasticity of large arteries (that influences the afterload 
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and systolic output) in controlling arterial pressure (Magder, 2014). Several studies 
have demonstrated a J-shaped relationship between DBP and carotid intimal 
thickness, progression of atherosclerotic plaques and cardiovascular events, 
especially in hypertensive or elderly population (Farnett et al., 1991; Bots et al., 
1996; Somes et al., 1999). It has been hypothesised that central arterial stiffness may 
lower DBP and subsequently impair coronary blood flow and LV function 
(Cruickshank, Thorp and Zacharias, 1987; Sleight, 1988). SBP is also dependent on 
the stiffness of central arteries, stroke volume, and wave reflections from peripheral 
arteries. LV mass and contractility, in turn, are affected by long-term alterations in 
SBP.  Thus, endothelial dysfunction, intimal thickening and atherosclerosis may be 
the factors underlying this phenomenon (Witteman et al., 1994).  
The contribution of fat and lean compartments to the regulation of systemic blood 
pressure has been extensively discussed in the literature review. The relevance of 
metabolic load-capacity balance to BP has been emphasised in the Avon 
Longitudinal Study of Parents and Children (ALSPAC) which illustrated positive 
effect of DXA-measured FM/LM ratio and the negative effect of birth weight  on 
DBP, SBP, and the odds for hypertension at 9 years among white European children 
(Grijalva-eternod, Lawlor and Wells, 2013). Based on the thrifty phenotype 
hypothesis, metabolically active organs (kidneys, liver, pancreas, vasculature, 
hypothalamic-pituitary-adrenal axis and sympathetic systems) of individuals with 
restricted foetal and post-natal growth are not fully equipped to tolerate the 
metabolic load imposed on them by the environmental factors and the linear growth 
during childhood and early adulthood, predisposing these individuals to metabolic 
syndrome, hypertension and type 2 diabetes later in life (Hales and Barker, 2001). In 
addition, height, fat mass, BP, and (more strongly) lean mass are independently 
significant determinant of LV mass in children and adolescents (Daniels et al., 
1995)(Janz, Burns and Mahoney, 1995)(Urbina et al., 1995). In this regard, low 
ASM/VFA ratio emerged as an independent risk factor for metabolic syndrome and 
arterial stiffness (measured by brachial artery pulse wave velocity(baPWV)) in the 
KSOS. Furthermore, the age and sex-adjusted favourable effect of a high ASM/VFA 
ratio on DBP, SBP, baPWV, fasting glucose, and HDL cholesterol contrasted the 
adverse effect of a high ASMI on these entities (Kim et al., 2011). A separate 
analysis of the data from the KSOS also demonstrated the multivariable-adjusted 
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association between higher levels of visceral fat to thigh muscle area (VFA/TMA) 
ratio and unfavourable profile of metabolic syndrome components (Lim et al., 
2010). As reviewed in chapter 2, the individual links between fat and lean 
compartments, lung function, atherosclerosis, arterial stiffening, insulin resistance, 
and inflammation have been repeatedly underscored in a large battery of studies. 
Thus, this is conjecturable that components of total and segmental body composition 
exert interactive inflammatory, endocrine and metabolic effects on the development 
and function of respiratory system through or in parallel to the static and dynamic 
changes in the elements of cardiovascular system. This possibility will be discussed 
in more details in the next chapter.  
 
7.4 Moderation of total body composition-lung function relationship by 
isometric grip strength 
The present research also shed light on the moderating role of muscle strength in the 
association between metabolic homeostasis and pulmonary function. FM/FFM ratio 
was a significantly negative predictor of all three spirometric parameters, i.e., FEV1, 
FVC and FEF 25-75% at high levels of isometric grip strength. In other words, SPs 
with the largest metabolic load and strongest grips had the lowest vital capacity and 
the expiratory flow rate as compared to other SPs, controlling for demographic, 
anthropometric and BP characteristics. Handgrip force, as an indicator of peripheral 
muscle strength, is a surrogate marker of respiratory muscle strength, a strong 
correlate of skeletal muscle mass and an independent predictor of physical 
functioning and clinical outcomes. It also correlates with maximal expiratory 
pressure (MEP) and more significantly maximal inspiratory pressure (MIP) in young 
and older healthy populations (Enrighi et al., 1994; Bahat et al., 2014; Efstathiou, 
Mavrou and Grigoriadis, 2016). Recently, a dose-dependent positive association was 
found between handgrip strength and pulmonary function in community dwelling 
older Korean women (Son et al., 2018). In this secondary analysis of KNHANES, 
women in the lowest quartile of hand-flexor strength were respectively 2.6 and 3.5 
times more likely to have impaired FEV1 and FVC (LLN values) as compared to 
those with stronger grips. Therefore, it can be conjectured that the effect of body 
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composition ratio on spirometric parameters is partially mediated via contractile 
force of inspiratory and (less strongly) expiratory muscles. 
Thus, the increased grip force, as a surrogate measure of respiratory muscle strength, 
may represent higher skeletal muscle mass and faster expiratory flow rate. In this 
group of individuals, elevated whole-body and segmental body composition ratios 
could be indicative of highly accumulated fat both totally and truncally. This may 
result in greater declines in vital capacity and flow rate as compared to individuals 
with weaker grip strength and probably lower skeletal muscle mass whose elevated 
body composition ratios would represent quantitatively smaller fat depots. 
This possibility could have been explored better if the absolute values of total and 
truncal fat mass as well as total fat-free mass and appendicular muscle mass had 
been included in the predictive models as separate variables.  
With regard to the handgrip measurement, the handheld dynamometer (Takei) used 
in this study may underestimate the grip force in the dominant and non-dominant 
hands of male and female adults  as compared to Jamar dynamometer which is 
considered to be the criterion standard for the assessment handgrip strength (Amaral, 
Mancini and Novo Júnior, 2012). This limitation together with the standing position 
of SPs during dynamometry could have entered some degrees of systematic and 
random errors in the analysis; however, the compliance with the standard protocols 
would have reduced these errors. Limitations addressed in previous chapters should 














Systemic Blood Pressure and Lung Function 
 
To test the hypothesis of the interrelation between systemic blood pressure and lung 
function, the main effects of systolic, diastolic and mean arterial blood pressure on 
spirometric parameters was analysed in the heteroscedasticity-corrected linear 
regression models adjusted for age, sex, ethnicity, height, NC, CC, TC, grip 
strength, FFMI and FMI.  
To create standardised coefficients of determination, Z-scores of the explanatory and 
outcome variables were calculated. Then, Z-score were included in the regression 
models instead of the absolute values.  
The conditional effect of systemic BP on spirometric indices was probed using 
moderation analysis. In the models pertinent to each spirometric index, DBP, SBP 
and MAP were separately included as main predictors while FM/FFM ratio was 
defined as the moderator. The effect of main predictors on each spirometric 




8.1 Systemic blood pressure as a predictor of pulmonary function 
Models incorporating DBP and SBP significantly predicted variability in FEV1 
(R2=.76, .74, p<0.001), FVC (R2=.73, .72, p<0.001) and FEF 25-75% (R
2=.32, .33, 
p<0.001).  
As presented in Table 8.1, DBP and SBP demonstrated significantly negative 
associations with FEV1 (standardised ꞵ=-.24, -.16, p<0.001), FVC (standardised ꞵ=-
.15, -.12, p<0.001), and FEF 25-75% (standardised ꞵ=-.30, p<0.001 and -.26, p<0.01), 
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respectively. This may be indication of increased airway resistance and airflow 
limitation with potentially collapsible small airways in healthy adults with higher 
systolic and/or diastolic pressures who are free of clinically apparent respiratory 
disease. 
In the DBP-included models, sex, ethnicity, height and grip strength were the 
significant covariates of FEV1 and FVC. FMI contributed significantly to the 
variation in FEV1 whereas TC, CC and FFMI were significant contributors to FVC 
prediction. Age, height, TC, CC and grip strength were significant predictors of FEF 
25-75%. Neither FMI nor FFMI displayed significant associations though. For SBP 
models, however, FMI significantly and negatively predicted the changes in FEV1 
(standardised ꞵ=-.16, p<0.05), FVC (standardised ꞵ=-.16, p<0.05), and FEF 25-75% 
(standardised ꞵ=-.20, p<0.001). In contrast, FFMI acted as a significant predictor 
only for FEV1 (standardised ꞵ=.16, p<0.05). Therefore, fat and lean body 

















Table 8.1 Systemic blood pressure as the predictor of lung function 
Spirometric 
parameter 












FEV1 (L) -.011(±.002) -.158 <.001 -.019(.004) -.246 <.001 
FVC (L) -.011(±.003) -.120 <.001 -.022(004) -.158 <.001 
FEF 25-75% 
(L/s) 
-.023(±.004) -.259 <.001 -.023(007) -.305 .002 
Multiple linear regression models were adjusted for age, sex, height, ethnicity, neck circumference, 
calf circumference, thigh circumference, grip strength, FFMI and FMI. 
DBP: diastolic pressure; SBP: systolic pressure; FEV1: forced expiratory volume in 1 s; FEF 25-75%: 


















8.2 Moderating effect of body composition phenotype on the relationship 
between systemic blood pressure and lung function 
To clarify the combined influence of fat and lean compartments on the link between 
haemodynamic status and respiratory capacity, total and segmental body 
composition ratios were included as moderators in the prediction models. 
DBP but not SBP predicted the variations in FEV1 (R
2=.76, p<0.001), FVC (R2=.72, 
p<0.001) and FEF 25-75% (R
2=.42, p<0.001) significantly. Sex, height, TC and grip 
strength were the significant covariates for all three spirometric measures while 
ethnicity associated significantly with FEV1 and FVC. In addition, NC and CC were 
significant predictors of FVC. 
DBP had a significantly negative effect on FVC across all levels of FM/FFM and on 
FEV1 at low and mid-range of FM/FFM (Table 8.2). The slope of association was 
steeper (Figure 8.1) at lower values (16th percentile) of FM/FFM compared with 
middle (50th percentile) and higher (84th percentile) values. Significant associations 
between DBP and FEV1 was observed for FM/FFM values below 0.45 whereas the 
relationship between DBP and FVC retained significance at FM/FFM values below 
0.49.  
For each 1mmHg rise in DBP, FEV1 declined by 35ml (ꞵ=-.035, p<0.001), 22ml 
(ꞵ=-.022, p<0.001) and 9ml (ꞵ=-.009, p>0.05) at low, mid and high levels of 
FM/FFM, respectively. In a similar order of interaction, FVC dropped by 37ml (ꞵ=-
.037, p<0.001), 23ml (ꞵ=-.023, p<0.001) and 9ml (ꞵ=-.009, p<0.01) per 1mmHg 
increase in DBP. In comparison, FEF 25-75% was negatively influenced by DBP at 
low (ꞵ=-.059, p<0.001) and middle (ꞵ=-.022, p<0.01) levels of FM/FFM whilst it 













Main effect Interaction with FM/FFM 






FEV1 (L) -.049*** 







FVC (L) -.052*** 







FEF 25-75% (L/s) -.104*** 







Values are presented as ꞵ(95% CI)  
*p<0.05; **p<0.01; ***p<0.001 
OLS regression models were adjusted for age, sex, height, ethnicity, neck circumference, calf 
circumference, thigh circumference and grip strength. 
DBP: diastolic pressure; FM/FFM: fat mass to fat-free mass ratio; FEV1: forced expiratory volume 























Figure 8.1. Moderating effect of whole-body composition phenotype on DBP relationship 
with a) FEV1, b) FVC and c) FEF 25-75%.  
FM/FFM values represent 16th, 50th and 84th percentiles. 
*FM/FFM level with significant effect of DBP on spirometric parameters.  
DBP: diastolic pressure; FM/FFM: fat mass to fat-free mass ratio; FEV1: forced expiratory volume 




Despite non-significant main effect of SBP on parameters of lung function, the 
associations of SBP with FEV1 and FVC became significant at FM/FFM values 
greater than 0.20 and 0.27, respectively. In SPs with mid (0.30 to 0.44) and high 
(≥0.44)-range FM/FFM, FEV1 decreased respectively by 12ml (ꞵ=-.035, p<0.001; 
95%CI -.018 to -.006) and 20ml (ꞵ=-.035, p<0.001; 95%CI -.027 to -.012) per 
1mmHg rise in SBP. The equivalent increase in SBP also predicted 10ml (ꞵ=-.010, 
p<0.001; 95%CI -.018 to -.002) and 23ml (ꞵ=-.035, p<0.001; 95%CI -.032 to -.013) 

















Figure 8.2. Moderating effect of whole-body composition phenotype on SBP relationship 
with a) FEV1, b) FVC. 
FM/FFM values represent 16th, 50th and 84th percentiles. 
*FM/FFM level with significant effect of SBP on spirometric parameters.  
SBP: systolic pressure; FM/FFM: fat mass to fat-free mass ratio; FEV1: forced expiratory volume in 








Thus, in otherwise healthy adults with low to moderate whole-body metabolic 
burden, FEV1 and FVC may drop to a larger extent than their metabolically 
overloaded peers per given increments in diastolic pressure. Oppositely, the inverse 
association of systolic pressure with FEV1 and FVC could be of a larger magnitude 
in otherwise healthy adults with medium to high metabolic overload than those with 
lower metabolic burden at whole-body level.  
Importantly, MAP exhibited significantly negative main effects on all three 
spirometric indices. FEV1, FVC and FEF 25-75% decreased by approximately 45ml, 
40ml, and 100 ml/s per 1mmHg increment in MAP. Moreover, total body 
composition phenotype significantly moderated the influence of mean arterial 
pressure on respiratory capacity. The magnitude of MAP effect on spirometric 
parameters decreased with continuous increments in FM/FFM ratio. FEV1, FVC and 
FEF 25-75% declines per unit increases in MAP were larger (33ml, 31ml and 68ml/s) 
at low levels (16th percentile) than high levels (84th) of FM/FFM ratio (13ml, 13ml 
and 11ml) (Table 8.3). Thus, in adults with no clinical respiratory disease and low 
metabolic load, vital capacity, expiratory flow rate and small airway calibre may 
decline more significantly than their metabolically overloaded counterparts per 


























FEV1 (L) -.044*** 















FEF 25-75% (L/s) -.101*** 







Values are presented as ꞵ(95% CI)  
*p<0.05; **p<0.01; ***p<0.001 
OLS regression models were adjusted for age, sex, height, ethnicity, neck circumference, calf 
circumference, thigh circumference and grip strength. 
MAP: mean arterial pressure; FM/FFM: fat mass to fat-free mass ratio; FEV1: forced expiratory 


















In the present study, diastolic and systolic pressures were inversely associated with 
all three spirometric indices, independent of age, sex, ethnicity, muscle strength and 
anthropometric as well as BIA-derived measures of lean and fat mass. The largest 
effect of DBP and SBP was exerted on FEF 25-75, followed by FEV1, implying that 
haemodynamic changes underlying the elevated systemic blood pressure can be 
more closely linked to the alterations in the structure and function of small airways 
rather than larger proximal airways.   
Another notable finding of this study was the emergence of an inverse association 
between diastolic pressure and dynamic lung function in otherwise healthy adults, 
particularly in those with low metabolic load at whole-body level.   
Hence, the magnitude of decline in FEV1, FVC and FEF 25-75% per increments in 
diastolic pressure could be larger when there is a predominance of lean over fat 
mass. As a result, the contribution of DBP to lung function can be partially 
attributed to the moderating role of body composition, though there should be other 
linking mechanisms too.  
In contrast, the effect of SBP on FEV1 and FVC was totally dependent on body 
composition, losing significance after adjustment for FM/FFM. Moreover, the 
negative association between respiratory performance and systolic pressure appeared 
only at mid and high levels of FM/FFM, indicating that individuals with metabolic 
overload at the whole-body level are more prone to the potentially adverse effects of 
elevated systolic pressure on their pulmonary function. Thus, it appears that SBP 
relates to respiratory capacity through mediation of metabolic imbalance. 
Predictive value of BP for lung function variations in adults free of respiratory 
problems has been addressed in a few studies. Adjusting for sex, age, height, weight, 
education level, smoking, and the history of pulmonary and cardiac diseases, high 
blood pressure and the use of beta blockers synergistically produced adverse 
respiratory effects in the participants of the Cooperative Health Research in the 
Region of Augsburg (KORA) F4 study. Patients who remained hypertensive despite 
using beta blockers would experience the largest reductions in FEV1 and FVC as 
compared to normotensive subjects without taking antihypertensive agents. There 
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was a significant interaction between sex and raised BP on FVC such that increased 
BP had a greater negative impact on the vital capacity of men. Also, hypertension 
and beta blocker use had independently inverse associations with FEV1 and FVC 
(Schnabel, Karrasch, et al., 2011). Similar results were reported from the European 
Community Respiratory Health Survey (ECRHS)-I Erfurt study which estimated 
150ml and 190ml reduction in multivariable (sex, age, BMI, education, smoking, 
and respiratory symptom) adjusted FEV1 and FVC among subjects with uncontrolled 
hypertension as compared to normotensive subjects not receiving antihypertensives. 
It was found, however, that the association between high blood pressure and 
spirometric indices lost significance when the medication use was added as a 
separate explanatory variable (Schnabel, Nowak, et al., 2011). Data from the non-
institutionalised Icelanders who took part in the Burden of Lung Disease Initiative 
(BOLD) yielded similar results. Multivariable adjusted FEV1% and FVC% predicted 
values were independently and inversely associated with hypertension, BMI and 
CRP (Margretardottir, Thorleifsson and Gudmundsson, 2012). Again, the 
associations with FVC% were stronger in male than female subjects. Furthermore, 
hypertension and increased CRP (>1.27mg/L) demonstrated additive effects on 
FEV1% whilst FVC% was lowest in the subjects with simultaneous increases in all 
three predictors, denoting the contribution of BP, body composition and systemic 
inflammation to the variability in lung function among adult population. In line with 
these findings, a cross-sectional analysis of French men without coronary heart 
disease exhibited significantly inverse association between arterial stiffness and 
pulmonary function. In this study, FEV1 and FVC declined respectively by 
approximately 200ml and 160ml per 2.5 m/s increments in carotid–femoral pulse-
wave velocity (cfPWV), accounting for age, height, weight, hypercholesterolaemia, 
diabetes and hypertension (Zureik et al., 2001). This accords with the inverse 
association between the mean arterial pressure and FEV1, FVC and FEF25-75% 
observed in the current study, indicating that arterial stiffness, more specifically 
vascular resistance, can be related to the expiratory flow, vital capacity and small 
airway calibre.  
The underpinning of the observed association between vascular and respiratory 
systems is poorly understood but a number of explanations have been offered. One 
possible reason could be the interstitial pulmonary oedema caused by left ventricular 
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dysfunction and elevated pulmonary artery pressure subsequent to persistently 
increased systemic BP and afterload. Fluid accumulation in lung parenchyma 
reduces lung compliance and functional residual capacity, reducing FEV1 and FVC. 
In fact, the Cardiovascular Health Study (CHS) provided evidence of the 
independent deteriorating influence of left ventricular (LV) enlargement, especially 
the end-diastolic posterior wall LV thickness, on (age, height, and waist girth) 
adjusted FEV1 and FVC among non-smoking elderly population without pulmonary 
disease. In addition, systolic hypertension (reflecting augmented arterial stiffness) 
was an independent predictor of FVC decline (Enright et al., 1995). Respiratory 
flow is limited further by the bronchoconstrictive effects of beta-blockers commonly 
prescribed to treat high BP (Doshan et al., 1986). Other blood pressure medications 
such angiotensin converting enzyme inhibitors (ACEI) and calcium channel 
blockers are also known for their respiratory side effects (Vegter and de Jong-van 
den Berg, 2010). The contributory role of smoking seems unlikely because the 
models operated in these studies controlled for smoking and the associations also 
existed in non-smokers. As dissected earlier, fat and lean compartments can 
significantly modify cardiovascular and respiratory functions, thereby linking the 
altered haemodynamics of the vascular bed to the impairments in the respiratory 
capacity. In this respect, it had been suggested that decreased FEV1 and FVC could 
be physiologic phenotypes of centripetal obesity and physical inactivity (Weiss, 
1991) as the impaired lung function was related to lower HDL, higher serum 
triglycerides and fasting insulin levels, and higher upper body obesity (measured by 
skin fold thickness). 
Mainly in patients with pulmonary disease, airflow limitation, emphysematous 
changes, and pulmonary vascular abnormalities have been related to endothelial 
dysfunction (assessed by flow-mediated brachial artery dilation), aortic calcification, 
carotid intima-media thickness and arterial stiffness (Barr et al., 2007; Iwamoto et 
al., 2009; Matsuoka et al., 2011). In addition, systemic inflammation (CRP, IL-6, 
TNF-α) has been linked to the impairments in pulmonary function as well as the 
atherosclerotic and hypertensive injuries in the systemic and pulmonary arteries 
(Poulain et al., 2008; Shore, 2008; Chaouat et al., 2009). On this account, 
endothelium-dependent and endothelium-independent vasomotor function can be 
involved in the individuals with the impaired lung function. Hence, vascular smooth 
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muscle and extracellular matrix may also be damaged, affecting the stiffness and 
blood flow in conduit and resistant arteries (Maclay et al., 2009). 
Dysregulation of lipid and glucose homeostasis, insulin resistance, neurohormonal 
aberrations and other abnormalities as well as coexisting local and systemic 
inflammation, aging, and exposure to toxic substances may all contribute to the 
pulmonary and vascular dysfunction. 
Although plausible, some of these pathophysiological events do not apply to the 
young and middle-aged healthy population who constituted the main group of SPs in 
the current research.  
Another plausible explanation that pertains to the healthy adult population with no 
history of cardiorespiratory disorders similar to the present research, is the parallel 
changes in the structural and functional properties of the airways and vessels arising 
from metabolic imbalance, developmental derangements, aging, and inflammatory 
processes.  
Airway elasticity, chest wall compliance and respiratory muscle performance 
worsen over the course of life as do the compliance and resistance of central and 
peripheral vessels. With ageing, thoracic wall undergoes anatomical and mechanical 
modifications because of the calcification of the rib cage structures that restricts 
chest wall expansion and the osteoporotic fractures that change the geometry and 
reduce the internal space of the thorax. This also alters diaphragmatic attachments 
and its expansile properties, impairing respiratory muscle strength. Respiratory 
muscle weakness is aggravated by the age-related loss of lean (and skeletal muscle) 
mass and the strength of peripheral muscles due to the malnourishment and 
neuromuscular alterations in the skeletal muscle tissue. There are degenerative 
changes in lung parenchyma as well. Destruction of the elastic fibres surrounding 
terminal airways results in the dilatation of the alveolar ducts and homogenous 
enlargement of the airspaces together with a reduction in the surface area, 
predisposing the small airways to collapse even when breathing at tidal volumes. 
Alongside, collagenous structures aggregate in the bronchoalveolar wall, narrowing 
the small airways (Janssens, Pache and Nicod, 1999; Milic-Emili, Torchio and 
D’Angelo, 2007). The functional consequences of these changes include reduced 
elastic recoil and chest wall compliance, hyperinflation, diminished expiratory flow, 
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increased FRC and RV, and ventilation/perfusion mismatch manifesting as steady 
decline in FEV1 and FVC, with faster rate in men as compared to women 
(Brandstetter and Kazemi, 1983; Cardus et al., 1997). 
The stiffening of arterial vessels also occurs due to the gradual loss of elastic 
materials and laminae, accumulation of collagen fibres and glycosaminoglycans, and 
misalignment of the structural units of vascular connective tissue. Persistent cyclic 
stress placed over the elastic fibres results in their rupture followed by the stretching 
and remodelling of the vessel wall, transferring the stress to the less extensible 
collagen fibres. These changes increase the pulse wave velocity generated by the 
earlier wave reflections from the peripheral arteries and the characteristic impedance 
in the ascending aorta, imposing an enormous load on the contracting LV and 
predisposing to LV hypertrophy and dysfunction (O’rourke, 1990; Debelle and 
Tamburro, 1999). 
Importantly, the present research found significantly independent association 
between increase in MAP, as a good indicator of arterial stiffness and reduced 
elasticity, and the decline in all three spirometric parameters. This implies that there 
should be a link between diminished compliance and elastic recoil in thorax, 
manifested as the reduction in vital capacity (FVC), expiratory flow rate (FEV1) and 
small airway diameter (FEF 25-75%) and declined elasticity of large arteries and 
perhaps increased resistance of medium-sized or small peripheral arteries. In 
addition, this relationship is moderated in part by whole-body metabolic status 
(indicated by FM/FFM ratio). In this piece of research, the negative influence of 
elevated MAP on lung function was ameliorated in SPs with proportionally lower 
FFM.  
Arterial stiffness has been found in adults with emphysema (McAllister et al., 2007). 
Moreover, these individuals have higher expression of anti-elastin antibodies (Lee et 
al., 2007). CRP and IL-6 are independent contributors to the spirometric and 
radiographic changes in lungs as well as the markers of reduced vascular elasticity 
even in otherwise healthy individuals (Yasmin et al., 2004; Sabit et al., 2007; Faner 
et al., 2014). The role of subclinical autonomic dysfunction in the narrowing of the 
airways, hyperactivity of bronchial and vascular smooth muscles, and baseline 
vascular tone cannot be overlooked too (Engström et al., 2009). 
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Thus, in addition to the moderating or mediating effects of body composition 
phenotypes, the potential role of early life experiences and inflammatory reactions 
appear to be more relevant to the relationships found in this study and will be 
discussed more extensively in the next chapter. 
This study added new lines of evidence to the possible connection between 
respiratory and cardiovascular systems and elucidated that metabolic homeostasis 
may modify this link via mechanisms that might involve the biomechanical 
determinants of vascular and airway elasticity or compliance. Also, it revealed the 
opposite interaction effect of metabolic balance and haemodynamic status on 
respiratory capacity using robust moderation analysis. To clarify these associations, 
better markers of lung and arterial elasticity (e.g., tonometrically measured pulse 
wave velocity or the systemic and intrapulmonary levels of matrix 
metalloproteinases and elastase were not used. In addition, the effect of segmental 
metabolic balance on the relationship between systemic BP and spirometric 
parameters was not explored. The inclusion of metabolic biomarkers and more 
DXA-determined measures of body composition would have improved on the 
accuracy of the results too. 
As stressed in chapter 3, the recording of blood pressure and pulmonary function 
were undertaken by validated instruments (COSMED Quark PFT system and 
OMRON automated oscillometric blood pressure monitoring device) in accordance 
with the protocols respectively recommended by the ATS/ERS and AHA. The 
accuracy of the OMRON oscillometric device has been shown to satisfy the British 
Hypertension Society (BHS) and the Association for the Advancement of Medical 
Instrumentation (AAMI) SP10 validation criteria for both systolic and diastolic 
pressures (Coleman et al., 2008) in the clinical setting. However, it has not been 
validated for research. Spirometric testing was performed using a valid modular 
diagnostic cardiopulmonary unit consisted of a turbine flowmeter which have been 
shown to meet the ATS for accuracy and precision in measuring FVC, FEV1, FEF25-
75% (Ors et al., 2013). It is noteworthy that, despite satisfactory precision and good 
level of agreement of spirometric measurements by COSMED Quark system, its 
upper limit of bias for FEV1 and FVC goes (±0.5% or 0.050 L) beyond the 
acceptable accuracy range recommended by the ATS/ERS.As the turbine 
flowmeters are flow and volume-sensitive and may underestimate and overestimate 
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PEF and FEV1 at low versus high tidal volumes (Jones and Mullee, 1995). The use 
of a pneumotachograph instead of a turbine flowmeter would have improved the 
accuracy of spirometric measurements. The other limitations of the study have been 


























Lung Function and Systemic Blood Pressure 
 
The role of spirometric parameters in the prediction of systemic blood pressure was 
explored in the OLS regression models adjusted for age, sex, ethnicity, height, AC, 
NC, CC, TC, FFMI, FMI, and VFA. FEV1, FVC and FEF 25-75 were included 
separately as main predictors while DBP and SBP were defined as the outcome 
variable. 
To create standardised coefficients of determination, Z-scores of the explanatory and 
outcome variables were calculated. Then, Z-score were included in the regression 
models instead of the absolute values.  
Thereafter, the interaction effect of each spirometric index and VFA on DBP and 
SBP was probed using moderation analysis. The moderating influence of three 
levels (16th, 50th and 84th percentile) of VFA on the association between spirometric 
predictors and systemic BP was visualised by drawing interaction plots. 
 
Results  
9.1. Lung function as a predictor of systemic blood pressure 
Models with FEV1, FVC and FEF 25-75% as the spirometric predictor, could 
significantly explain the variations in DBP (R2=.55, .54, .51; p<0.001) and SBP 
(R2=.41, .40, and .41; p<0.001), respectively. 
FEV1 and FVC were found to be significant independent negative predictors of DBP 
(standardised ꞵ=-.35 and -.40, p<0.001) and SBP (standardised ꞵ=-.38, -.30, 
p<0.001). FFMI (standardised ꞵ=-.46 and -.54,  p<0.001), female sex (standardised 
ꞵ=-.42, -.66, p<0.05)., and white ethnicity (standardised ꞵ=-.32, and -.44; p<0.05 
and <0.001, respectively) were other significantly negative predictors of DBP in 
corresponding regression models while VFA (standardised ꞵ=.34 and .37, p<0.001), 
NC (standardised ꞵ=.29 and .28, p<0.05), TC (standardised ꞵ=.24 and .21, p<0.001), 
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and height (standardised ꞵ=.15 and .18, p<0.05) were identified as positive 
predictors. For SBP, VFA (standardised ꞵ=.42 and .45, p<0.001), height 
(standardised ꞵ=.23 and .17, p<0.05) and TC (standardised ꞵ=.15 and .13, p<0.05) 
were significantly positive covariates whilst female gender remained a negative 
predictor (standardised ꞵ=-.60 and -.58, p<0.001) in the models incorporating FEV1 
and FVC, respectively. FEF 25-75% also contributed significantly to the prediction of 
DBP (standardised ꞵ=-.16, p<0.001) and SBP (standardised ꞵ=-.22, p<0.001). Age, 
ethnicity, NC, CC, TC, FFMI and VFA were the significant covariates of DBP 
whereas sex, VFA and TC remained significant predictors of SBP in these models. 
Taken together, FEV1 was the strongest spirometric predictor of DBP and SBP, with 
about 0.5 and 0.4SD (equal to 5.5mmHg and 5mmHg) decrease in DBP and SBP per 
1SD (0.9L) increase in FEV1. 
Thus, it can be inferred that lung function and blood pressure have mutual 
associations that are modified partially by total and/or segmental body composition 
phenotypes. Further, anthropometric measurements, particularly neck, calf and thigh 
circumferences play significant roles in the prediction of systemic blood pressure 
and pulmonary function, independent of total quantity of body fat or lean mass. 
 
9.2. Moderation of lung function effect on systemic blood pressure by visceral 
adiposity 
As VFA was identified as a significant covariate in the association of lung function 
parameters with DBP and SBP, the moderating effect of visceral adiposity on this 
relationship was probed in the OLS regression models adjusted for age, sex, 
ethnicity, height, NC, CC, TC and grip strength. 
The moderation analysis revealed that the effect of all three spirometric indices on 
SBP was conditioned on visceral adiposity (Figure 9.1). Variations in SBP were 
predictable by changes in FEV1, FVC and FEF 25-75% at VFA values greater than 
59.2cm2, 67.45 cm2 and 59.68 cm2, respectively. SBP would rise significantly by 
2.9mmHg (ꞵ=-2.92; 95%CI (-5.08, -.776), p<0.01) and 8.35mmHg (ꞵ=-8.35; 95%CI 
(-10.67, -6.03), p<0.001) per 1L decrement in FEV1 at middle (50
th percentile) and 
high (84th percentile) levels of VFA. Each 1L decrease in FVC was significantly 
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predictive of about 5mmHg rise in SBP at 84th percentile of VFA (ꞵ=-5.14; 95%CI 
(-6.72, -3.57), p<0.001). For each 1L/s decline in FEF 25-75%, 1.7mmHg (ꞵ=-1.75; 
95%CI (-2.87, -.635), p<0.01) and 5.6mmHg (ꞵ=-5.63; 95%CI (-7.02, -4.24), 























Figure 9.1. Moderating effect of visceral adiposity on SBP relationship with a) FEV1, b) 
FVC and c) FEF 25-75%.  
VFA values represent 16th, 50th and 84th percentiles. 
*VFA level with significant effect of spirometric parameters on SBP. 
SBP: systolic pressure; VFA: visceral fat area; FEV1: forced expiratory volume in 1s; FVC: forced 
vital capacity; FEF 25-75%: forced expiratory flow at 25–75% of FVC 
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In contrast, visceral adiposity did not moderate the effect of spirometric indices on 
DBP except FEF 25-75%. At middle and high levels of VFA, 1L/s decrease in mid-
expiratory flow rate was respectively associated with about 1.7mmHg (ꞵ=-1.69; 
95%CI (-2.78, -.608), p<0.01) and 3mmHg (ꞵ=-3.09; 95%CI (-4.38, -1.81), 
p<0.001) increase in DBP.  
These observations suggest that the contribution of visceral adiposity to the inverse 
association between pulmonary function and haemodynamic parameters varies by 
the components of systemic pressure. Whilst increases in systolic pressure per 
decremental changes in spirometric indices occurs in otherwise healthy adults with 
moderate to high levels of visceral fat, the opposite changes in spirometric 
parameters (FEV1, FVC) and diastolic pressure are independent of visceral adiposity. 
FFMI, however, significantly moderated the effects of all three lung function 
measures on DBP (Figure 9.2). DBP rose by 3.3mmHg (ꞵ=-3.35; 95%CI (-5.88, -
.832), p<0.01) and 7.3mmHg (ꞵ=-7.30; 95%CI (-8.80, -5.81), p<0.001) per 1L fall 
in FEV1 at middle and high levels of FFMI with significant transition at FFMI 
>16.95kg/m2. 1L decline in FVC was associated with about 5mmHg elevation in 
DBP at 84th percentile of FFMI (ꞵ=-5.13; 95%CI (-6.53, -3.72), p<0.001). 
Significant effects were observed in SPs with FFMI larger than 17.77kg/m2. At high 
level of FFMI, DBP also increased by approximately 3.7mmHg (ꞵ=-3.72; 95%CI (-
4.74, -2.71), p<0.001) per 1L/s decline in FEF 25-75%. No significant interaction was 
observed between spirometric parmeters and FFMI in relation to SBP. 
This is in contrast to the moderating role of visceral fatness. Here, total leanness 
influenced the inverse association of the dynamic lung capacity and diastolic 
pressure. The opposite changes in spirometric parameters and systolic pressure were, 











Figure 9.2. Moderating effect of FFMI on DBP relationship with a) FEV1, b) FVC and c) 
FEF 25-75%.  
FFMI values represent 16th, 50th and 84th percentiles. 
*FFMI level with significant effect of spirometric parameters on DBP. 
DBP: systolic pressure; VFA: visceral fat area; FEV1: forced expiratory volume in 1 s; FVC: forced 





In the current research, FEV1, FVC, and FEF 25-75% were the independent negative 
predictors of diastolic and systolic pressure, adjusting for age, sex, race, 
anthropometric measures, as well as fat and lean mass indices. This corroborates 
with the previous cross-sectional and longitudinal reports on the inverse association 
between pulmonary function and systemic blood pressure in adults. In the normative 
aging study (Sparrow et al., 1988), lower residual (age and height adjusted) FVC 
predicted higher 10-year incidence of hypertension in normotensive white men 
controlling for age, BMI, smoking, alcohol intake, DBP, SBP and 
electrocardiographic (ECG) abnormalities. In an exploratory analysis of data from 
the Kaiser Permanente Multiphasic Health programme, reduced FEV1 and FVC were 
reported as the significant precursors of subsequent hypertension in adults, 
independent of their race, sex, height, BMI, smoking, alcohol consumption, salt 
intake, serum chemistry , baseline DBP and SBP, heart rate and chest X-ray 
abnormalities (Selby, Friedman and Quesenberry, 1990). A similar trend was also 
observed in the PRC-US Cardiopulmonary Epidemiology Study where the absolute 
and height-standardised FEV1 and FVC were inversely associated with DBP and 
SBP in north and south Chinese women and north Chinese men cross-sectionally 
even after adjustment for age. Prospectively, lower initial FEV1 and FVC were 
significant predictors of increased 4-year risk of developing hypertension in south 
Chinese women adjusting for age, BMI, smoking, socioeconomic status and baseline 
SBP (Wu et al., 1998). These findings were further expanded by the results of the 
CARDIA study which disclosed a significant role of longitudinal (10 and 20 year) 
decline in FVC (and FEV1 ) in the prediction of future hypertension (after 10 years) 
in black and white American adults after adjustment for age, sex, race, height, BMI, 
smoking, physical activity, history of asthma and SBP, indicating significant 
relationships between inter-and intra-individual changes in pulmonary function and 
the risk of elevated blood pressure (Jacobs et al., 2012). Several explanations have 
been offered for these observations in free-living adults without pulmonary disease. 
One possibility is the contributory role of age as it relates to lung function and blood 
pressure changes oppositely. Accordingly, the strength of association between 
spirometric parameters and measures of systemic blood pressure diminished 
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appreciably in Chinese adults from the PRC-US CES cohort (Wu et al., 1998). 
Nevertheless, (height and age adjusted) Z-scores of FVC and FEV1 remained 
significantly related to SBP, DBP and the relative risk of hypertension. The 
confounding effect of cigarette smoking is unlikely because, in a majority of the 
available studies, the associations were observed in non-smokers too and the 
inclusion of smoking history in the predictive models did not influence the 
significance of associations between lung function and BP (Selby, Friedman & 
Quesenberry, 1990 ; Sparrow et al., 1988 ; Wu et al., 1998) . The role of hypoxemia 
is improbable as the subjects of these studies had a relatively normal vital capacity at 
baseline and over time. Reduced lung compliance caused by the underlying left 
ventricular hypertrophy and secondary interstitial pulmonary oedema is also an 
implausible mechanism because the relationships between spirometric indices and 
systemic BP and/or hypertension were independent of ECG and radiographic 
markers of LVH as well as baseline BP in these studies. Quantity and distribution of 
fat and lean mass can be more plausible explanations for the observed associations. 
It has been proposed that reduced lung function can be a phenotypic physiologic 
marker of (central) obesity and physical inactivity (Weiss, 1991), known to be 
significant cardiorespiratory risk factors. FEV1 and FVC have been consistently 
shown to be negatively related to anthropometric and body compositional measures 
of total and truncal adiposity across sex and age groups (Chen et al., 2007; Fenger et 
al., 2014; Santamaria et al., 2011; Wannamethee, Shaper & Whincup, 2005). In the 
CARDIA study, proportional HR for subsequent hypertension decreased 
substantially after BMI adjustment although FEV1 and FVC retained their significant 
effects (Jacobs et al., 2012). The strength of lung function and raised BP was also 
greater in the American cohorts with higher prevalence of obesity as compared to 
Chinese adults (Wu et al., 1998). Nonetheless, there has been no study exploring the 
interaction of direct measures of fatness and spirometric parameters on BP so far. 
Restricted lung and chest wall compliance reflected as reduced FVC as well as the 
loss of elastic recoil and increased airway resistance indicated by decreased FEV1 
may result from the abnormal accumulation and distribution of fat depots (Babb, 
Wyrick, et al., 2008; King et al., 2005;  Salome, King & Berend, 2010;  Sutherland 
et al., 2008 ) . Moreover, pulmonary and systemic inflammatory and 
immunometabolic responses triggered or mediated by central adiposity may worsen 
lung capacity and respiratory muscle function. The interaction of visceral adiposity 
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and insulin resistance may also impair lung function (Cardet et al., 2016;  
Sadeghimakki & McCarthy, 2019; Shore, 2008; Thyagarajan et al., 2010). In 
parallel, excess adiposity, particularly of central type, precedes elevation in SBP and 
DBP and increases the risk of hypertension via several mechanisms, including 
tubuleglomerular compression (Hall et al., 2014), stress-induced kidney injury 
(Unger et al., 2013), activation of renin angiotensin aldosterone and sympathetic 
nervous system (Lohmeier and Iliescu, 2013), endothelial dysfunction (Hall et al., 
2015) and vascular stiffening (Lyon, Law and Hsueh, 2003). In contrast, total and 
regional, particularly trunk and lower limb muscle mass, are positively associated 
with spirometric indices and ventilatory capacity in young and elderly populations 
(Enright et al., 1994; Lazarus et al., 1998; Karacan et al., 2008; Martín Holguera et 
al., 2017). Age, inactivity, and pathology-related loss of lean mass and muscle 
strength deteriorate respiratory performance and ventilatory function due to reduced 
elastic recoil, chest wall compliance and respiratory muscle function (Watsford, 
Murphy and Pine, 2007). Despite inconsistent findings,  it has been suggested that 
total and segmental (except lower limb) muscle mass may be positively associated 
with elevated SBP and DBP and the risk of subsequent hypertension in different 
populations (Peppa et al., 2014; Vaziri et al., 2015; Ye, 2018). In addition, 
intramuscular fat infiltration in lower limbs has been shown to be an independently 
significant predictor of incident hypertension (Zhao et al., 2017). Moreover, an 
interaction effect of abdominal obesity and upper-limb leanness on the prevalence of 
metabolic syndrome has been found in postmenopausal women (Peppa et al., 2014). 
LVH and carotid wall thickening, arterial stiffness (Leischik et al., 2014; Moreno et 
al., 2015), myofiber type shift in hypertrophied muscles (DiCesare et al., 2017), and 
SNS activation(Saito, Iwase and Hachiya, 2009) have been proposed as the putative 
mechanisms underlying BP-raising effect of high skeletal muscle mass. This 
indicates that the association between pulmonary function and systemic BP can be 
moderated by the combined effect of fat and lean compartments of body 
composition.  
In agreement with this hypothesis, the present study found that FFMI, VFA, and NC 
were significant predictors of spirometric and sphygmomanometric parameters in 
separate multivariable regression models. Notably, visceral adiposity and total 
leanness differentially affected the association between lung function and 
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haemodynamic status. Whereas lower FEV1, FVC and FEF 25-75% predicted increased 
systolic pressure in individuals with excessive visceral fatness (>60 cm2), the inverse 
association of FEV1, and FVC with diastolic pressure was observed in individuals with 
expanded fat-free compartment (>17kg/m2). Again, the conditional BP-elevating influence 
of FEV1 decline outpowered that of FVC and FEF 25-75% decrements. Thus, central fatness 
and whole-body leanness may link respiratory capacity and vascular function differentially. 
Further, SPs with high total and appendicular fat and skeletal muscle phenotypes had 
significantly increased MAP (a surrogate measure of arterial narrowing and increased 
peripheral vascular resistance).  
Apart from body composition phenotypes, other metabolic and inflammatory 
processes may also play important roles in the crosstalk between respiratory and 
vascular systems. In a large longitudinal study of initially nondiabetic Swedish 
adults, baseline FVC predicted percentage in men and women was inversely 
associated with glucose and insulin concentrations at follow up (14 years). Further, 
the odds of developing insulin resistance were significantly lower in male and 
female subjects with higher percentage of predicted FVC at baseline controlling for 
sex, age at screening, follow-up time, smoking, BMI, plasma glucose level at 
baseline, and follow-up WHR and physical activity. Importantly, subjects with low 
baseline FVC% who developed IR at follow-up, had significantly higher risk of 
cardiovascular events over 7 years after their follow-up examination even after 
adjustment for sex and age, smoking, cholesterol, systolic blood pressure, waist–hip 
ratio, physical activity, history of myocardial infarction or stroke at the follow-up 
examination (Engström et al., 2003). Previously, a cohort study of male participant 
in the Malmö preventive project had reported significantly higher levels of 
inflammation-sensitive plasma proteins (ISPs) in the subjects at lowest quartile of 
FVC adjusted for age, sex, BMI, cholesterol, SBP, recent respiratory infection, 
diabetes, smoking, and physical inactivity. Of note, the risk of long-term (14-year) 
cardiac events and cardiovascular mortality was highest among subjects with low 
FVC whose ISPs fell into the top quartile of concentration. Moreover, ISP 
adjustment attenuated the relationship between FVC and relative risk of future 
cardiac events (Engstrom et al., 2002). Based on the findings from the CARDIA 
study, systemic inflammation is longitudinally associated with the impaired lung 
function (Kalhan et al., 2010). In this cohort of young adults, higher levels of plasma 
fibrinogen and hs -CRP at year-7 follow-up predicted greater decline in FEV1 and 
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FVC 13 years later independent of cigarette smoking, body habitus, baseline lung 
function and demographic factors. In the Whitehall II Study (Gimeno et al., 2011), 
baseline and 12-year changes in hs -CRP and IL-6 concentrations were 
independently associated with deteriorated spirometric parameters (FVC and FEV1) 
among subjects without pulmonary disease. 
In a separate data analysis of the CARDIA study, it was shown that subjects at the 
lowest quartile of intercellular adhesion molecule (ICAM)-1, a key player in the 
initiation of inflammatory responses in the endothelium of pulmonary and systemic 
arteries expressed on the surface of endothelial cells and pneumocytes, 
concentration quartile had significantly higher FEV1 and FVC 5 years later 
(Thyagarajan et al., 2009) after discounting for  race, gender, height, age, physical 
activity, smoking status, alcohol intake, BMI, and asthma status. Interestingly, 
baseline (year 5) and time-dependent changes (between year 5 and 10) in FEV1 and 
FVC were predictive of year-15 ICAM-1 concentration, with lower quartiles and 
larger decline in the spirometric parameters being associated with higher ICAM-1 
concentration. Formerly, the age and BMI-independent association of plasma 
fibrinogen with longitudinal (5-and 10 year) decline in FEV1and FVC had been 
reported in a substudy of the CARDIA involving healthy adults aged 22–36 
(Thyagarajan et al., 2006). It is noteworthy that no significant relationship was 
found for FEV1/FVC in the above studies, indicating the potential contribution of 
low-grade inflammation to a restrictive rather than obstructive pattern of impairment 
or an early-stage deterioration in lung function among healthy population. 
As a further evidence for the concomitant changes in the inflammatory profile and 
pulmonary function, the aggravation of systemic inflammation (assessed by CRP) 
over 8 years was significantly associated with annually progressive loss of FEV1 
among young adults in in the European Community Respiratory Health Survey 
(ECRHS) notwithstanding the non-significant relationships between these variables 
at baseline (Shaaban et al., 2006). The involvement of inflammation and endothelial 
dysfunction in the interplay between lung tissue and the vasculature was supported 
by the results of the Multiethnic Study of Atherosclerosis (MESA). In this 
observational study of healthy adults 45 years and older, fibrinogen, hs -CRP and 
IL-6 demonstrated significantly negative individual associations with small artery 
elasticity (SAE) in men (derived from tonometric arterial waveform assessment) and 
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FVC in men and women adjusting for age, ethnicity, anthropometric measures, 
smoking, history of antihypertensive and antihyperlipdaemic medications, heart rate, 
and components of metabolic syndrome (Duprez et al., 2013). IL-6 and hs -CRP 
have also been associated cross-sectionally with other tonometric parameters 
including augmentation index (a composite measure of central haemodynamic and 
peripheral oscillatory compliance) and carotid-femoral pulse wave velocity (cfPWV) 
in normotensive and hypertensive adults (Yasmin et al., 2004; Mahmud and Feely, 
2005; Schnabel et al., 2008) as well as patients with COPD (Sabit et al., 2007). 
However, this association was not confirmed in a larger cohort of COPD patients 
where emphysema severity determined by high resolution CT and MAP 
significantly predicted carotid-radial PWV measured by applanation tonometry but 
hs -CRP did not contribute significantly to the variations in PWV. 
The putative linking mechanisms include reduced nitric oxide bioavailability, 
proliferation of smooth muscle cells and the accumulation of non-elastic ECM 
(Chadwick and Goode, 2008). 
Given the fact that these inflammatory markers also increase the risk of 
cardiovascular disease (Ernst and Resch, 1993; Danesh et al., 1998), it can be 
postulated that local and systematic inflammatory and metabolic reactions underpin 
pathophysiologically parallel processes in the structural units of respiratory and 
vascular organs, including bronchoalveolar epithelium, endothelium, and smooth 
muscle cells, leading to airway remodelling, loss of elastic recoil, small airway 
narrowing, endothelial dysfunction, reduced vascular elasticity and non-
atherosclerotic arterial stiffness and carotid wall thickening (McAllister et al., 2007; 
Mills et al., 2008), aggravating the afterload and pulse pressure width with 
subsequent LVH, vascular remodelling, atheromatous plaque formation and 
essential hypertension (Lacolley et al., 2002). The observation of the significant 
association of FEF25-75%, a measure of small airway involvement, DBP and SBP in 
the present study is in line with the notion that structural changes in peripheral 
airways and peripheral arteries may occur contemporaneously. In addition, the 
stronger effect of FEV1 on DBP and SBP as compared to FVC and FEF25-75% may 
indicate that vascular physiology (including elasticity and resistance) is more closely 
related to the airway resistance and lung compliance rather than lung volume and 
small airway patency. Although not tested in the current research, poor lung function 
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(reflected by decreased FEV1 ) was found to be an independently significant 
predictor of pulse pressure widening (an indicator of reduced arterial compliance 
and elasticity) in a cross-sectional analysis of healthy adults older than 40 years 
(Jankowich, Taveira and Wu, 2009). Impaired respiratory capacity has also been 
significantly associated with increased aortic PWV, as a more accurate measure of 
central arterial stiffness. In an evaluation of otherwise healthy male cohorts from the 
Caerphilly Prospective Study (CaPS), FEV1 and FVC in mid-life were inversely 
related to carotid-femoral PWV measurements about 20 years later even after 
adjustment for early life and social factors, inflammatory markers, components of 
the metabolic syndrome and haemodynamic features of vascular system, with FEV1 
having a larger effect size than FVC . Among the inflammatory markers, fibrinogen 
was the only significant predictor of long-term cfPWV (Bolton et al., 2009). Of 
importance, spirometric parameters measured later in life did not predict PWV 
above and beyond the mid-life values, implying the involvement of the early life 
experiences in the structural and physiological attributes of cardiovascular and 
respiratory systems. Consistent with this speculation, growth trajectories relate 
oppositely to BP and lung function. In a prospective follow-up of the Northern 
Finland Birth Cohort (NFBC) from foetal to adult life, respiratory capacity 
(measured by FEV1 and FVC) rose persistently over a continuum of birth weight 
and infantile weight gain in men and women independent of gestational age, 
maternal smoking during pregnancy, weight and height, physical activity and 
smoking status at 31 years (Canoy et al., 2007). Also, a meta-analysis of 25000 
children demonstrated that preterm birth, low birth weight and lesser infant weight 
gain were significant predictors of lower FEV1 , higher FEV1/FVC and greater risk 
of asthma during childhood (Herman et al., 2016). Systemic BP in prepubertal 
period is significantly influenced by prenatal, post-natal, and early childhood 
growth. Findings from the Avon Longitudinal Study of Parents and Children 
(ALSPC) revealed that SBP at 10 years was inversely related to weight and weight 
for length at birth while it was directly associated with the rate of gaining weight, 
height and weight for height during and after infancy, with weight (total body mass) 
exerting the largest effect. A similar yet weaker pattern of association was also 
observed between DBP and the 3 size parameters at birth and during post-infancy 
period but not in the infancy period. Moreover, the magnitude of effect on BP was 
greater for post-infancy growth than for prenatal or infantile growth, especially for 
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DBP (Jones et al., 2012). These observations are supported by the earlier finding of 
negative effect of birth weight and positive effect of BMI z-score changes in early 
school (7-11 years) and (more strongly) in late school (12-13 years) ages on adult 
SBP (>20 years) from the life-course path analysis of a cohort of Danish males after 
adjustment for their current BMI (Gamborg et al., 2009). Taking the mediating role 
of adiposity into consideration, another follow-up of the ALSPC cohort illustrated 
that BMI changes from birth until later childhood (7–8.5 and 8.5–10 years) were 
closely related to DXA-measured fat mass in adolescence and the fact that the 
association between childhood BMI changes and BP at age 15 was largely 
attenuated by accounting for adolescent fat mass (Howe et al., 2010). 
Whereas the natural history of diastolic and systolic blood pressure variability track 
from late infancy to young adulthood, i.e., individuals at the higher or lower ranks of 
BP maintain their positions in the cohort at any given time period (Labarthe, Eissa 
and Varas, 1991), it is comprehensible that haemodynamic characteristics of aorta 
and large conduit vessels (including elastin-collagen balance) are determined by the 
critical events operable during foetal and postnatal life as well as the environmental 
factors affecting growth in late childhood (Martyn and Greenwald, 1997).  
A unifying explanation has not been presented for the aetiopathologic mechanisms 
linking loss of lung function and deteriorated vascular outcomes yet, but a plausible 
scenario can be the insidious degradation of elastic elements in the connective tissue 
of the alveoli and arterial wall in genetically and developmentally susceptible 
individuals. In patients with Marfan syndrome, a inherited connective tissue disorder 
caused by defective production of the extracellular matrix protein, fibrillin, which 
serves as a substrate for elastin, co-occurrence of aortic root stiffness and 
emphysema has been documented even in never-smokers (Pyeritz, 2000).  
In accord with this hypothesis, increased level and activity of the elastolytic protein 
MMP-9 has been respectively detected in the bronchioalveolar and serum samples 
of emphysematous (Finlay et al., 1997) and hypertensive (Zhou et al., 2007) 
patients, especially those with LVH. Relevant to the study population of the present 
research, elevated levels of MMP-9 and increased serum elastase activity have been 
associated with arterial stiffness in healthy individuals (Yasmin et al., 2006). This 
stiffening property is enhanced further by the pro-fibrotic action of MMP-9 which 
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stimulates biologically active peptides such as transforming growth factor-ꞵ (TGF-
ꞵ), favouring extracellular matrix (ECM) accumulation (including increased 
collagen synthesis and deposition) that impairs the compliance of flexible arteries 
(Ahmed et al., 2006).  
Therefore, parallel structural and biochemical alterations in the airways and the 
vasculature arising from complex interplay between genetic, epigenetic and 
environmental factors may explain the observed associations between respiratory 
capacity and vascular performance in young to middle-aged healthy adults. This 
association could also be partially mediated via metabolic, inflammatory and 
neuroendocrine mechanisms that stem in part from body composition and 
physiologic phenotypes. 
To the best of the author’s knowledge, it is for the first time that the compartment-
specific effect of body composition on the reciprocal changes in pulmonary function 
and systemic blood pressure is revealed. The statistically robust identification of 
body composition levels where the significantly inverse associations appear is 
another strength of this research. Also, the adjustment for one BP component in the 
models with the other component as the outcome improves the clarity of the 
associations. However, additional body composition compartments were not 
discounted in the models which incorporated a given pair of lean and fat 
compartment. Instead of absolute measures of body composition, total or segmental 
ratios could have been included as predictors to enable the exploration of metabolic 
homeostasis or relative body composition effect on respiratory-haemodynamic 
associations. Again, the interpretive yield of these analyses is limited by the lack of 
data on the metabolic profile, inflammatory markers, vascular stiffness, lung 
elasticity and airway resistance. It should also be noted that, despite established 
accuracy for the estimation of total and segmental lean mass and total fat mass, 
segmental multifrequency BIA underestimates visceral fat in adults with BMI≤35 
kg/m2 and overestimates visceral adiposity in individuals with higher BMI (Berker et 
al., 2010).  
Further research employing objective measures of haemodynamic status and elastic 
capacity of the respiratory and vascular system as well as markers of metabolic 
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overload and inflammation is required to test the hypothesis proposed by this study 



























Conclusion and Study Overview 
This research provides important insights into complex relationships between body 
composition phenotypes, systemic blood pressure, peripheral muscle strength and 
pulmonary function. 
It demonstrates that almost none of the conventional or non-conventional 
anthropometric measures are exclusively related to muscle mass in free-living 
healthy men and women. Although AC had strong relationships with total and 
segmental muscularity, only ABSI could be considered as a proxy for total and 
regional muscle depletion in men. In women, BMI and NBMI appeared to be the 
strongest anthropometric indicators of total and segmental fatness. In men, WHR, 
WC and WHtR were the strongest anthropometric markers of general and central 
adiposity whereas BMI, WHR and WC are strongest anthropometric indices of 
peripheral adiposity. By contrast, waist to height ratio and waist circumference 
could be used as the surrogate measures of adiposity in both sexes as they did not 
correspond to leanness indices. Nevertheless, these measures cannot differentiate 
optimally between central and peripheral fatness. In this regard, neck and mid-upper 
arm circumferences were the only anthropometric measures that specifically 
represented non-visceral adiposity.  
High appendicular, particularly leg, fat and muscle content were respectively the 
only significant measures of deterioration or improvement in lung function among 
healthy adult males. In females, however, total and regional fat and muscle content 
were both inversely but non-significantly related to lung function parameters. 
Further, the joint contribution of fatness and leanness to vascular function is linked 
markedly to diastolic and mean arterial pressures but not systolic and pulse pressures 
both totally and segmentally. Additionally, whole-body and segmental metabolic 
overload, respectively manifesting as the dominance of total and truncal fat mass 
over total fat-free mass and appendicular skeletal muscle mass correspond to 
elevated diastolic pressure more significantly than systolic pressure in healthy 
adults. Thus, the interaction of adipose and skeletal muscle tissue may alter 
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haemodynamic properties of resistance vessels to a larger extent than the elasticity 
and stiffness of conduit and central arteries. This finding has important clinical 
implications in the non-elderly population as it indicates that targeting systemic 
vascular resistance may be a more effective strategy for the prevention and 
management of high blood pressure in this group as compared to improving the 
compliance and distensibility of large to medium-sized vessels. 
According to the present study, sexual dimorphism exists in the association of lung 
function with fatness leanness. In men, total and segmental adiposity had negative 
impact on pulmonary function while total leanness and segmental muscularity 
improve it. In women, however, both compartments inversely associated with lung 
function. Importantly, the effect of total and regional adiposity on lung volume and 
flow rate depends on the corresponding leanness or muscularity status. Greater 
overall leanness as well as truncal and appendicular muscularity may aggravate 
detrimental influence of excessive adiposity on the dynamic lung function in healthy 
adults. In a broader sense, there could be a link between metabolic homeostasis and 
pulmonary function. Furthermore, this relationship can be modified by systemic 
blood pressure and muscle strength. The dominance of metabolic load over 
metabolic capacity at whole-body level (FM/FFM) could worsen lung function 
(FEV1 and FEF 25-75%) if diastolic pressure is low. At segmental level (TFM/ASM), 
however, high systolic pressure moderates the unfavourable effect of metabolic 
overload on lung function (FEV1 and FEF 25-75%). From a physiologic perspective, 
this may be an indication of parallel and progressive decline in the compliance, 
elasticity and diameter of the airways and the vasculature. These unfavourable 
biological alterations may have been initiated or promoted by longstanding 
metabolic imbalance which first manifests segmentally as elevated systolic pressure 
and expiratory flow limitation and then involves the whole body and presents as 
diminished diastolic pressure and concomitant fall in vital capacity and flow rate. 
Additionally, this research shows that the negative impact of incremental growth in 
whole-body and segmental metabolic burden on lung function (FEV1, FVC and FEF 
25-75%) is exerted at higher levels of the isometric grip force. Consequently, adults 
with stronger hand grips may be more susceptible to the adverse effect of metabolic 
imbalance on respiratory capacity due to the quantitatively larger restriction of their 
greater baseline respiratory muscle strength. 
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This research also reveals a bidirectional association between systemic blood 
pressure and lung function. Systolic, diastolic and mean arterial pressure are 
independently negative predictors of spirometric parameters (FEV1, FVC and FEF 25-
75%). Reciprocally, FVC, FEF 25-75% and more strongly FEV1, are the independent 
negative predictors of diastolic and systolic pressure in this population of healthy 
adults. Of note, total body composition phenotype (FM/FFM) modifies the influence 
of rising blood pressure on pulmonary function. Elevated MAP and DBP impair 
vital capacity and expiratory flow rate more prominently when fat-free mass exceeds 
fat mass. In contrast, elevated SBP predicts impaired dynamic lung function when 
FM predominates over FFM. Furthermore, healthy adults with larger areas of 
visceral fat may benefit more from the SBP-lowering effects of the increased 
baseline FEV1 and FVC than those with limited visceral fat depots. In comparison, 
improvement in baseline FEV1, FVC and FEF 25-75% would have more reducing 
effects on DBP in leaner adults. 
Therefore, it can be postulated that the physiology of respiratory and vascular 
systems in healthy adults are partly linked via shared developmental and metabolic 
events that determine the functional properties of the airways and arteries.  
Nevertheless, further research is required to elaborate on these observations. More 
specifically, investigating the interactive effects of body composition phenotypes, 
glucose and lipid metabolism, endothelial function, systemic and local 
inflammation, adipomyokines, matrix metalloproteinases, elastin-collagen balance 
and neuroendocrine factors can disentangle these complex relationships.  
The present study has several strengths. This is the first study that explores the 
interaction effect of body composition phenotypes and blood pressure as well as 
muscle strength on lung function in the form of moderation analysis. For the first 
time, this study bases the investigation of the association between body composition 
and pulmonary function on the concept of metabolic load- capacity model that 
emphasises the importance of the balance between the physiologic potential of the 
organs and tissues determined during foetal life to early childhood and the metabolic 
burden imposed on them by the extrinsic factors during late childhood and adult life 
in maintaining health and well-being (Wells, 2009). Using absolute and height-
adjusted total and segmental components of body composition in the current 
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research allows for a more comprehensive analysis and a better understanding of the 
crosstalk between adipose tissue, skeletal muscle and the cardiorespiratory system. It 
also draws an extensive correlative comparison between conventional and recently 
developed anthropometric measures in relation to the quantity and distribution of fat 
and muscle mass. Another important feature of this study is the exploration of the 
mutually effective link between lung function and blood pressure with the additional 
moderator involvement of body composition phenotypes. The inclusion of free-
living non-elderly healthy adults minimises the confounding effect of pathological 
processes and reduces the potential interaction of other risk factors. Hereby, it forms 
a basis for the study of baseline relationships in the general population. From a 
technical perspective, employing the BODPOD system and multifrequency 
segmental BIA improved the precision and accuracy of estimating body composition 
compartments. Both techniques have demonstrated good levels of agreement with 
reference methods for the estimation of FFM, FM and %BF in healthy young to 
middle-aged men and women (Sardinha et al., 1998; Fields, Goran and McCrory, 
2002; Ling et al., 2011; Verney et al., 2015). Blood pressure measurements were 
undertaken using an accurate oscillometric device which has been reported to satisfy 
the British Hypertension Society (BHS) and the Association for the Advancement of 
Medical Instrumentation (AAMI) SP10 validation criteria for both systolic and 
diastolic pressures (Coleman et al., 2008). Spirometric testing was performed using 
a valid modular diagnostic cardiopulmonary unit consisted of a turbine flowmeter 
which have been shown to meet the ATS for accuracy and precision in measuring 
FVC, FEV1, FEF25-75% (Ors et al., 2013). In addition, the absolute spirometric 
measurements were included in the analytical procedures instead of the percentage 
of predicted values. Adopting this approach avoids the inaccuracies arising from the 
inclusion of fixed percentages that ignore nonlinear relationship of FEV1 with age 
and height (Stanojevic et al., 2008; Miller et al., 2011). Statistically, the study gains 
from the conditional process modelling by the PROCESS which enables the 
integration of moderation and/or mediation analysis in multivariable regression 
models and illuminates the processes by which the effect of a predictor is exerted via 
several modifiers on the outcome variable. This method is robust against the 
estimation bias and heteroscedasticity. It also facilitates probing of two and three-
way interactions at different percentiles of the modifiers instead of three fixed points 
(-1SD, mean, 1SD). This ensures the values would not fall outside the range of the 
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data. The application of the Johnson-Neyman technique adds to the analytical depth 
of this procedure by identifying the exact values of the moderator where the 
significant transitions occur in the conditional effect of the predictor on the outcome 
(Hayes, 2012). Another statistical advantage of this research was the implementation 
of multiple imputations to replace the missing data. Multiple imputation is a valid 
method for predicting missing data based on the values of the observed data through 
multiple iterations (Barnes, Lindborg and Seaman Jr, 2006). Using several rounds of 
simulation and pooling the results of these simulations to generate a complete set of 
data increases the accuracy of this method. Despite the limited availability of 
suitable observed donor cases, PMM method performs well under small sample size 
(n≤50) and mild missingness(≤20%) in terms of standardised bias of mean change 
(the difference between the average of parameter estimates across a given number of 
replications and actual population parameter estimate divided by the standard error 
of estimate), coverage rate (the percentage of simulation replications in which the 
confidence interval estimates cover the actual value) and interval width (Barnes, 
Lindborg and Seaman, 2006). 
This study has several limitations too. Relatively small sample size of the study 
affects the statistical power, accuracy and the outcome variance, leading to type II 
errors. The presence of missing data also reduces the analytical power of the study 
as it reduces the proportion of observed values. Even multiple imputation cannot 
capture the actual distribution of the missing values. The non-probability sampling 
method of this research introduces selection and observational bias as the study 
population is not representative of the general population. Although male and female 
sexes had relatively similar representation, white ethnicity was overrepresented. 
Likewise, majority of participants were younger than 50 yr. This may distort the 
interpretation of the results and limit the generalisability of the findings. The cross-
sectional design of this research precludes the assessment of temporality and does 
not allow inferences about the causality of the relationships. Another shortcoming of 
this study is the implication of two-compartment model in the assessment of body 
composition. This model does not differentiate between storage and functional fat, 
involves the assumption of FFM constancy and does not control for interindividual 
variation in hydration status. Additionally, it assumes a constant ratio of mineral to 
protein, leading to inaccurate estimation of FM and FFM in the individuals with 
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compositional characteristics. Hence, the use of BIA method for the assessment of 
total and regional body composition in this study is still subject to estimation bias 
and measurement error despite adherence to calibration and measurement protocols 
and the employment of MF-BIA. In principle, BIA and ADP both provide estimates 
of body composition components based on prediction equations rather than direct 
measurements. Compared to DXA, MF-BIA underestimates body fat in underweight 
or normal-weight and fat-free mass in overweight or obese adults. On the contrary, it 
overestimates fatness in adults with overweight or obesity and underestimates 
leanness in individuals with low BMI (Shafer et al., 2009).  It also does not provide 
direct information about the subcutaneous adipose tissue and ectopic fat. In contrast, 
ADP overestimates body fat in underweight and underestimates it in overweight or 
obese subjects as compared to DXA (Ginde et al., 2005). Employing DXA or 
imaging techniques could have been advantageous for more detailed and accurate 
study of body composition compartments. DXA discriminates among fat, non-
osseous lean and osseous lean compartments.in can also provide estimations of 
visceral and subcutaneous adipose tissue. Despite its reliability and accuracy, this 
method is subject to intra and interlaboratory variation and may overestimate FFM 
depending on the model and manufacturer. The reliability of DXA is also reduced in 
extremes of body composition (Duren et al., 2008). 
Despite satisfactory precision and good level of agreement of spirometric 
measurements by COSMED Quark system, its upper limit of bias for FEV1 and FVC 
goes (±0.5% or 0.050 L) beyond the acceptable accuracy range recommended by the 
ATS/ERS.As the turbine flowmeters are flow and volume-sensitive and may 
underestimate and overestimate PEF and FEV1 at low versus high tidal volumes 
(Jones and Mullee, 1995). The use of a pneumotachograph instead of a turbine 
flowmeter would have improved the accuracy of spirometric measurements. 
With respect to blood pressure measurement, OMRON M7 has been validated as an 
accurate oscillometric SBP and DBP-measuring device for professional and home-
use purposes; however, it has not been validated for research. 
In terms of adjustments for potential confounders, the present research did not 
explore the contribution of other components of lean body mass (body water, protein 
and mineral) to the prediction of lung function and blood pressure. Although a large 
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proportion of participants were educated, moderately active and non-smoker, these 
factors were not used as covariates in the analyses. Although, the participants did 
not have a diagnosed medical condition, the study did not control for diet, alcohol 
consumption, allergy, cardiometabolic and inflammatory biomarkers. The 
assessment of plasma glucose concentration, glycated haemoglobin, lipid profile, 
insulin sensitivity, adipocytokine and CRP level, thyroid function, serum or urinary 
creatinine, serum uric acid and vitamin D status would have provided a more 
comprehensive analysis. Finally, the effect of extreme deviations from the mean 
values of body composition (including, excessive visceral adiposity, morbid obesity, 
high muscularity, under-fatness and  sarcopenia), BP (hypertension or hypotension) , 
grip strength (dynapenia) or spirometric measurements (obstructive, restrictive or 
mixed patterns of respiratory impairment) could not be studied satisfactorily because 
the participants were healthy and young to middle-aged. 
Collectively, this research underscores the crucial role of body composition 
phenotyping in the evaluation of biologic relationships between body organs, 
particularly respiratory and vascular systems. The present findings suggest that 
derangements in whole-body and segmental metabolic homeostasis can have 
deleterious impacts on haemodynamic and respiratory characteristics of otherwise 
healthy adults. 
Integrating total and regional measures of adiposity and muscularity as the 
indicators of metabolic status in the conceptual model of metabolic load-metabolic 
capacity may result in more informative categorisation, more accurate risk 
stratification, more consistent monitoring, more effective care and support, and 
subsequently, more personalised treatment, resulting in lower morbidity, higher 
survival, and better quality of life among individuals at risk or with pulmonary, 
cardiovascular and metabolic disorders. However, this model should be tested in 
large-scale studies on a diverse group of adults with specific clinical conditions to 
establish its implication as an effective strategy for individualising management 
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Appendix C: Participant Information Sheet 
 
 
PARTICIPANT INFORMATION SHEET 
 
Full title of Project: Body composition, lung function, blood pressure, and muscle strength, 
a comparative study. 
 
You are being invited to take part in a research study. Before you decide whether or not to 
take part, it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully. 
 
What is the purpose of the study? 
Fat mass and skeletal muscle mass contribute to the alterations in lung function and blood 
pressure in a variety of conditions. The aim of this project will be to investigate the contribution 
of fat and lean mass regional distributions to respiratory function and blood pressure of 
otherwise healthy adults. Thereby, a solid dataset is provided which could be expanded upon 
further in clinical studies on respiratory, cardiovascular and metabolic diseases. 
 
Why have I been invited to participate? 
You are approached because you meet the age range and are based in the area of London 
where we are conducting the study. We are looking to recruit a total of 100 participants from 
free-living healthy adults to measure a number of parameters such as body fat mass and fat-






Do I have to take part? 
      It is up to you to decide if you like to take part. Refusal to take part will involve no penalty or 
loss of benefits to which you are otherwise entitled. If you do decide to take part, you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to 
take part, you are still free to withdraw at any time and without giving a reason.  
 
What will happen to me if I take part? 
Following agreeing to take part in the study you shall be asked and assisted by a health 
professional to complete a health questionnaire. If you do not meet the requirements of the 
study at this stage, you will not be able to take part. Once you are accepted into the study, 
we shall assess your usual diet and will ask you to complete a physical activity and quality of 
life. Then, we measure your weight and height, as well as waist, hip, and thigh circumferences 
using a tape. Also, we shall take your blood pressure in a sitting position. Later, you will be 
asked to sit in a chair, take a deep breath and breathe out slowly as long as you can into a 
tube attached to a spirometer which assesses your lung function. It is required to repeat this 
manoeuvre for a minimum of three times. After a period of rest, you breathe in fully again but 
then blow out into the device as rapidly as you can, for a minimum of three times. Next, you 
will stand on the base of a body fat scale and hold the hand grips so that your body 
composition can be measured by sending a low, safe electrical current through the body. You 
will then be asked to sit very still in a large egg-shaped two-chamber unit, called BODPOD, 
that uses pressure changes between two chambers to determine your body density and 
thereby estimate your body fat percentage. Required clothing include a close-fitting swimwear 
and a swimming cap. Specific measures are taken into consideration for females. The BOD 
POD door is closed for1 minute to take the measurements, opened for 30 seconds and it is 
repeated one more time. While sitting inside the BODPOD, you can see the professional 
through a window and hear his/her voice. In in the unlikely event that you feel uncomfortable 
you can press the cancel button to terminate the test and exit the BODPOD. 
Lastly, you will have to squeeze a handle which records the maximum force of your grip to 
measure your muscle strength. All procedures are undertaken in the physiology-nutrition lab 
at the science centre of London Metropolitan University by trained professionals. 
 
What are the possible disadvantages and risks of taking part?  
There should be no major risks as this is a body composition and spirometric study, involving 
no testing of new medication. It is expected that this burden would be small. This applies to 
all study instruments, including BIA devices and BODPOD. To minimise inconvenience, we 
shall arrange the date and time of the visit to the Science Centre well in advance. None of the 




What are the possible benefits of taking part? 
By taking part into this study, you will contribute to the development of a composite dataset 
consisted of parameters related to body composition, lung function, blood pressure and 
nutritional status of the adult population which could be used by researchers as a reference 
to predict and possibly improve the clinical outcomes of the patients affected by a wide range 
of chronic diseases. In the meantime, you will have a comprehensive check of your specified 
measures. 
 
Will my data be kept confidential? 
All information collected about you will be kept strictly confidential (subject to legal limitations). 
Access to the data will only be by researchers working on this study. Computer files will be 
password protected and all data, codes and identifying information will be kept in locked filing 
cabinets. The findings generated in the course of the research will be kept securely for a 
period of ten years after the completion of a research project. 
 
What should I do if I want to take part? 
If you would like to take part in this study, you can do so by contacting the researchers at the 
address, phone number or email address given at the end of this information sheet or by 
returning the reply slip in the pre-paid envelope. 
 
What will be the next step if the results (e.g. spirometry test) are abnormal? 
You will be advised by the professional to discuss the results (e.g. impaired lung function) 
with your GP. 
 
What will happen to the results of the research study? 
The results of this research will be published in a scientific journal. Your identity will not be 
recognisable from this. If you would like a copy of the published research you can contact 
the researchers at the address, phone number or email address given below following 




Who is organising and funding the research? 
This study is being conducted by Public Health Nutrition Research Group at London 
Metropolitan University. This research is not funded by any internal or external source. 
 
Who has reviewed the study? 
This research has been approved by the Research Ethics Committee. 
 
Contact for Further Information: 
 
Prof. H David McCarthy 
Institute for Health Research & Policy 










Public Health Nutrition Research Group  
London Metropolitan University 
Holloway Road 
London 











Please tick the box which applies: 
 
 Yes I am interested in participating in this research.  Please contact me on Home 
number………………………Mobile number:……………………. 
 
 No I am not interested in this research 
 
 






















Appendix D: Consent Form 
 
Title of Project:  
Body composition, lung function, blood pressure, and muscle strength, a comparative study 
  
FULL CONSENT FORM FOR ALL ACTIVITIES 
Name of individual (capitals)________________________________ 
 
Please initial each statement to show your agreement 
 
1. I confirm I have read the participant information sheet on the above project and 
have been given a copy to keep.  I have had the opportunity to ask questions about the 
project and I am satisfied with the information that I have been given.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being affected.  
 
3. I agree to undergo the required tests and measurements in the above project. I 
understand that all data will be made anonymous prior to being circulated to other scientists.   
 
4. I agree that the information gathered about me can be kept anonymously for use in 
future projects.  I understand that researchers other than this research team may carry out 
some of these projects, that the results of these investigations are unlikely to have any 




5. I agree to take part in the study and know how to contact the research team if I need 
to. 
Volunteer’s signature ____________________   Date _____________ 
 
I confirm that I have fully explained the nature of this study to the abovenamed volunteer. 
 
Co-ordinator’s signature _________________      Date____________ 
 
 
 
 
 
 
 
 
